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ABSTRACT
THE ROLE OF SUPPRESSOR OF CYTOKINE SIGNALLING 3 IN 
REGULATING TOLL LIKE RECEPTOR-MEDIATED INTESTINAL 
EPITHELIAL HOMEOSTASIS AND REPAIR
Imtiyaz Thagia, MSc
The surface o f the alimentary tract is lined with a single layer o f intestinal epithelial 
cells (IEC) that functions as a barrier between commensal microflora and the 
underlying immune system. Maintenance o f IEC barrier, subsequent to injury or 
physiological damage is essential in maintaining homeostasis. IECs express Toll-like 
receptors (TLR) on their surface which are able to detect microbial ligands such as 
helminth proteins, Poly I:C, lipopolysaccharide and flagellin, recognised by TLR2, 
TLR3, TLR4 and TLR5, respectively. Recent evidence proposes TLR-induced 
inflammatory pathways are vital for mucosal homeostasis with dysregulated repair 
predisposing individuals to inflammatory bowel disease (IBD). In IBD, the expression 
o f suppressor o f cytokine signalling -3 (SOCS3), a negative feedback inhibitor o f 
inflammatory cytokines (TNFa, 1L-6) is enhanced. The aim of this study was to 
investigate the role o f SOCS3 on TLR-induced IEC responses associated with normal 
homeostasis and epithelial repair. SOCS3 over-expressing IEC were developed to 
assess its function on epithelial repair, gene and protein expression in response to 
microbial stimulation. Our results support previous data implicating TLR ligands 
being imperative for repair of damaged epithelial surfaces, and highlight a pivotal role 
o f SOCS3 in mediating TLR-induced epithelial repair. Our results then go onto 
indicate over-expression o f SOCS3 in IBD may perpetuate inflammation by promoting 
the production o f pro-inflammatory TNFa in response to commensal microflora. In the 
final part o f this study we show IEC become tolerant to commensal flora, protecting
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against incessant immune activation by commensals. In conclusion, these studies give 
credit to the hypothesis that SOCS3 influences microbial-induced IEC responses 
associated with normal homeostasis and epithelial repair. Furthermore, our data 
indicates SOCS3 expression must be tightly regulated permitting TLR-induced 
epithelial repair. The findings presented within this study offer a strong foundation for 
future in vivo studies on how SOCS3 impacts on intestinal disease.
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1.1 The human digestive system
1.1.1 Overview of the human digestive system
The human digestive system is composed o f two groups o f organs; these are the 
gastrointestinal (GI) tract and the accessory organs. The GI tract or alimentary canal is 
a continuous tube that extends from the mouth to the anus through the thoracic and 
abdomino-pelvic cavities measuring between 5-7 metres in length. The organs o f the 
GI tract include the mouth, oesophagus, stomach and both the small and large 
intestines. The accessory digestive organs include the teeth, tongue, salivary glands, 
liver, pancreas and gallbladder. Teeth aid in the mechanical breakdown o f food, while 
the tongue facilitates with chewing and swallowing. The remainder o f the accessory 
organs do not come into direct contact with food, but produce or store secretions 
aiding the chemical breakdown of food (Snell 2003).
The GI tract contains food from the time it is ingested until it is digested and 
absorbed or eliminated from the body. Muscular contractions o f the wall o f the GI 
tract physically breakdown food by churning and propelling food from the oesophagus 
to the anus. Additionally, the contractions also help to breakdown food by mixing it 
with fluids secreted into the tract. Food is also chemically broken down by enzymes 
secreted by the accessory digestive organs and cells lining the GI tract (Snell 2003). 
Organic substrates, electrolytes (inorganic ions), vitamins and water are absorbed by 
epithelial cells lining the lumen of the GI tract, which subsequently pass into blood or 
lymph and circulate to cells throughout the body. The digestive tract and glandular 
organs discharge waste products into the lumen of the GI tract, which after mixing 
with the indigestible residues, are eliminated from the body (Martini 2006).
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1.1.2 Anatomy of the colon
The colon is the concluding section of the vertebrate digestive system measuring 
approximately 1.5 metres in length, 0.1 metres in diameter, and constituting almost 
one-fifth o f  the entire alimentary canal. The caecum operates as a valve connecting 
and permitting the passage of processed material between the small intestine and the 
colon. In humans, the colon is composed of four key segments; these are: the 
ascending colon, the transverse colon, the descending colon and finally, the sigmoid 
colon. The rectum is located at the end of the colon and faeces are stored here before 
they are eliminated from the body. Collectively, both the colon and the rectum are 
referred to as the large bowel; but they are more commonly denoted as the large 
intestine or the gut (Snell 2003).
Transverse colon 
—  Ascending colon
Descending colon — -
'  I mJ &
Cecum |
Sigmoid colon
Anatomy of the human colon, composed of four segments: the 







1.1.3 M icroanatomy o f the colon
The microanatomy of the colon is similar to that o f other structures within the 
digestive tract. Visualizing the layers of the gut radially inwards these are the:
■ Serosa -  or adventitia, the outermost layer of the colon. It is constructed from 
loose connective tissue coated with mucus to thwart friction damage and 
abrasion from other tissues and organs.
■ Muscularis extema -  comprising of an inner circular layer and an outer 
longitudinal layer o f smooth muscle. Both groups o f muscle work 
simultaneously to create a wavelike motion (peristalsis) moving waste material 
along the colon.
■ Submucosa -  comprising collagen and elastic fibers, this layer provides 
increased capacity and stretching for peristalsis. Blood, lymphatic vessels and 
nerves also form part of the submucosa.
■ Mucosa -  the inner most layer comprising the glandular epithelium, lamina 
propria, and the muscularis mucosae. The glandular epithelium forms tubular 
structures, called crypts. The lamina propria supports the epithelium and 
comprises reticular connective tissue with elastic and collagen fibers, plasma 
cells, lymphocytes, granulocytes, as well as lymphatics and capillaries. The 
muscularis mucosae consist of a thin layer o f smooth muscle between the 
mucosa and the submucosa (Feldman, Friedman et al. 2010).
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1.1.4 Differentiation o f intestinal epithelial stem cells
The luminal surface of the intestine is lined by a simple columnar epithelium, 
folded into a number of deep cavities or crypts of Lieberkiihn, and embedded in 
connective tissue. In healthy adults, colorectal epithelial cells undergo continual rapid 
renewal where cell loss is precisely balanced with cell proliferation (Kirkland and 
Henderson 2001; Potten, Booth et al. 2003). The continuous supply of new cells 















Figure 1-2 Intestinal epithelial stem cells become increasingly differentiated while 
migrating along the vertical axis of the crypt (Chell, Kadi et al. 2006)
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These cells undergo a stringent programme of proliferation and differentiation as 
they migrate from the base o f the crypt to the luminal surface yielding three epithelial 
lineages:
■ Goblet cells -  flat shaped cells that produce mucin protecting the epithelial 
surface and facilitating movement o f food along the GI tract.
■ Enteroendocrine cells -  located in the intestinal crypt comprising -1 %  o f the 
epithelial cell population. There are at least 15 subtypes, each secreting several 
peptide hormones which regulate the physiological and homeostatic functions 
o f the GI tract.
■ Absorptive cells -  also called colonocytes. These cells form the majority o f the 
intestinal epithelium. A microvillus brush border develops along the apical 
surface as the cells differentiate along the upper crypt increasing the surface 
area across which molecules and ions can be rapidly transported (Potten, Booth 
et al. 2003; Moran, Leslie et al. 2008; Stemini, Anselmi et al. 2008).
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1.1.5 Organisation o f intestinal tissue
The entire surface o f the colon is lined with a single layer o f intestinal epithelial 
cells (IEC) that form intracellular tight junctions, preventing macromolecules and 
microbes from passing transversely across while guarding against opportunistic 
infections and pathogens. The immune system of the digestive tract is often referred to 
as the gut-associated lymphoid tissue (GALT) functioning to protect the body from 
invading organisms (Mayer 2000). The GALT is the largest collection o f lymphoid 
tissues in the human body, due to the vast numbers o f lymphoid and quantities of 
immunoglobulins produced. This is principally due to the colossal antigen load to 
which these cells are continually exposed to (Mayer 2000; Chehade and Mayer 2005; 
Forchielli and Walker 2005). GALT comprises o f organised lymphoid tissues, such as 
mesenteric lymph nodes (MLN), Peyer’s patches (PP); and more diffusely dispersed 
lymphocytes in the crypt region of the intestinal lamina propria (Forchielli and Walker 
2005).
Figure 1-3 indicates that despite the epithelial surface, some bacteria are able to 
penetrate the IEC directly (1), whereas others use M (microfold) cells, which are 
positioned over lymphatic aggregates to contravene the barrier (2). Another newly 
discovered route o f Tuminal sampling’ uses uptake by dendritic cell (DC) projections 

















Figure 1-3 Diagram showing the mucosal layer of the colon, comprising the 
epithelium and the underlying lamina propria (Gewirtz and Madara 2001)
DCs express tight junction proteins such as claudin 1, occludin and zonula 
occludens 1, allowing them to send dendrites outside the epithelium by opening tight 
junctions, while maintaining epithelium integrity. These DCs are then able to acquire, 
process, and exhibit antigens present within the lumen (Rescigno, Rotta et al. 2001; 
Rescigno, Urbano et al. 2001).
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1.1.6 The role o f commensal flora in maintaining colonic physiology
Traditionally the function o f the colon is to reclaim water and salts before they 
are eliminated from the body. By this phase o f the digestive process approximately 
90% o f water is reclaimed by the colon, leaving 1.5-2L in the faeces (Harrell and 
Chang 2006). However, over recent decades the importance o f the colon as a home to 
diverse microflora has been revealed. Commensal microflora has evolved making the 
colon a natural habitat with mutual benefits to both themselves and the host. The 
intestinal habitat o f a healthy adult harbours between 300-500 distinctive species of 
microflora; with species varying between individuals (Guamer and Malagelada 2003; 
Fava and Danese 2011). Prevalent genera o f commensals within the colon include 
Bacteroides, Bifidobacterium , Clostridium and Eubacterium. Whereas aerobes such as 
Enterobacter, Enterococcus, Klebsiella, Escherichia and Lactobacillus are among the 
subdominant genera (Pirzer, Schonhaar et al. 1991; Macpherson, Khoo et al. 1996; 
Guamer and Malagelada 2003). The number o f microbial cells within the gut lumen is 
about 10 times greater than the number o f eukaryotic cells in the entire human body 
(Bengmark 1998). The highest concentrations o f genera found in the lumen are similar 
to those found in colonies growing under optimal conditions over the surface o f 
laboratory plates, with concentrations peaking at 10n -1012 flora per gram o f luminal 
content (Guarner and Malagelada 2003; Abreu, Fukata et al. 2005). Almost 60% of 
faecal solid is comprised o f bacteria (Stephen and Cummings 1980). Fluctuations in 
the composition o f flora can be seen in cases o f acute diarrheal illness, antibiotic 
treatment and to a lesser extent dietary interventions, however; an individual’s flora 
composition usually remains stable (Brandtzaeg, Halstensen et al. 1989; Pirzer, 
Schonhaar et al. 1991; Guarner and Malagelada 2003).
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The traditional function o f the colonic microflora is the fermentation o f non- 
digestible dietary deposits and endogenous mucus. Examples o f such residues include 
large polysaccharides such as starch, pectin, cellulose and hemicelluloses (Cummings, 
Pomare et al. 1987). Oligosaccharides which have evaded the digestive process and 
unabsorbed alcohols and sugars are also exploited by gut flora. The outcome is the 
fabrication o f short-chain fatty acids which can be utilised by IEC (Guamer and 
Malagelada 2003; Cummings, Beatty et al. 2007). Putrefaction o f proteins and 
peptides by gut flora also generate short-chain fatty acids. Potential sources o f 
peptides include collagen and elastin from dietary sources, sloughed epithelial cells, 
lysed bacteria and enzymes. A drawback to this process is the generation o f a series of 
potentially toxic thiols, phenols, indols, ammonia, and amines all o f which are 
generally absorbed by gut flora (Macfarlane, Cummings et al. 1986; Smith and 
Macfarlane 1996). The overall outcome o f these processes is the reclamation of 
absorbable substrates and energy for the host, and a source o f energy and nutrients for 
microflora. The symbiotic relationship provides approximately 100 calories o f energy 
per day to the host (Smith and Macfarlane 1996; Guarner and Malagelada 2003; 
Munkholm 2003; Salminen, Bouley et al. 2007). Less traditional critical functions o f 











Figure 1-4 Fermentation within the colon (Guarner and Malagelada 2003)
The use o f antibiotics is shown to upset the ecological balance and permit the 
excessive growth of the commensal Clostridium difficile (C. difficile), a species with 
potential pathogenicity linked to pseudomembranous colitis (Waaij 1989). In vitro 
studies have shown that commensal flora compete with each other for attachment sites 
in the brush border o f IEC, preventing the attachment and subsequent invasion of 
pathogenic enteroinvasive bacteria (Bemet, Brassart et al. 1994). Additionally, these 
non-pathogenic floras compete for nutrient availability in ecological niches, limiting 
nutrient availability for pathogenic bacteria. Lastly, flora can also limit the growth o f 
pathogenic bacteria by secreting antimicrobial substances termed bacteriocins (Lievin, 
Peiffer et al. 2000; Guarner and Malagelada 2003; Manco, Putignani et al. 2010). The 
immune system is not ignorant to microflora, the secretion o f antibodies such as
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immunoglobulin A (IgA) and T-cells are capable o f interacting with our colonic 
microflora, limiting bacteria associating with the epithelium and penetration o f host 
tissue (Macpherson, Gatto et al. 2000; Macpherson, Geuking et al. 2005). These 
processes occur through a variety o f highly conserved innate immune receptors 
( 1.2 . 1).
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1.2 Interaction between intestinal epithelial cells and gut 
microbiota
1.2.1 Toll-like receptors and Toll-like receptor signalling
The intestinal immune system is highly evolved as its duel function protects the 
host from pathogenic organisms which could potentially cause infection, as well as 
coexistence with myriad commensal organisms. Studies have verified that microflora 
have an influential role in the preservation o f IEC homeostasis and that the host is able 
to recognise and respond to luminal flora (Lee, Mo et al. 2006; McCole and Barrett 
2007; Artis 2008). Mice bred in a germ-free environment display a decline in IEC 
proliferation in comparison to mice which have been colonised with conventional flora 
(Guamer and Malagelada 2003). Other studies demonstrate smaller specialised follicle 
structures, lower densities o f lymphoid cells, and depleted levels o f immunoglobulin 
within germ-free animal blood (Alam, Midtvedt et al. 1994; Abreu, Fukata et al.
2005).
Numerous papers have publicised that humans express pattern recognition 
receptors (PRRs) that recognise microbe-associated molecular patterns (MAMPs), 
especially those from pathogens, regulating the activation o f both innate and adaptive 
immune responses (Akira, Yamamoto et al. 2003; Takeda, Kaisho et al. 2003; Takeda 
and Akira 2004; Beutler 2009). Cross-talk between commensal microflora and the host 
is mediated by Toll-like receptors (TLRs) (Abreu, Fukata et al. 2005; Abreu 2010; 
Brown, Wang et al. 2011). TLRs are a cohort o f single membrane spanning protein 
receptors that together with the interleukin-1 receptor form a receptor superfamily, 
known as the ‘interleukin-1 receptor/Toll-like receptor superfamily’; but they are 
generally identified as Toll-IL-1 receptors (TIR) (Kluwe, Mencin et al. 2009).
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The link between TLRs and innate immunity was first identified in Drosophila. 
TLRs were initially recognised and classified as transmembrane receptors requisite for 
the establishment o f dorso-ventral polarity in the developing embryo (Hashimoto, 
Hudson et al. 1988). Toll signalling in Drosophila displayed notable resemblance to 
the mammalian interleukin-1 (IL-1) signalling pathway, triggering the transcription of 
nuclear factor kappa-1 ight-chain-enhancer of activated B cells (NF-^B), responsible for 
many features o f inflammatory and immune responses (Belvin and Anderson 1996). 
Based on these parallels, it was suggested that TLR-mediated pathways could 
potentially be implicated in regulating immune responses. This was evidently 
confirmed in mutant Drosophila deficient in distinct components o f the TLR signalling 
pathway. Mutant flies were found to be highly susceptible to fungal infection as they 
were unable to express drosomycin, an anti-fungal peptide (Lemaitre, Nicolas et al. 
1996).
TLRs are highly conserved from Drosophila to humans, both sharing analogous 
structural and functional patterns. They are structurally characterised by the presence 
o f a leucine-rich repeat (LRR) domain in their extracellular domain and a TIR domain 
in their intracellular domain (Rock, Hardiman et al. 1998). The LRR domain is 
separated from the transmembrane region by a carboxy-terminal domain. The TIR 
domain which spans about 200 amino acids, has contrasting degrees o f similarity 
among TLRs and is required for intracellular signalling (Akira, Yamamoto et al. 2003; 
Kawai and Akira 2009). TLRs contain three box sequences which are highly 
conserved among family members. Box 1 is believed to be the conserved sequence 
among all TLRs, whereas both boxes 2 and 3 contain amino acids essential for 
signalling (Carpenter and O'Neill 2007).
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TLRs are among the most investigated and described PRR, due to their ability to 
detect a variety o f pathogen associated molecular patterns (PAMPs). To date, 10 TLRs 
have been identified in humans, with each TLR having a specific set o f detectable 
ligands (Kawai and Akira 2007; Kumar, Kawai et al. 2009). The existence o f a large 
number o f TLRs enables the innate immune system to differentiate between PAMPs 
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Figure 1-5 TLRs are involved in the recognition o f microbial molecular patterns. 
Following the specific recognition of a microbial ligand by TLRs, various adaptor 
molecules are recruited to the TLR. This leads to the activation o f signalling pathways, 
the transcription o f inflammatory genes and the regulation o f innate and adaptive 
immune responses. Adapted from (Zhu and Mohan 2010)
Although each TLR detects specific ligands, many of the signalling pathways 
that mediate intracellular responses are shared by most TLRs. For example, all TLRs 
signal through one or two adaptor molecules, myeloid differentiation factor 88 
(MyD88) and TIR domain-containing adaptor-inducing interferon-p (TRIF). MyD88
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is part o f the signalling cascade o f all TLRs except TLR3, whereas TRIF only interacts 
with TLR3 and TLR4 (Kluwe, Mencin et al. 2009; Zhu and Mohan 2010; Brown, 
Wang et al. 2011; Lin, Li et al. 2011).
One o f the best described TLR signalling pathways is that o f the interaction o f 
TLR4 with its corresponding ligand lipopolysaccharide (LPS), an outer cell wall 
constituent o f Gram-negative bacteria (Takeuchi, Hoshino et al. 1999; Takeda and 
Akira 2004). Binding results in the conscription o f the adaptor signalling molecule 
MyD88 and TRIF within the cytoplasm o f the cell. The MyD88 adaptor molecule is 
then able to activate other molecules within the cell including protein kinases thus 
propagating the initial signal. Protein kinase IL-1 receptor-associated kinase (IRAK) is 
activated and phosphorylated by MyD88. This is then followed by the recruitment and 
activation o f TRAF6 [TNF (tumour necrosis factor) receptor-associated factor 6] 
(Buer and Balling 2003; Abreu, Fukata et al. 2005). Once the TRAF6 pathway has 
been activated; the MAPK (mitogen-activated protein kinase) pathway is also 
activated due to an evolutionary conserved signalling intermediate within the TLR 
signalling pathway (Abreu, Fukata et al. 2005).
The upshot o f this is the amplification o f the initial signal and ultimately the 
stimulation or suppression of genes that coordinate the inflammatory response (Buer 
and Balling 2003). Activation of TLR4, and other TLRs lead to the transcription o f a 
number o f pro-inflammatory cytokines such as IL-6, IL-8, IL-22 and tumour necrosis 
factor a  (TNFa) (Zhu and Mohan 2010). TLR4 has also been shown to induce cyclo- 
oxygenase-2 (COX-2) and prostaglandin E2 (PGE2) in both vitro and vivo studies; both 
being imperative for apoptosis and proliferation in response to intestinal mucosal 
injury (Fukata and Abreu 2007).
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As illustrated in Figure 1-5, the mechanism by which TLR5 propagates its signal 
is similar to that o f TLR4, but unlike TLR4, TLR5 does not require TRIF as an 
intracellular adaptor molecule to disseminate its signal (Kluwe, Mencin et al. 2009). 
Ligation o f TLR5 also consequents in the activation of NF-*B, driving the expression 
o f numerous pro-inflammatory genes, such as neutrophil chemo-attractant IL-8, thus 
functioning to protect the cell (Vijay-Kumar, Aitken et al. 2008; Kluwe, Mencin et al.
2009).
TLR3 ligates with double stranded ribonucleic acid (dsRNA) and recruits its sole 
cytosolic adaptor molecule TRIF, initiating downstream signalling (Hoebe, Du et al. 
2003; Leonard, Ghirlando et al. 2008). Subsequently, the transcription factors NF-*B 
and interferon regulatory factor (IRF)-3 are activated and induce the secretion o f 
interferon-p (IFN-p), as well as a number o f other inflammatory cytokines (Leonard, 
Ghirlando et al. 2008).
TLR2 appears to be capable of distinguishing a significant range o f microbes. 
This is somewhat due to its ability to form hetrodimers with TLR1 and TLR6. TLR2 
and TLR6 activate downstream effector molecules similar to the previously mentioned 
TLRs (Kawai and Akira 2007; Zhu and Mohan 2010). TLR27' and TLR6'7' mice are 
shown to have reduced levels o f IL-lp, TNFa and transforming growth factor-p (TGF- 
P), but elevated levels o f IL-4 and IL-6 in response to Mycobacterium tuberculosis (M. 
tuberculosis) (Sugawara, Yamada et al. 2003).
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1.2.2 TLR ligands
IEC express a cohort o f PRRs, termed TLRs, which are able to communicate and 
respond to microbes, such as bacteria, viruses, parasites and their structural 
constituents (Kawai and Akira 2007; Kumar, Kawai et al. 2009). For the purposes o f 
this study I shall be focusing on TLR2, TLR3, TLR4, TLR5 and TLR6 as these are the 
TLRs which are imperative for bacterial, viral and helminth detection.
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1.2.2.1 TLR4 signalling
Bacteria are a large cohort o f unicellular microorganisms typically a few 
micrometres in length. They can exist as different shapes from spheres (coccus) and 
rods (bacillus) to spirals. Escherichia .coli (E. coli) is a Gram-negative bacterium that 
is commonly found within the colon. Most strains o f this bacterium are harmless; but 
some strains can cause critical food-poisoning within humans such as 0157:H7 
(Simon and Gorbach 1984; Borriello, Welch et al. 1988). The innocuous strains form a 
constitute o f the normal gut flora and can aid the host by yielding vitamin K, or by 
occupying a niche thus averting the establishment of pathogenic bacteria within the 
colon (Prescott, Harley et al. 2002).
LPS is a large molecule formed from a lipid and a polysaccharide joined by a 
covalent bond, located on the outer membrane o f Gram-negative bacteria. LPS is 
fundamental to the bacterium because it protects and helps stabilise the membrane 
structure (Prescott, Harley et al. 2002). However, LPS is also an endotoxin to humans 
as binding to TLR4 promotes the secretion o f pro-inflammatory cytokines in many cell 














Figure 1-6 Cell membrane of a Gram-negative bacterium. The cell wall is 
composed o f two main structures: the internal membrane (cytoplasmic membrane) and 
the outer membrane. A thin peptidogylcan cell wall and a periplasmic space that 
contains substrate-binding enzymes separate the two membranes. (Prescott, Harley et 
al. 2002)
As well as detecting LPS. TLR4 is also able to detect a number o f other 
endogenous ligands such as High-mobility group protein B1 (HMGB1), fibronectin, 
hyaluronic acid fragments, antiphospholipid fragments and saturised fatty acids (Seki, 
Tsutsui et al. 2005)
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1.2.2.2 TLR5 signalling
Salmonella enterica (S. enterica) is a rod shaped flagellated, aerobic Gram- 
negative bacterium which has more than 2000 serovars or strains (Prescott, Harley et 
al. 2002). One o f these is Salmonella typhimurium (S. typhimurium), which can cause 
gastroenteritis within humans. This is caused by inflammation within the 
gastrointestinal tract and results in acute diarrhoea. Inept treatment of gastroenteritis 
kills between 5 to 8 million people world-wide each year, and is the principal cause of 
death among children under five (Simon and Gorbach 1984; Borriello, Welch et al. 
1988).
The bacterial flagellum is composed o f a filament that is attached to a molecular 
base (the basal body and hook complex). Flagellin, a protein with a mass o f between
30,000 and 60,000 daltons, arranges itself into a hollow cylinder to form the filament 
in the bacterial flagellum (Samatey, Imada et al. 2001; Smith, Andersen-Nissen et al. 
2003; Yonekura, Maki-Yonekura et al. 2003). The correct assembly o f the flagella 















Figure 1-7 The bacterial flagellum consists of three parts, the basal body (within 
the cell envelope), the hook (blue) and the filament (yellow) constructed from multiple 
subunits o f flagellin, the TLR5 ligand (Beatson, Minamino et al. 2006)
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1.2.2.3 TLR3 signalling
Numerous studies have shown that TLR3 is implicated in the recognition o f viral 
dsRNA, produced during the replication cycle o f viruses (Kawai and Akira 2007; 
Beutler 2009). Rotavirus is a member o f the Reoviridae family, type III viruses that 
are characterised by their dsRNA (Arias, Isa et al. 2002). Rotavirus is highly 
pathological as it causes severe gastroenteritis, leading to an estimated 600, 000 to
870,000 deaths in young children every year in developing countries (Morris and Estes 
2001; Arias, Isa et al. 2002). Rotavirus evades host immune responses resulting in 
altering the functional activity o f IEC, leading to diarrhoea, generally considered to be 
linked to enterocyte obliteration (Rollo, Kumar et al. 1999). Zhou and colleagues 
(2007) have shown that genomic dsRNA from rotavirus, and its synthetic analogue 
polyinosinic:polycytidylic acid (Poly I:C), provokes severe mucosal damage o f the 
small intestine (Zhou, Wei et al. 2007). Ligation o f TLR3 expressing IEC with dsRNA 
are also shown to upregulate the secretion o f IL-15, causing an increase in intestinal 
epithelial lymphocytes (IELs) and augmenting the cytotoxicity o f IELs (Zhou, Wei et 
al. 2007). TLR3-deficient mice are shown to have a limited response to synthetic Poly 
I:C (Alexopoulou, Holt et al. 2001). These results imply that as well as dsRNA, its 
synthetic analogue poly I: C is able to cause a breakdown o f mucosal homeostasis 
when ligating with its complementary receptor TLR3.
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1.2.3.4 TLR2/6 signalling
Gastrointestinal nematode parasites cause some of the most prevalent human 
diseases world-wide. Infections tend to be chronic, with high rates o f reinfection after 
drug treatment. Trichuris trichiura (T. trichiura), the human whipworm currently 
infects more than 1 billion people globally (De Silva, Chan et al. 1997). Most o f our 
current understanding o f immune-regulatory mechanisms underlying resistance or 
susceptibility to T. trichiura infection has come from the laboratory Trichuris muris 
(T. muris), a parasite mouse model as both share similar cross-reactive antigens (Else 
and deSchoolmeester 2003). The parasite generally lives partially buried within the 
epithelium o f the large intestine, forming syncytial tunnels through which they move 
and feed. T. muris excretory/secretory proteins (ES) form a heterogeneous solution o f 
worm proteins containing substances that are shown to express structures bearing 
mannose and jV-acetylglucosamine residues; products recognised by colonic epithelial 
TLR (TLR2, TLR4 and TLR6) (deSchoolmeester, Martinez-Pomares et al. 2009). 
TLR2 is involved in the recognition o f a diverse array o f microbial molecules, 
representative o f a broad group of species such as Gram-positive and Gram-negative 
bacteria, as well as yeast and mycoplasma. TLR2 is able to recognise a number of 
components such as lipoteichoic acid, lipoprotein and peptidoglycan, all cell-wall 
components o f gram-positive bacteria as well as lipoarabinomannan from 
mycobacteria and zymosan from yeast (Takeuchi, Hoshino et al. 1999; Ozinsky, 
Underhill et al. 2000; Morr, Takeuchi et al. 2002). Unlike other TLR, TLR2 is able to 
form hetrodimers with TLR1 and TLR6 expanding the ligand spectrum enabling the 
innate immune system to identify diverse structures present in various pathogens 
(Farhat, Riekenberg et al. 2008).
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Numerous studies have demonstrated exposure to helminths prevent 2.4,6- 
trinitrobenzene sulfonic acid (TNBS)-type colitis (Khan et al., 2002; Elliot et al., 
2003; Moreels et al., 2004); suggesting helminth products promote mucosal healing in 
animal models o f colitis. Other studies have shown after exposure to T. muris, some 
mice strains expel the parasite and develop resistance (e.g. BALB/c and BALB/k). 
Whereas, other strains o f mice fail to expel the parasite permitting chronic infection. 
Numerous studies have also indicated resistance or susceptibility to T. muris is 
dependent upon T-helper 2 (Th2) and Thl immune responses, respectively (Else, 
Hultner et al. 1992; Else, Finkelman et al. 1994; Helmby, Takeda et al. 2001).
Mice infected with T. muris also display a profound increase in the rate o f 
epithelial cell turnover, termed ‘epithelial escalator’ during parasite expulsion (Cliffe, 
Humphreys et al. 2005). One study showed an almost doubling o f IEC proliferation, 
whereas only an insignificant elevation in IEC proliferation in mice which did not 
expel the parasite. This was most notable in IL-13'7' mice, which did not expel the 
parasite displaying a reduced rate of IEC turnover, similar levels to those observed in 
naturally susceptible wild-type mice (Bancroft, Artis et al. 2000). The expression of 
IFN-y produced in mice which do not naturally expel the parasites and initiate a Thl 
response acts not only to counter-regulate the potential protective Th2 response, but 
through the induction o f C-X-C m otif chemokine 10 (CXCL10), slows the turnover of 
IEC. In vitro studies have shown blocking CXCL10 increases IEC turnover rate, 
causing worm expulsion without altering the current Thl cytokine response generally 
observed in susceptible mice (Cliffe, Humphreys et al. 2005).
Studies have also shown IL-4, IL-9 and IL-13 all play an important role in 
parasite expulsion (Bancroft, McKenzie et al. 1998; Bancroft, Artis et al. 2000), 
whereas IFN-y is associated with chronic infection (Lee, Wakelin et al. 1983; Else,
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Finkelman et al. 1994). In vivo studies have shown that obstruction o f TNFa in normal 
resistant mice significantly delays worm expulsion for the duration o f treatment. 
Furthermore, knockdown of the TNFa receptor in mice does not allow parasite 
expulsion, initiating a predominant Thl response, indicating lack o f TNF signalling 
considerably modifies the phenotype o f the response (Artis, Humphreys et al. 1999).
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1.2.3 Establishment o f gut microbiota
All organs within the human body undertake a remarkable transition at birth, 
from an isolated intra-uterine environment to the drastically distinctive environment o f 
the outside world. This is also observed in the GI tract o f a foetus where up until birth, 
the GI tract is sterile. However, upon delivery and swiftly thereafter, there is a rapid 
transition to primary colonisation o f the neonatal GI tract, posing a critical challenge 
to the immune system o f the newborn. Studies have shown that the gut can be 
colonised by as much as 108 to 1010 bacteria per gram of faeces within the first few 
days o f birth (Bettelheim, Breadon et al. 1974; Bezirtzoglou 1997; Fanaro, Chierici et 
al. 2003). The GI tract is initially colonised by facultative aerobes. But after 
consuming all the oxygen, these bacteria create an anaerobic environment making it a 
favourable environment for strict anaerobic species, generally belonging to the 
Clostridium, Bacteroides and Bifidobacterium generas. As these anaerobes multiply, 
the facultative bacteria are no longer able to tolerate the environmental changes and 
consequently, decline in number (Adlerberth and Wold 2009; O'Toole and Claesson
2010). Studies have shown children born by vaginal delivery have higher levels of 
Bifidobacteria and lower levels of C. difficile compared to infants born by caesarean 
section (Grolund, Lehtonen et al. 1999; Penders, Thijs et al. 2006). Studies have also 
shown hospitalisation and prematurity are associated with increased counts o f C. 
difficile (Penders, Thijs et al. 2006). Other factors which influence the composition o f 
intestinal microbiota in neonates are modes o f infant feeding and hygiene measures 
(Orrhage and Nord 1999). The microbiota o f breast-fed children are dominated by 
Bifidobacteria, perhaps due to the presence o f Bifidobacteria growth factors in breast 
milk (Coppa, Bruni et al. 2004; Morelli 2008). Infants also have significantly lower 
levels o f C. difficile, E. coli, B. fragilis group species, and Lactobacilli than formula-
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fed infants (Penders, Thijs et al. 2006). However, after introduction o f solid foods and 
weaning, the microflora o f breast-fed infants become comparable to that o f formula 
fed infants (Penders, Thijs et al. 2006; Manco, Putignani et al. 2010).
Given the limited exposure to antigens in utero, the infant to a significant extent 
must depend upon the innate immune system for protection, as the innate immune 
system can direct the adaptive immune response (Janeway Jr and Medzhitov 2002; 
Firth, Shewen et al. 2005; Levy 2007). The GI tract o f the foetus and newborn also 
express TLRs on their IEC surface to detect the presence o f microbial components 
(Imler and Hoffmann 2001; Akira, Yamamoto et al. 2003; Doyle and O ’Neill 2006). 
Human small IEC are known to express basolateral TLR2 and TLR4 at 18 to 21 weeks 
after gestation (Fusunyan, Nanthakumar et al. 2001). Other studies have shown 
human and mouse tissue cultured foetal IEC express TLR4 and MyD88, with elevated 
NF-*B activation and production o f CXCL8 in comparison to adult IEC 
(Nanthakumar, Fusunyan et al. 2000; Lotz, Giitle et al. 2006). The robust 
inflammatory response to LPS could cause a significant risk after birth, when the 
newborn is rapidly being colonised by micro flora (Fanaro, Chierici et al. 2003; 
Penders, Thijs et al. 2006).
Exposure o f perinatal IEC to LPS has been shown to result in the loss o f IEC 
responsiveness to LPS. This was linked to down regulation in the expression o f 
IRAKI, a crucial intermediate of TLR4 signalling (Lotz, Giitle et al. 2006). Mice 
which were delivered vaginally, in comparison to caesarean mice, were more exposed 
to the mother’s microflora and quickly became unresponsive to LPS by down 
regulating the signal transduction protein IRAKI. However, mice which were 
delivered via caesarean and therefore had no previous exposure to gut flora, were 
shown not to downregulate IRAKI and remained responsive to LPS (Chassin, Kocur
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et al. 2010). The authors o f this study showed that the regulation o f IRAKI is 
mediated by microRNA mIR-146a, which is itself upregulated in response to LPS. 
This suggests upregulation o f mIR-146a in neonates is fundamental for protecting the 
gut from mucosal damage after induction o f large concentrations o f LPS when the gut 
becomes colonised. (Chassin, Kocur et al. 2010).
The developmental expression o f TLR4 in neonates is o f great importance as 
this may lead to necrotizing enterocolitis (NEC), an intestinal disease that ensues in 
preterm newborns (Jilling, Simon et al. 2006; Lin and Stoll 2006). Failure o f preterm 
neonates to correctly downregulate responses to LPS appears to significantly 
contribute to neonates susceptibility to NEC. Neonatal intestinal immunity can be 
radically altered by breastfeeding. It has been suggested that breast-milk helps mediate 
intestinal immunomodulation permitting sub-clinical infections that progressively 
inspires immunological memory while limiting inflammation (Newburg 2005; 
Newburg and Walker 2007). Human breast-milk also contains factors which influence 
TLR signalling, such as soluble TLR2, acting as a decoy receptor, competitively 
inhibiting signalling through membrane bound TLR2 (LeBouder, Rey-Nores et al. 
2003).
The innate immune system in newborns is highly immature, which results in 
increased susceptibility to numerous infections. However, the immune system o f the 
gut does allow the colonisation o f microflora building up tolerance and establishment 
o f mucosal homeostasis. Mechanisms by which IEC develop tolerance will be 
investigated in chapter 6.
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1.2.4 Oral tolerance
Miscellaneous interactions between the epithelium, GALT and microflora are 
implicated in sculpting the memory mechanism o f systematic immunity. Following 
antigen feeding, systematic administration o f the same antigen results in a reduced 
inflammatory response compared with unfed, control mice. This occurrence has been 
termed ‘oral tolerance’ (Higgins and Weiner 1988; Chen, Kuchroo et al. 1994). 
Microflora have also been implicated in oral tolerance, as this effect persists for 
several months in mice with conventional flora, whereas in germ-free mice systematic 
unresponsiveness persists for only a few days after ingesting the same antigen 
(Moreau and Gaboriau-Routhiau 1996). Germ-free mice orally administered with 
ovalbumin (OVA) as a tolerogen, before a systematic dose with OVA, show an 
abrogated Thl mediated immune response such as reduction o f IgG2a and IFN->>, 
while the Th2-mediated immune response is maintained generating IgE, IgGl and IL- 
4 against OVA. This aberration can be remedied after colonisation with conventional 
flora, such as Bifidobacterium , one of the predominant intestinal floras. This restores 
the susceptibility o f these Th2 responses to oral tolerance induction, but the process is 
only effective when such reconstitutions are performed in neonates, not in mice o f an 
older age (Sudo, Sawamura et al. 1997; Guamer and Malagelada 2003). The results 
from this study indicate intestinal microflora play a fundamental role in generating a 
Th2 immune response, and are altogether quite susceptible to the induction o f oral 
tolerance, perhaps influencing development o f the immune system at the neonatal 
stage.
Endotoxin shock is often a fatal consequence o f bacterial infection, that may 
occur when LPS enters the blood stream (bacteremia), causing a systemic
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inflammatory reaction. However, some studies have shown that moderate 
concentrations o f LPS do not induce TLR4-mediated responses in several human IEC 
lines such as HT-29, Caco-2 and NCM460 (Rakoff-Nahoum, Paglino et al. 2004; 
Rhee, Keates et al. 2004; Rhee, Kim et al. 2006), indicating IEC are able to tolerate 
higher exposure levels o f LPS than many other cell types. Potential mechanisms of 
this hyporesponsiveness include studies suggesting mouse intestinal crypt epithelial 
mICci2 cells harbour TLR4 at the golgi apparatus rather than at the cell surface. This 
consequently means LPS has to be internalised before the signal can be propagated, 
therefore receptors are shielded from direct interaction with the immense levels o f LPS 
within the lumen (Homef, Normark et al. 2003; van Aubel, Keestra et al. 2007).
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1.3 Suppressor of Cytokine Signalling -  3
1.3.1 Structure and function of Suppressor o f cytokine signalling - 3
Cytokines are known to regulate many physiological responses and conserve 
homeostasis; they do this by influencing proliferation, differentiation, and functional 
activity o f cells o f the immune system, as well as those o f most other tissues and 
organs. The kinetics and extent o f cytokine signalling via the Janus Kinase (JAK)/ 
signal transducer and activator o f transcription (STAT) pathway must be tightly 
controlled. The suppressor o f cytokine signalling (SOCS3) family comprising eight 
members, SOCS1 to SOCS7 and cytokine inducible SH2 (CIS); are a collection o f 
intracellular proteins, whose expression is induced in response to a wide range o f 
growth factors, cytokines and hormones (Alexander and Hilton 2004; Piessevaux, 
Lavens et al. 2008). SOCS proteins were initially identified as inhibitors o f the JAK- 
STAT signalling pathway, operating in a negative feedback loop (Endo, Masuhara et 
al. 1997; Krebs and Hilton 2001). This hypothesis was supported when SOCS I '7' mice 
succumbed to a multifaceted neonatal inflammatory disease, illustrated by the 
hyperactivation o f T-cells and hyper-responsiveness to IFN-y (Naka, Matsumoto et al. 
1998; Alexander, Starr et al. 1999; Marine, Topham et al. 1999). SOCS2'7' mice 
display enhanced growth, characteristic of a heightened response to insulin-like 
growth factor-1 (IGF-1) and/or growth hormones (Horvat and Medrano 2001). 
SOCS3'7' knockdown results in mid-gestation embryonic lethality due to placental 
insufficiency; mice are also found to display disproportionate erythropoiesis (Marine, 
McKay et al. 1999; Roberts, Robb et al. 2001). Furthermore, embryonic lethality can 
be rescued by substituting the SOCS3-deficient placenta with SOCS3+/+ placenta, 
signifying an essential role o f SOCS3 in placental development (Takahashi, Carpino et 
al. 2003).
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The S0CS3 protein is composed o f three domains, a variable N-terminal region, 
a central Src homology 2 (SH2) domain and a 40 amino acid carboxyl-terminal 
module, termed the SOCS box. The N-terminal domain contains an extended SH2 
subdomain (ESS) that aids the SOCS3 protein with substrate binding (Yasukawa, 
Sasaki et al. 2000; Alexander 2002; Kile, Schulman et al. 2002; Babon, McManus et 
al. 2006).
The kinase inhibitory region (KIR) o f the SOCS3 protein is located in the N- 
terminal, adjacent to the SH2 domain. The KIR domain contains a 12 amino acid 
region, which is proposed to act as a pseudo-substrate, binding to the catalytic cleft, 
thus blocking subsequent JAK enzymatic activity (Croker, Kiu et al. 2008). Although 
SOCS3 interacts with both JAK and receptor, a two-step model o f interaction has been 
proposed whereby the SOCS3-SH2 domain is first recruited to the cytoplasmic 
domain o f the receptor, this is followed by a subsequent bi-model binding to JAK 
through the KIR and SH2 domain resulting in a higher affinity interaction, thus 
impeding the enzymatic activity o f JAK (Krebs and Hilton 2001; Croker, Kiu et al. 
2008). Point mutations in KIR are show to abrogate the actions o f SOCS3 without 
affecting SH2 domain binding (Sasaki, Yasukawa et al. 1999; Yasukawa, Sasaki et al. 
2000).
Studies have identified two small regions at the N-termini and C-terminus o f the 
SOCS3-SH2 domain. These are termed N- and C-extended SH2 subdomain (N-ESS 
and C-ESS, respectively); both are required for phosphotyrosine binding (Sasaki, 
Yasukawa et al. 1999; Yasukawa, Sasaki et al. 2000; Croker, Kiu et al. 2008). The N- 
ESS forms a 15-residue alpha helix, which directs the phosphotyrosine-binding loop 
influencing its orientation. Conservation o f these important residues indicates N-ESS
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is highly likely to be a mutual structural feature among SOCS-SH2 domains (Babon, 
Yao et al. 2005; Babon, McManus et al. 2006; Croker, Kiu et al. 2008).
All SOCS proteins contain a 40 amino acid SOCS box motif, which in most 
cases, is located in the C-terminus of the protein. The SOCS box consists o f three a- 
helices packed together (Croker, Kiu et al. 2008; Piessevaux, Lavens et al. 2008).
KIR ESS SH2 SOCS box
Hi I I
/  ^  v/ ^
Interaction with: JAK Kinase domain Phospho-Tyr Elongin B C  SOCS Adaptors
1 1 /  \ X \ \
Mode of action: Inhibition kinase Competition SOCS Target SOCS Other
activity with STATs stabilisation degradation degradation signalling
pathways
Figure 1-8 Diagram depicting the various domains o f the SOCS3 protein, sites of 
interaction and mode o f action. Adapted from (Piessevaux, Lavens et al. 2008)
Receptor
Perturbations in SOCS3 are shown in several intestinal pathologies including 
inflammatory bowel disease (IBD) and colorectal cancer (CRC). IBD is a term used 
to describe a cohort of diseases in which there is chronic recurrent colonic 
inflammation within the bowel, Ulcerative colitis (UC) is a phenotype o f this, and is 
associated with an increased risk of developing CRC (Eaden and Mayberry 2000; 
Eaden, Abrams et al. 2001). Destruction of the epithelial layer can be caused by 
chronic inflammation. Cytokines released in response to inflammation stimulate the 
proliferation o f IEC to compensate for the loss of IEC. This chronically stimulated 
state o f the IEC layer may ultimately lead to the development o f UC-CRC (Sartor
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2006; Schottelius and Dinter 2006; Li, de Haar et al. 2010). There is considerable 
evidence to suggest cytokines, predominantly IL-6 directly stimulate the proliferation 
o f IEC (Schneider, Hoeflich et al. 2000). Elevated levels o f IL-6 have been detected in 
both serum samples and colonic biopsy specimens o f patients with UC, with levels of 
IL-6 correlating with disease severity (Chung and Chang 2003; Carey, Jurickova et al. 
2007). A mutation in the IL-6 receptor (IL-6R) is associated with an increased risk o f 
colon cancer in humans (Landi, Gemignani et al. 2006). In addition to the membrane 
bound IL-6R, IL-6 can also signal through soluble IL-6R, a process termed trans­
signalling. Inhibitors o f soluble IL-6R are known to ameliorate IBD (Mitsuyama, 
Matsumoto et al. 2006). Typically, IL-6 binds to its corresponding membrane receptor, 
ligation initiates gpl30 dimerisation and activation o f JAK2 (Heinrich, Behrmann et 
al. 2003). This subsequently permits the activated JAK2 to phosphorylate the tyrosine 
reside on the cytoplasmic tail of the receptor, presenting a docking site for proteins 
with an SH2 domain, for instance, the STAT3 protein (Mitsuyama, Matsumoto et al.
2006). STAT3 is able to bind to the receptor where it is activated through 
phosphorylation through JAK, leading to homo-hetro-dimerisation o f STAT3 
(pSTAT3). Mice with mutated STAT3 binding sites are shown to have impaired 
healing after acute injury with dextran sulphate sodium (DSS) (Tebbutt, Giraud et al. 
2002). Mice with mutated binding sites on gpl30 are found to develop spontaneous 
gastric tumours associated with increased STAT3 (Judd, Alderman et al. 2004). The 
pSTAT3 hetero-dimers translocate to the nucleus, where they interact with specific 
DNA sequences and induce the transcription o f target genes (Krebs and Hilton 2001; 
Yoshimura, Naka et al. 2007; Li, de Haar et al. 2010).
SOCS3 is transcribed by the IL-6/pSTAT3 pathway and serves as a major 
negative feedback inhibitor o f the JAK/STAT signalling cascade (Suzuki, Hanada et
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al. 2001; Li, de Haar et al. 2010). STAT3 activates the transcription o f Socsim RNA 
by binding to the promoter region o f the Socs3 gene (Aman and Leonard 1997; Starr, 
Willson et al. 1997). SOCS3 then translocates out o f the nucleus where it inhibits 
signalling by binding to STAT3 no longer allowing it to bind to the receptor (Schmitz, 
Weissenbach et al. 2000). SOCS3 also inhibits signalling by binding to 
phosphotyrosine sites on the cytoplasmic domain o f the receptor and blocking STAT3 
recruitment to the receptor. The mechanism of SOCS3 action was established by 
investigating the primary SOCS3-binding sites within the gpl30 signalling pathway 
(Nicholson, Willson et al. 1999). This was achieved by establishing the affinity to 
which SOCS3 binds to several phosphopeptides derived from the JAKs, STATs and 
the gpl30 subunit o f the IL-6R. It was discovered that SOCS3 binds with highest 
affinity to a phosphopeptide in an area surrounding Y757 within the gpl30, while 
exhibiting weaker binding affinity to STAT3. Furthermore, when Y757 is mutated to 
phenylalanine the inhibition o f SOCS3 on gpl30 is greatly reduced (Nicholson, 
Willson et al. 1999; Schmitz, Weissenbach et al. 2000).
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Plasma Membrane





Figure 1-9 The molecular mechanism by which SOCS3 negatively regulates IL-6 
signalling. Adapted from (Yoshimura, Naka et al. 2007)
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1.3.2 Role o f  SOCS3 in mediating TLR signalling
SOCS3 appears to influence secondary effects o f LPS by modulating cytokine 
signalling, but may also play a role in direct regulation o f TLR signalling. The 
majority o f studies determining the role o f SOCS3 in TLR signalling have focussed on 
immune cells (Yoshimura, Ohishi et al. 2004; Qin, Roberts et al. 2007; Yoshimura, 
Naka et al. 2007). Macrophages stimulated with LPS trigger the production o f 
numerous cytokines including IL-6 and IL-10; all o f which upregulate the expression 
of SOCS3. These cytokines influence the LPS response in either a positive or a 
negative manner (Dimitriou, Clemenza et al. 2008).
Studies have shown SOCS3 is a key regulator o f the opposing actions o f 
cytokines in macrophages. IL-6R and IL-10R signalling pathways both involve JAK- 
STAT3 signalling (Yoshimura, Ohishi et al. 2004). IL-6 is a pro-inflammatory 
cytokine and plays a functional role in many inflammatory diseases. Whereas IL-10 is 
an immunoregulatory cytokine, which has anti-inflammatory properties (Dimitriou, 
Clemenza et al. 2008). Although both cytokines exhibit opposite effects, both require 
the transcription factor STAT3 for functional activity (Takeda, Clausen et al. 1999).
SOCS3 binds to phosphorylated Y759 on the IL-6R subunit gpl30, thus 
uncoupling IL-6 mediated STAT3 activation (Nicholson, De Souza et al. 2000; 
Yasukawa, Ohishi et al. 2003). In contrast, SOCS3 does not bind to IL-10R. 
Yasukawa and colleagues (2003) showed that macrophages lacking the SOCS3 gene 
or possessing a mutation in the gp 130 binding site cause prolonged STAT3 activation 
and an anti-inflammatory response similar to that observed in response to IL-10 
(Yasukawa, Ohishi et al. 2003). Therefore, SOCS3 is vital in defining the dichotomous 
effects o f LPS-induced IL-6 and IL-10 responses in macrophages. However, the exact
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mechanism by which S0CS3 function results in differential STAT3 activity remains 
unclear.
Taken together, these studies indicate SOCS3 may not directly target TLR 
signalling intermediates in immune cells, but may influence secondary effects o f TLR 
signalling by modulating cytokine signalling in macrophages. In the subsequent 
chapters I will investigate the role o f SOCS3 in regulating TLR-mediated intestinal 
epithelial homeostasis and repair.
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1.3.3 Role o f SOCS3 in proteosomal degradation
Zhang and colleagues (2008) have suggested that SOCS3 may also promote the 
degredation o f specific signalling proteins. They had suggested that the SOCS box, 
located at the C-terminal of SOCS3, acts as an adaptor molecule that recruits activated 
signalling molecules to the proteosome (Zhang, Farley et al. 1999). SOCS3 associates 
with a complex containing elongins B and C (elongin BC) via the SOCS box 
(Kamura, Sato et al. 1998; Zhang, Farley et al. 1999). This subsequently allows cullin- 
2 to associate with elongin BC to form the E3 ligase scaffold. As SOCS3 contains an 
SH2 domain that interacts with tyrosine-phosphorylated signalling molecules, SOCS3 
then acts as an adaptor that facilitates ubiquitination and subsequent degredation o f the 
associated signalling molecule (Krebs and Hilton 2001; Babon, Sabo et al. 2008; 






Figure 1-10 Proposed mechanism by which SOCS3 targets signalling molecules for 
proteosomal degradation by the proteasome (Krebs and Hilton 2001)
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1.4 Tissue homeostasis and repair following damage
1.4.1 Intestinal epithelial homeostasis and repair following injury
The mucosal surface epithelial cells o f the alimentary tract are highly 
proliferative with complete turnover every 4-5 days (Tsujii and DuBois 1995). The 
proliferative compartment is localised to the crypt region and is separated from a 
gradient o f increasingly differentiated epithelial cells along the functional villus 
compartment (Dignass 2001). The integrity o f the mucosal surface o f the colon is 
essential in forming a barrier between the diverse immunogenic and noxious 
compounds present within the gastrointestinal lumen and the underlying mucosal 
immune system (Sturm and Dignass 2002). Damage or impairment o f the intestinal 
surface barrier is observed in the course o f a number o f diseases, and these may lead to 
an increased infiltration and immunological intolerance o f luminal contents, leading to 
inflammation and disequilibrium of homeostasis o f the host. Thus, rapid resealing o f 
the mucosal surface, subsequent to injury or damage is essential in maintaining 
conventional homeostasis (Rakoff-Nahoum, Paglino et al. 2004; Ben-Neriah and 
Schmidt-Supprian 2007).
Numerous studies have demonstrated the potential o f the intestinal epithelium to 
rapidly re-establish itself after extensive damage (Feil, Wenzl et al. 1987; 
McCormack, Viar et al. 1992; Nusrat, Delp et al. 1992). The continuity o f the 
epithelium is re-established by at least three distinctive phases. Firstly, the epithelial 
cells neighbouring the damaged surface migrate into the denuded area, 
dedifferentiate form pseudopodia-like structures, re-organise their cytoskeleton and 
then re-differentiate after closure o f the damaged wound. This process is termed 
restitution and can arise within minutes to hours after injury in both in vitro and in
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vivo. Restitution is followed by the second phase proliferation; this is when IEC divide 
to replenish the reduced cell numbers. Thirdly, the undifferentiated epithelial cells 
mature and differentiate to maintain the functional activity o f the epithelium (Dignass 
2001; Dignass, Baumgart et al. 2004; Sturm and Dignass 2008).
















Figure 1-11 Simplified model of repair of superficial epithelial cell injury within the 
intestine (Dignass 2001)
The illustration provides a simplified model of repair to better understand the 
physiology and pathophysiology of intestinal epithelial wound repair. However, the 
three distinctive phases do overlap and moreover, additional repair mechanisms that 
involve inflammatory processes may also be requisite as a result of deeper lesions or 
penetrating injuries (Dignass 2001).
The repair o f the intestinal surface barrier is regulated by a broad spectrum of 
structurally distinct regulatory peptides, non-peptide factors, extracellular matrix 
factors and direct cell-cell interactions. Cytokines and growth factors have both been
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shown to play a role in regulating differential epithelial cell functions to conserve 
habitual homeostasis and integrity o f the intestinal epithelium. Epidermal growth 
factor (EGF), TGF-a, and TGF-p to name a few have been shown to enhance 
epithelial cell restitution (Podolsky 1997; Wilson and Gibson 1997). Other compounds 
such as short-chain fatty acids, phospholipids and adenine nucleotides, have also been 
shown to modulate intestinal epithelial repair mechanisms. Some o f these factors are 
released by injured or dying IEC, whereas others reach the intestinal mucosa via the 
intestinal lumen or bloodstream (Wilson and Gibson 1997; Dignass 2001; Sturm and 
Dignass 2002; Dignass, Baumgart et al. 2004).
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1.4.2 TLR signalling and intestinal epithelial regeneration
In addition to their role in mammalian host defence from adverse microbes, TLRs 
are also involved in several features o f mammalian homeostasis such as development, 
the recognition o f cellular tissue injury, tissue repair and regeneration (Zhang and 
Schluesener 2006; Rakoff-Nahoum and Medzhitov 2008). Other studies have 
demonstrated that TLR signalling is essential for maintaining tissue integrity and 
repair o f damaged tissue in models o f chemical, radiation and colonic injury (Fukata, 
Michelsen et al. 2005; Rakoff-Nahoum and Medzhitov 2008). Studies in wound 
healing models have shown that the absence o f TLR4 had notable consequences on 
both the inflammatory and repair phases o f lesions (Mollen, Anand et al. 2006). This 
can be supported by both Rakoff-Nahoum (2004) and Abreu (2005) who have both 
indicated that mice deficient in TLR4 or MyD88 are at an increased risk o f epithelial 
injury following the application o f DSS (Rakoff-Nahoum, Paglino et al. 2004; Abreu, 
Fukata et al. 2005). Similarly, gut-sterilised mice exhibit a promotion in intestinal 
injury and DSS-induced death as MyD88-defecient mice inferring PAMPs from 
intestinal microbiota stimulate cytoprotective pathways to prevent epithelial injury 
(Rakoff-Nahoum, Paglino et al. 2004; Kluwe, Mencin et al. 2009). Studies have also 
shown germ-free mice have a reduced rate o f crypt cell production, with crypts also 
containing fewer cells than mice colonized with conventional flora; indicating 
commensal flora effect IEC proliferation and subsequent repair (Alam, Midtvedt et al. 
1994).
Numerous studies have shown the importance of TLR5 signalling to be 
paramount for maintaining tight junction assembly and cytoprotection within IEC 
layers (Jones, Edwards et al. 2004; Otte, Cario et al. 2004; Vijay-Kumar, Sanders et al.
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2007). Vijay-Kumar and colleagues (2008) had shown that mice systematically 
injected with purified flagellin do not display the clinical features o f inflammation. 
Furthermore flagellin is shown to shield mice against pathological, chemical and 
ionizing radiation (Vijay-Kumar, Aitken et al. 2008). More recent studies have also 
supported the role o f flagellin pre-treatment in protecting the intestinal mucosa from 
injury resulting from irradiation-induced apoptosis (Jones, Sloane et al. 2011).
Numerous studies have demonstrated that exposure to helminths prevents TNBS- 
type colitis (Khan et al., 2002; Elliot et al., 2003; Moreels et al., 2004); suggesting 
helminth products promote mucosal healing in animal models o f colitis. Colitis is 
supressed by inhibiting inflammatory cytokines, such as TNFa and IL-12 or 
stimulating the secretion o f immunoregulatory cytokines such as TGF-P and IL-10 
(Elliott, Summers et al. 2007; Ruyssers, De Winter et al. 2008).
Looking at the molecular mechanism coupling TLR signalling to epithelial 
homeostasis, it has been shown that stimulation of epithelial TLR induce the activation 
o f a group o f receptors with tyrosine kinase activity. Notably, all four members o f the 
epidermal growth factor receptor (EGFR) family, including ErbB-1, ErbB-2, ErbB-3 
and ErbB-4 display elevated phosphorylation levels (Shaykhiev, Behr et al. 2008). 
EGFR is known to play a predominant role in mediating wound healing induced by 
TLR ligation in IEC, since specific obstruction of the receptor tyrosine kinase (RTK) 
associated TLR completely abolishes the effect o f ligation on epithelial migration and 
repair (Rakoff-Nahoum, Paglino et al. 2004).
In addition to recognising PAMPs, TLR are also able to recognise damage- 
associated molecular patterns (DAMPs), a group o f endogenous molecules released 
from injured or inflamed tissue; implying TLR may also appear to regulate
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inflammatory responses during the wound healing process. Such DAMPs that are able 
to ligate with TLR include hyaluronan, HMGB1, S I00 protein 60 and heat shock 
proteins (Miyake 2007; Kluwe, Mencin et al. 2009). However, there is still on-going 
debate with respect to some endogenous ligands, as many of these have either been 
purified in bacterial systems or have a high affinity to bacterial products, such as LPS, 
which proposes that the bacterial products rather than the suggested ligands 
themselves mediate their TLR-activating effect (Tsan 2007; Kluwe, Mencin et al. 
2009).
Previous studies have demonstrated that flagellin treatment is also a potent 
activator o f host defence/cytoprotective gene expression in IEC (Zeng, Carlson et al. 
2003; Zeng, Wu et al. 2006). Research conducted by Vijay-Kumar (2008) and 
colleagues have demonstrated that clinical features, such as loss o f body weight, 
shortening o f the colon and robust inflammation in mice induced by the ingestion of 
DSS were all greatly abrogated by a single administration o f flagellin upon initial 
exposure to DSS indicating flagellin can protect the gut from chemical injury (Vijay- 
Kumar, Aitken et al. 2008).
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1.4.3 TLR signalling in epithelial regeneration o f other tissues
The involvement o f TLRs in the regeneration o f other tissues has also been 
studied recently. Shaykhiev and colleagues (2008) had found that Staphylococcus 
aureus (S. aureus) signals via TLR2 and TLR5, both signalling pathways triggering a 
cohort o f non-immune lung epithelial cell responses including cell migration, 
proliferation, wound repair, and survival o f epithelial cells (Shaykhiev, Behr et al.
2008). Jiang and colleagues (2005) had shown that TLR signalling is required for liver 
regeneration after partial hepatectomy; with other studies exhibiting the significance o f 
TLR signalling displaying protection from bleomycin- and hyperoxic-induced liver 
injury (Jiang, Liang et al. 2005; Seki, Tsutsui et al. 2005). In the central nervous 
system, TLR have also been shown to coordinate the protective responses after axonal 
and crush injuries o f the brain and spinal cord (Babcock, Wirenfeldt et al. 2006; 
Kigerl, Lai et al. 2007; Kim, Kim et al. 2007).
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1.5 Role of microbes in intestinal diseases
1.5.1 Inflammatory bowel disease
The ability o f the host to initiate an inflammatory response following injury or 
exposure to foreign antigens is imperative for host homeostasis and survival. 
However, a continually heightened immune response such as that perceived in chronic 
inflammatory conditions severely weakens host organ activity, eventually leading to 
disease progression (Medzhitov 2008). IBD refers to chronic inflammation that affects 
the GI tract (Barbosa and Rescigno 2010; Maloy and Powrie 2011). There are two 
principal clinical forms o f IBD, Crohn's disease (CD) characterised by transmural, 
patchy inflammation generally affecting the ileum and the colon, but can occur 
anywhere within the GI tract; and ulcerative colitis (UC) which is more superficial 
with pathology restricted to the colonic mucosa (Podolsky 1991; Hanauer 2006; 
Strober, Fuss et al. 2007). Manifestations o f both diseases include abdominal pain, 
diarrhoea rectal bleeding, and malnutrition. Studies have shown that the incidence of 
CD is 8/100, 000 and UC 11/100, 000 within the UK population (Garcia Rodriguez, 
Gonzalez-Perez et al. 2005).
The exact aetiology o f IBD remains undecided, but three distinct categories are 
known to contribution to disease pathology; these have been identified as: the host 
immune system, genetic factors and environmental factors such as the gut microbiota 
(Baumgart and Carding 2007; Hill and Artis 2009). Swidsinski and colleagues (2007) 
have shown that the colonic mucus layer o f patients with IBD is greatly reduced, and 
unevenly distributed in patients with colitis, leaving significant areas o f the epithelium 
exposed to luminal contents (Swidsinski, Loening Baucke et al. 2007). This may be 
attributed to a decline in the population o f goblet cells as observed in the colonic 
epithelium of patients with UC (Kolios, Valatas et al. 2002).
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Patients with IBD have also been reported to exhibit less diversity in microflora, 
possibly associated with a relatively lessened proportion o f protective bacteria. The 
molecular-phylogenetic classification o f colonic microflora permitted the 
identification o f phyla selectively depleted in biopsy specimens o f IBD patients, 
namely the Firmicutes group (Manichanh, Rigottier-Gois et al. 2006; Sokol, Pigneur et 
al. 2008). A number o f other studies have shown Yersinia enterocolitica (Y. 
enterocolitica) and other species of Yersinia are associated with CD (Lamps, 
Madhusudhan et al. 2003; Saebo, Vik et al. 2005; Zippi, Colaiacomo et al. 2006). 
Overall, at least 18 different bacterial species or genera have been implicated in CD 
(Man, Kaakoush et al. 2011).
TLR play a major role in the detection o f microbiota, additionally stimulation o f 
these receptors is requisite in maintaining intestinal epithelial homeostasis, often 
interrupted in IBD (Fukata and Abreu 2007; Danese and Mantovani 2010). Studies 
have shown mutations in TLR4 are associated with CD and UC (Fukata, Michelsen et 
al. 2005). Other studies have shown that TLR4 is upregulated in IEC o f active UC and 
CD patients (Cario and Podolsky 2000). TLR4 signalling induces COX-2, PGE2 and 
reactive oxygen species (ROS) fundamental for the development o f CRC and colitis 
associated cancer (CAC) (Gupta and DuBois 2001; Fukata 2006; Wang and DuBois
2009). Several studies have also found that polymorphisms in TLR4 (D299G) are 
associated with increased risk of both UC and CD (Franchimont, Vermeire et al. 2004; 
Torok, Glas et al. 2004; Gazouli, Mantzaris et al. 2005; Ouburg, Mallant-Hent et al. 
2005).
Numerous studies have demonstrated flagellin is endotoxic to humans as binding 
to TLR5 instigates the transcription of pro-inflammatory genes, which may play a role 
in triggering acute flares of inflammation in IBD (Kluwe, Mencin et al. 2009). The
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implication o f flagellin in IBD, has been supported by polymorphisms in TLR5 
negatively correlating with CD and commensal-derived flagellin being identified as a 
dominant antigen to this disorder (Erridge, Duncan et al. 2010).
A number o f studies have shown that the expression profile o f other TLRs, such 
as TLR2, TLR3 and TLR8, are dissimilar between IEC of patients with CD and non- 
IBD controls (Cario and Podolsky 2000; Szebeni, Veres et al. 2008; Steenholdt, 
Andresen et al. 2009). Taken together, emerging evidence suggests that defective TLR 
sensing o f microbial components may lead to susceptibility to CD and UC.
IBD is sometimes described as a dysregulated immune response to commensal 
microflora in genetically susceptible individuals. Numerous studies have shown that 
there is a strong relationship between inflammation and progression to colon cancer, 
as observed in patients with IBD (Itzkowitz and Yio 2004; Yang and Pei 2006). The 
severity o f inflammation correlates with the risk of cancer in IBD patients (Itzkowitz 
2002; Rutter, Saunders et al. 2004). Mouse models of IBD have shown commensal 
flora are required for the initiation of colitis and the promotion o f dysplasia or cancer 
(Sellon, Tonkonogy et al. 1998; Itzkowitz and Yio 2004). Conversely, germ-free rats 
are less prone to dysplasia and cancer following exposure to carcinogens (Reddy, 
Narisawa et al. 1976; Laqueur, Matsumoto et al. 1981).
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1.5.2 Role o f microbes in colorectal cancer
Colorectal cancer is one o f the most common causes o f cancer morbidity and 
mortality within the western world; with 36, 500 new cases being diagnosed each year 
within the UK. Almost three quarters of these cases arise in individuals over the age of 
75 (UK 2013).
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Figure 1-12 Average number of deaths per year and age-specific mortality rates of 
colorectal cancer, by sex, UK, 2008-2010 (UK 2013)
Over the last few decades there has been a steady increase in the incidence o f 
colon cancer within the western world (Slattery 2000; Giovannucci 2002). This may 
be attributed to changes in diet and the types o f bacteria that reside within our gut 
(Munkholm 2003). Although there is no recognised bacterial pathogen for human 
colorectal cancer; some bacteria have been shown to cause infection which may herald
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cancer. Streptococcus bovis (S. bovis) is an element o f the human enteric flora and 
patients with colon cancer have an increased faecal carriage o f S. bovis in contrast to 
healthy patients or those with non-malignant enteric disease. It has been suggested that 
S. bovis carriage maybe associated with the promotion o f intestinal carcinogenesis 
(Klein, Warman et al. 1987; Ellmerich, Scholler et al. 2000; Biarc, Nguyen et al. 
2004).
The role o f microbes in mediating an anti-tumour effect was first recognised in 
the 18th when Deidier observed a positive correlation between infection and remission 
o f malignant cancers (Garay, Viens et al. 2007). Coley (1894) then went further by 
showing microbial products showed significant tumour regression and even cure in a 
large group o f patients (Coley 1894). A recent study has shown that both TLR4 and 
MyD88 play a crucial role in anti-tumour responses following irradiation and 
chemotherapy (Apetoh, Ghiringhelli et al. 2007). TLR4 A mice are shown to have 
significantly larger tumours following oxaliplatin therapy or irradiation than control- 
mice, with both types displaying similar levels o f growth in the absence o f treatment 
(Apetoh, Ghiringhelli et al. 2007). It has been suggested that there are a number o f 
mechanisms through which TLR agonists mediate their anti-tumour activity. TLR 
agonists are shown to directly kill both tumour cells and ancillary cells located in the 
tumour microenvironment (Andaloussi, Sonabend et al. 2006; Salaun, Coste et al. 
2006; Rakoff-Nahoum and Medzhitov 2008). TLR activation can also lead to tumour 
regression by increasing vascular permeability, recruitment o f leukocytes, activation 
o f natural killer- (NK-) and cytotoxic T-cells, and increasing the "sensitivity o f tumour 
cells to assisted killing through TNFa, TRAIL and perforin/granzyme B (Smyth, Dunn 
et al. 2006; Akazawa, Ebihara et al. 2007; Garay, Viens et al. 2007).
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Studies have shown that TLR ligands enhance the growth o f adoptively 
transferred tumours (Harmey, Bucana et al. 2002; Luo, Maeda et al. 2004; Sfondrini, 
Rossini et al. 2006; Huang, Zhao et al. 2007). A spontaneously metastasising 
mammary adenocarcinoma cell line was first injected into a mouse model and LPS 
was then systematically injected into the mouse. The results showed LPS 
administration increased both migration and invasion to secondary locations (Harmey, 
Bucana et al. 2002). A similar model, but using a colonic adenocarcinoma cell line, 
showed intraperitoneal injection o f LPS displayed an increase in proliferation and a 
decrease in apoptosis o f metastatic tumours (Luo, Maeda et al. 2004). Other studies 
have shown TLR4 expression is strongly upregulated in the epithelial compartment of 
tumours o f patients with UC and colon cancer, as well as in murine models o f 
inflammation-associated bowel cancer (Fukata, Chen et al. 2007). Furthermore, 
TLR4'7' mice display overwhelmingly reduced dysplasia, number and size o f tumours 
(Fukata, Chen et al. 2007). Similar findings have also been reported in a study which 
explored the role of Myd88 in colon cancers. MyD88 deficiency was found to lessen 
carcinogenesis in ApcMin/+ mice, a non-inflammatory model o f colon cancer as well as 
in azoxymethane (AOM) models. The study also showed MyD88-deficiency depicted 
a reduction in size and number of polyps. Additionally, although polyps showed 
parallel levels o f proliferation between MyD88 and wild-type mice, higher levels of 
apoptosis was observed in polyps o f the MyD88- deficient mice in comparison to 
control mice (Rakoff-Nahoum and Medzhitov 2007).
Rhee and colleagues (2008) investigated whether TLR5 signalling inspires 
innate immune responses in regulating anti-tumour activity in mouse xenograft models 
o f human colon cancer. They showed blocking TLR5 dependent signalling 
significantly promoted tumour growth and impeded tumour necrosis whereas ligation
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o f TLR5 with its ligand flagellin drastically regressed tumour progression. Indicating 
engagement o f TLR5 with flagellin elicits inhibitory activity against human colon 
adenocarcinoma cells (Rhee, Im et al. 2008).
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1.5.3 Role o f microbes in necrotising enterocolitis
Necrotising enterocolitis (NEC) is among the most common and distressing 
diseases in neonates. NEC was first described over a century ago, but the disease has 
still remained an enigma. Pathogenesis o f NEC is still unconfirmed; treatment is 
problematic and regularly proves ineffective; with no successful prevention approach 
agreed upon. An epidemiological study conducted by Rees and colleagues (2010) had 
shown that NEC prevalence decreases significantly with increasing birth rate and 
increasing gestation (Rees, Eaton et al. 2010). There are a multitude o f NEC-like 
conditions with a diverse presentation of symptoms. However, the most characteristic 
signs and symptoms of ‘classical’ NEC in preterm infants include abdominal 
distension, feeding intolerance and bloody stools 8 to 10 days after birth (Neu and 
Walker 2011).
The pathophysiology of NEC remains poorly understood. However, 
epidemiological studies strongly indicate a multifactorial cause (Claud and Walker 
2001). Immature intestinal motility and digestion could possibly predispose preterm 
infants to NEC. Animal and human foetal studies have suggested that the development 
of GI motility commences in the second trimester, but matures in the third trimester 
(Sase, Lee et al. 2005; Sase, Miwa et al. 2005). Studies have shown premature infants 
have immature motility patterns when compared with full-term infants, although 
enteral feeding can mature these responses (Berseth 1989; Ittmann, Amamath et al. 
1992; Al Tawil and Berseth 1996; Lin and Stoll 2006). Studies in animal models of 
NEC and human foetal-cell cultures have proposed that foetuses and preterm infants 
have a disproportionate inflammatory response to microbial flora (Otte and Podolsky 
2004).
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Another hypothesis suggested to initiate NEC is the inappropriate initial 
microbial colonisation o f the GI tract in preterm infants, predominantly since NEC 
occurs about 8 to 10 days after birth, at a time when anaerobic bacteria have colonized 
the intestinal lumen (Claud and Walker 2001). Additionally, experimental NEC does 
not transpire in germ-free animals (Morowitz, Poroyko et al. 2010). The evaluation of 
faecal microflora from unaffected preterm infants and infants suffering from NEC has 
shown that the ailment is associated with both unusual intestinal microbial species and 
a global reduction in the diversity of microbiota (Vollaard and Clasener 1994; Wang, 
Hoenig et al. 2009; Mshvildadze, Neu et al. 2010). The reduction in microbial 
diversity and alteration in microbial species may limit colonisation resistance, making 
the infant more susceptible to colonisation by hospital-acquired pathogens that can 
cause intestinal inflammation. Additionally, commensal flora as well as pathogens 
have been shown to elicit a disproportionate inflammatory response as compared with 
mature enterocytes (Claud, Lu et al. 2004). The disparity in responses appears to be 
arbitrated to a developmental immaturity in the expression o f f B  (a molecule that 
impedes N F - k B  activated cytokines) (Claud, Lu et al. 2004; Neu and Walker 2011).
Numerous strategies have been proposed for the prevention o f NEC. These 
approaches include using enteral antibiotics; withholding enteral feeding and feeding 
infant milk expressed from mothers (Neu and Walker 2011). A recent study reported 
probiotics decrease the incidence o f NEC, but not mortality from NEC. Another newly 
proposed preventative strategy for NEC is to supplement feeding with prebiotics, or 
nutrients that have the potential to enhance the growth o f beneficial intestinal 
microflora (Gibson, Probert et al. 2004). The efficacy o f prebiotics as a preventative 
measure for NEC is still unclear because prebiotics enhance the proliferation of 
endogenous flora, such as Bifidobacteria. However; they demand appropriate
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preliminary colonisation o f the gut, that which is lacking in NEC infants (Moro, 
Minoli et al. 2002).
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1.6 Probiotics and prebiotics
1.6.1 Probiotics
The term probiotic refers to ‘a live microbial food ingredient that is beneficial to 
health’ (Salminen, Bouley et al. 1998). Examples o f probiotics include selected lactic 
acid bacteria (LAB) such as Lactobacillus, Streptococcus and Bifidobacterium  which 
can be ingested in fermented milk products or as a supplement (Rafter 2003; Rijkers, 
Bengmark et al. 2010). The health-promoting benefits credited to probiotics are 
widespread, and include serum cholesterol reduction, the improvement o f constipation 
and alleviation o f symptoms due to lactose intolerance (Rafter 2003).
In addition to these favourable effects, several experimental observations have 
also implied a potential protective effect of LAB against the progression o f colon 
tumours (Sanders 1994; Brady, Gallaher et al. 2000; Wollowski, Rechkemmer et al. 
2001). In animals, LAB ingestion was shown to block carcinogen-induced pre­
neoplastic lesions and tumours (Goldin, Gualtieri et al. 1996; Challa, Rao et al. 1997; 
Rowland, Rumney et al. 1998). Additionally, direct evidence for anti-tumour 
properties o f LAB have been attained using pre-implanted tumour cells in animal 
models. Studies indicate feeding cultures containing LAB or fermented milk inhibits 
the growth o f tumour cells injected into mice (Kato, Kobayashi et al. 1981). In 
addition to a probable role in the prevention o f cancer, probiotics have also been 
suggested to boost the immune system and impede the growth o f existing tumours 
(Geier, Butler et al. 2006). Probiotics containing LAB are shown to increase the 
survival rate o f mice injected with tumour cells, correlating with an increase in the 
number o f NK cells, T cells, MHC class 11+ cells and CD4-CD8+ T cells (Lee, Kim et 
al. 2004).
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Epidemiological studies looking at the association between fermented milk 
products and colorectal cancer have found that the consumption o f large quantities of 
dairy products containing Bifidobacterium and Lactobacillus may correlate with lower 
incidence o f colon cancer (Shahani and Ayebo 1980). In a two population-based case 
study o f colon cancer, an inverse relationship was observed for yogurt when the study 
was adjusted for possible co-founding variables (Peters, Pike et al. 1992). In another 
case-control study, an inverse relationship was observed again between the 
consumption o f yogurt and risk o f colon adenomas in both males and females 
(Boutron, Faivre et al. 1996).
There have been a number o f clinical trials that have demonstrated that probiotics 
improve health in patients with IBD for both CD and UC patients (Venturi, Gionchetti 
et al. 1999; Guslandi, Mezzi et al. 2000; Kruis, Fric et al. 2004; Tursi, Brandimarte et 
al. 2004; Furrie, Macfarlane et al. 2005; Karimi, Pena et al. 2005). Guslandi and 
colleagues (2005) had shown that patients given Saccharomyces boulardii (S. 
boulardii) as a probiotic displayed relapse in only 6% o f CD patients vs. 38% of 
patients given conventional treatment only (Guslandi, Mezzi et al. 2000). Another 
study showed probiotic treatment given to UC patients was just as effective as 
conventional treatments (mesalazine and balsalazide) in maintaining remission (Kruis, 
Fric et al. 2004; Tursi, Brandimarte et al. 2004). Other studies have also noted the anti­
inflammatory properties o f probiotics; such as improvement o f clinical appearances o f 
chronic inflammation in patients, decreases in TNFa, improvement o f histology in 
TNBS models o f rat colitis, reduction in the number o f activated T-lymphocytes in the 
lamina propria o f CD mucosa and reduced production o f pro-inflammatory cytokines 
to name a few (Sheil, McCarthy et al. 2004; Furrie, Macfarlane et al. 2005; Peran, 
Sierra et al. 2007). Probiotics have also been shown to decrease luminal pH in patients
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with CD thus antagonising pathogenic bacteria; as well as promoting the production of 
peptides that inhibit a broad range o f pathogens such as Staphylococcus, 
Enterococcus, Listeria, Bacillus and Salmonella (Venturi, Gionchetti et al. 1999; 
Flynn, van Sinderen et al. 2002).
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1.6.2 Prebiotics
A prebiotic was first defined as ‘a non-digestible food ingredient that 
beneficially affects the host by selectively stimulating the growth and/or activity of 
one or a limited number o f bacteria in the colon, thus improving host health (Gibson 
and Roberfroid 1995). Since its introduction, there have been a number of 
oligosaccharides and polysaccharides that have claimed to have prebiotic activity, 
without due consideration to the criteria required. Not all carbohydrates are prebiotics, 
and clear criteria need to be recognised for the classification o f foods as prebiotics. 
These criteria are:
(1) Resistance to gastric acidity, hydrolysis by mammalian enzymes and 
gastrointestinal absorption;
(2) Is fermented by intestinal microflora;
(3) Selectively stimulates the growth and/or activity o f intestinal bacteria 
associated with health and well-being.
Common prebiotics include inulin, oligosaccharides, lactulose and resistant 
starch. Dietary fibre has also been shown to convey prebiotic responses (Lim, 
Ferguson et al. 2005). Numerous studies have suggested colonic microflora are a risk 
factor for colon cancer. However, modifying the metabolic activity or composition of 
colonic microflora through the use of prebiotics could be a preventative measure in 
reducing the prevalence o f colorectal cancer. Mechanisms by which prebiotics may 
bestow beneficial effects include detoxification o f exogenous carcinogens, decreasing 
luminal pH, improving solubility of and uptake o f ions, namely magnesium, calcium 
and iron; and modulation o f immune responses (Lim, Ferguson et al. 2005).
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Numerous studies have looked at the protective effects o f prebiotics, namely 
fructooligosaccharides and inulin on colon cancer. Femia and colleagues (2002) had 
reported that the expression o f genes involved in colon carcinogenesis - Glutathione S- 
transferase (GST) and GST placental enzyme pi type, were lowered when rats were 
fed with prebiotics individually, and in combination with Bifidobacterium lactis (B. 
lactis) B bl2 and Lactobacillus rhamnosus (L. rhamnosus) (Femia, Luceri et al. 2002). 
Additionally, inducible nitric oxide synthase (iNOS), found to play a significant role in 
colon tumour growth was also reduced in tumours o f mice fed with prebiotics (Ahn 
and Ohshima 2001). COX-2, an enzyme generally upregulated in cancer, is also found 
to be increased in the tumours o f control rats but not in those fed with prebiotics 
(DuBois, Radhika et al. 1996; Ahn and Ohshima 2001).
Numerous studies have observed the effect o f prebiotics on experimental colitis 
(Ewaschuk and Dieleman 2006; Geier, Butler et al. 2007). Inulin and lactulose have 
both been shown to attenuate inflammation in IL-10”/_ mice and DSS-induced colitis 
respectively (Madsen, Doyle et al. 1999; Videla, Vilaseca et al. 2001; Ewaschuk and 
Dieleman 2006). Another study, again using lactulose showed a dose-dependent 
positive effect o f lactulose on DSS-induced colitis in rodents, including improvement 
in areas o f colonic ulceration, reduced diarrhoea, increased body weight, and a 
reduction in myeloperoxidase activity and microscopic colitis (Rumi, Tsubouchi et al. 
2004). In another experiment of TNBS-induced colitis, rats which were fed for two 
weeks with lactulose prior to the induction of colitis had reduced myeloperoxidase 
activity, colonic TNFa and leukotriene B production (Camuesco, Peran et al. 2006). 
Some studies have explored the use of an insoluble mixture o f hemicellulose-rich 
dietary fibre and glutamine-rich protein termed germinated barley foodstuff (GBF) on 
epithelial repair. Fukudo and colleagues (2002) had discovered that feeding GBF to
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rodents with DSS-induced colitis significantly reduced colonic inflammation scores 
and increased butyrate concentrations in cecal contents o f rodents (Fukuda, Kanauchi 
et al. 2002). Another study in rodents with DSS-induced colitis also observed similar 
results, and further concluded that the dietary fibre component rather than the protein 
component o f GBF is responsible for the beneficial effects o f GBF (Kanauchi, 
Mitsuyama et al. 2003).
There have been a number o f prebiotics investigated in clinical trials, primarily 
in UC patients (Ewaschuk and Dieleman 2006; Geier, Butler et al. 2006; Geier, Butler 
et al. 2007). GBF has been shown to lower the severity o f UC both clinically and 
endoscopically (Bamba, Kanauchi et al. 2002). GBF has also been found to prolong 
the period o f remission in UC and stimulate the growth o f Bifidobacterium  and 
Eubacterium  (Kanauchi, Suga et al. 2002; Kanauchi, Mitsuyama et al. 2003; Hanai, 
Kanauchi et al. 2004).
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1.7 Role of SOCS3 in intestinal disease
Chronic inflammation, that which is observed in IBD has been associated with 
an increased risk o f developing CRC (Eaden and Mayberry 2000; Eaden, Abrams et 
al. 2001; Li, de Haar et al. 2012). Numerous studies have begun to unravel the core 
mechanisms that may drive the development o f IBD-CRC (Breynaert, Vermeire et al. 
2008; Brackmann, Aamodt et al. 2010; Saleh and Trinchieri 2010). The activation o f 
the immune system in IBD triggers the production of mediators that promote the 
destruction o f the epithelium further enhancing inflammation. Other inflammatory 
mediators secreted by immune cells or IEC themselves augment wound-repair by 
encouraging IEC proliferation. It is a combination o f these events which leads to the 
development o f IBD-CRC (Eaden 2004; Sartor 2006).
Studies have uncovered the molecular mechanism of intracellular signalling 
pathways o f inflammatory cytokines such as TNFa and IL-6, implying signalling 
transpires through the JAK-STAT signalling pathway (Krebs and Hilton 2001; 
Yoshimura, Naka et al. 2007; Li, de Haar et al. 2010). SOCS3, a natural endogenous 
regulator o f inflammatory mediated signalling has been shown to limit transcription 
factor activation/translocation in response to inflammatory stimuli (Sasaki, Yasukawa 
et al. 1999; Suzuki, Hanada et al. 2001; Jamicki, Putoczki et al. 2010; Li, de Haar et 
al. 2012). Therefore; SOCS3 provides a self-regulating mechanism to control 
inflammation within IEC.
There is compelling evidence to support the role o f SOCS3 in IBD, as increased 
expression o f SOCS3 is detected in mouse models o f inflammation (Suzuki, Hanada et 
al. 2001). Furthermore, inflamed biopsy specimens o f UC patients express greater
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levels o f SOCS3 mRNA than non-inflamed biopsies (Miyanaka, Ueno et al. 2007; Li, 
de Haar et al. 2010).
Studies investigating the progression from UC-CRC have shown that the 
numbers o f SOCS3-positive IEC are significantly reduced during UC-CRC in 
comparison to patients with UC. With reduced expression o f SOCS3 also detected at 
dysplastic and cancerous regions o f the colon (Li, de Haar et al. 2010). The decline in 
SOCS3 expression is due to epigenetic regulation via enhanced DNA methylation (Li, 
de Haar et al. 2010; Li, Deuring et al. 2012).
STAT3 has already been demonstrated to have a stimulatory effect on cell 
survival and proliferation (Grivennikov and Karin 2010). Therefore, restricting 
SOCS3 may be associated with the development o f cancer. Numerous studies have 
supported the role of SOCS3 as a tumour suppressor, for example targeted deletion of 
SOCS3 in IEC promotes tumour incidence and growth in the colon; with methylation 
silencing o f SOCS3 shared in multiple tumour types (Ogata, Chinen et al. 2006; 
Rigby, Simmons et al. 2007). In vitro studies have shown that SOCS3 is a potent 
suppressor o f proliferation in both transformed and non-transformed IEC lines (Rigby, 
Simmons et al. 2007).
Taken together, SOCS3 is a critical regulator of cytokine signalling and the 
subsequent immune response. Since, SOCS3 regulates the activity o f a number o f 
cytokines linked to IBD and cancer, SOCS3 also plays a fundamental role in the 
promotion o f these diseases.
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1.8 Hypothesis
“SOCS3 impacts on TLR-induced intestinal epithelial responses associated with 
normal homeostasis and epithelial repair”.
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1.9 Aims
To investigate the above hypothesis (1.8) we aimed to determine:
1. Whether SOCS3 influences microbial-induced epithelial wound repair.
2. Whether SOCS3 influences IEC cytokine production in response to microbial 
challenge.
3. Whether SOCS3 mediates IEC tolerance to TLR ligation
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1.10 Specific Aims
1. To address whether SOCS3 influences microbial-induced epithelial wound 
repair; we aimed to:
A) Determine the effect o f TLR ligands on epithelial wound repair in a model 
system
B) Determine the effect o f SOCS3 on epithelial wound repair.
2. To investigate whether SOCS3 influences IEC cytokine production in response 
to microbial challenge; we aimed to:
A) Identify cytokines upregulated in response to microbial stimulation
B) Determine the effect o f SOCS3 on microbial-induced cytokine production 
and signalling.
3. To investigate whether SOCS3 mediates IEC tolerance to TLR ligation; we 
aimed to:
A) Monitor TLR and SOCS3 expression levels in IEC following TLR ligation.
B) Assess SOCS3 and cytokine expression in a model o f conventional and 
disrupted IEC monolayers
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For the purposes o f this study, colon adenocarcinoma cell lines were purchased 
from the European Collection o f Cell Cultures (ECACC). The cell lines used as part of 
this study were:
■ The human colorectal cancer SW480 epithelial cell line derived from a 
grade 3-4 colon adenocarcinoma. SW480 IEC were chosen as they are 
epithelial like in morphology and have extensively been used as an in 
vitro model to investigate cell signalling in colorectal studies.
■ The human colorectal cancer Caco-2 epithelial cell line derived from a 
grade 2 colon adenocarcinoma. In vitro, Caco-2 IEC undergo a process 
o f spontaneous differentiation leading to the formation o f an IEC 
monolayer. These monolayers express several functional and 
morphological features of mature enterocytes. The characteristic features 
o f Caco-2 IEC forming monolayers will be used as an in vitro model to 
investigate epithelial wound repair.
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2.1.2 TLR ligands
Lipopolysaccharide (LPS) from E. coli (Sigma Aldrich)
Flagellin (FLA) from S. typhimurium (InvivoGen)
Poly I:C HMW (InvivoGen)











B-actin Cell Signalling 
Technologies
4967 45 Rabbit 1:1000
SOCS3 Cell Signalling 
Technologies
2923 26 Rabbit 1:1000
pSTAT3 Cell Signalling 
Technologies
9145 79, 86 Rabbit 1:1000
STAT3 Cell Signalling 
Technologies
9139 79, 86 Mouse 1:1000
NF-kB Cell Signalling 
Technologies





Life Technologies A21206 1:200
rabbit IgG- 
HRP
Santa Cruz sc-2030 1:5000
mouse IgG- 
HRP
Santa Cruz sc-2031 1:5000
Table 2-1 List o f manufacturers, product codes, molecular weight, source and 
working dilution o f primary and secondary antibodies
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2.1.4 Primers
Primers were designed and checked for specificity using the National Centre for 
Biotechnology Information (NCBI). The primer sequences used to amplify genes 
were:
RPLPO (142bp) Forward: GC A AT GTT GC C AGT GTCTG and Reverse: 
GCCTTGACCTTTTCAGCAA
SOCS3 (119bp) Forward: TCGATTCGGGACCAGCCCCC and Reverse:
T GCT GT GGGT GACCATGGCG
TNFa (82bp) Forward: AGGTTCTCTTCCTCTCACATAC and Reverse:
ATCATGCTTTCAGTGCTCATG
TNFR2 (221 bp) Forward: G AGT GGT G A ACTGT GT CAT G A and Reverse:
GAGCTCGGCGCTGTGATC;
TLR4 (134bp) Forward: GC C CT GCGT GG AGGT GGTT C and Reverse:
AGCTGCCTAAATGCCTCAGGGGA





2.2.1.1 Culturing cell lines
The human colorectal cancer SW480 epithelial cell line was maintained in 
Leibovitz growth medium (Gibco) supplemented with 10% foetal bovine serum (FBS) 
(Life Technologies), 50 units/ml o f penicillin and streptomycin (Sigma Aldrich) and 
0.11 mg/ml o f sodium pyruvate. Cells were allowed to differentiate under an 
atmosphere o f 100% air at 37°C in a humidified incubator (incu safe).
The human colorectal cancer Caco-2 epithelial cell line was maintained in 
Minimal Essential Medium-MEM (Gibco) supplemented with 10% FBS, 50 units/ml 
o f penicillin and streptomycin, and 1% MEM Non-Essential Amino Acids (Gibco). 
Cells were allowed to differentiate under an atmosphere o f 95% (v/v) air-5% CO2 at 
37°C in a humidified incubator (incu safe).
2.2.1.2 Trypsinisation of cells
To maintain cell growth, cells were routinely passaged once cells had reached 
70-80% confluence to prevent cells from becoming over-confluent and terminally 
differentiated. In order to split cells, either for passaging or seeding for subsequent 
experiments, medium was removed from flask and cells were washed three times with 
Dulbecco's Phosphate-Buffered Saline (DPBS) without Ca2+ or Mg2+ (Gibco). 
Trypsin-EDTA (IX ) with Phenol Red (Gibco) was then added to the flask (0.5mls 
Trypsin per T25 flask). Cells were incubated with trypsin for 6 minutes at 37°C, to 
allow cells to detach from flask. Once cells were no longer adherent, 5mls o f growth
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medium was added to inactivate trypsin. Cells were then pipetted gently to create a 
single cell suspension and allow for an accurate cell count using a haemocytometer. 
Cells were then seeded into a new T25 flask containing 6mls o f new growth medium 
at the required density, depending upon when cells would next be passaged. For the 
purposes o f our experiments, cells were only used between passage 20 and 50, to 
reduce divergence from parent lines.
2.2.1.3 Frozen cell stocks
To reduce divergence from parent cell lines, cells were frozen down for future 
use after 5-6 passages. To create a frozen stock, the cell suspension was transferred to 
a 15ml centrifuge tube and centrifuged at 1000 RPM for 5 minutes to form a pellet. 
The medium was removed and the pellet resuspended in 1ml o f appropriate medium 
containing 40% FBS and 10% Dimethyl sulfoxide (DMSO) (Sigma Aldrich). The cell 
suspension was immediately transferred to a 1.8ml polypropylene cryo-vial and stored 
in a NALAGENE Freezing container filled with isopropanol overnight at -80°C to 
allow gradual freezing before being transferred to liquid nitrogen (-180°C) for long 
term storage.
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2.2.2 Plasmid preparation for transfection
2.2.2.1 Transforming E.coli with the GS50726 pIERESneo- 
Human_SOCS3 plasmid
The GS50726 pIERESneo-Human_SOCS3 plasmid was transformed into E. coli 
using the One shot ®OmniMAX™-Tl Chemically competent E. coli kit (Life 
Technologies). To do this, one vial o f the OneShot®OmniMAX™-Tl chemically 
competent E. coli was thawed slowly on ice. Five microlitres o f the GS50726 
pIERESneo-Human_SOCS3 plasmid was then added to the vial and mixed gently. The 
vial was incubated on ice for 30 minutes. Cells were heat-shocked at 42°C for 30 
seconds without shaking. Cells were again placed on ice for 2 minutes. Two hundred 
and fifty microlitres o f pre-warmed S.O.C Medium was then added to the 
transformation.
2.2.2.2 Clone selection using LB plates
The transformation was streaked on an LB plate containing 50pg/ml of 
ampicillin (Sigma Aldrich). Care was taken not to streak too much transformed 
bacteria on plate as it may not be absorbed into the medium. Plate was then incubated 
upside down at 37° for 16-24h. As the SOCS3 plasmid also contains an ampicillin 
resistance cassette, E. coli which had acquired the SOCS3-plasmid will selectively 
grow on the LB plate forming a single cell clone.
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2.2.23 Amplification o f clone
Using a sterile loop, a single clone was transferred into a 25ml universal tube 
containing 5ml o f LB Broth (Life Technologies) with ampicillin at a final 
concentration o f 50pg/ml. Universal tube was incubated at 37°C overnight in a 
shaking incubator.
2.2.2.4 Isolation of plasmid DNA
The illustra plasmidPrep Mini Spin Kit (GE Healthcare) was be used to extract 
and purify the plasmid DNA, with DNA eluted in 15pl o f elution buffer.
2.2.2.5 Linearisation of plasmid DNA
The NanoDrop (Thermo Scientific) was used to determine the concentration and 
purity o f extracted DNA. Following on from this, a reaction mixture containing the 
Ahd I restriction enzyme (NEB) was used to linearise the plasmid, incubating at 37°C 
overnight. To do this, 5pl o f NEB Buffer 4, 0.5pl o f BSA, 3pl o f enzyme and plasmid 
were added together. dH20 was then added to bring the total volume to 50pl, mixture 
was incubated at 37°C for 16h. The mixture was then incubated at 65°C for 20 
minutes the following day to stop the reaction. Some of the plasmid was retained 
before linearisation so DNA could be electrophoresed on an agarose gel to confirm 
plasmid had been linearised.
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2.2.2.6 Ethanol precipitation
Ethanol precipitation was carried out to purify DNA from the aqueous solution 
by adding ethanol as an anti-solvent. Five microlitres o f 3M sodium acetate and 1 lOpI 
of neat ethanol was added to the tube, and mixed gently. The tube was then incubated 
at -20°C for 90 minutes. After 90 minutes, the tube was centrifuged in the cold room 
(4°C) at full speed for 20 minutes. Three hundred microlitres o f 80% ethanol was then 
added to the tube, again in the cold room. The tube was then centrifuged at full speed 
for 5 minutes in the cold room. The supernatant was removed from tube in the culture 
hood, and the DNA pellet was resuspended in 30pl o f autoclaved dfhO  and stored on 
ice until further use.
2.22.1 Confirming plasmid has been linearised
Concentration and purity o f plasmid-prep was again established using the 
NanoDrop. DNA was reconstituted to lpg/fil, and aliquoted in 20pl volumes in 
labelled eppendorf tubes and stored at -20°C until further use. Both uncut and 
linearised plasmids were electrophoresed on an agarose gel with a lOObp ladder to 
confirm plasmid had been linearised.
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2.2.3 Transfecting IECs with plasmid DNA
Lipofectamine™ 2000 (Life Technologies) transfection reagent was used to 
transfect IEC with plasmid DNA. On the day before transfection, cells were plated in 
the appropriate medium without antibiotics such that they would be 80-90% confluent 
at the time o f transfection. For each transfection sample, DNA was diluted in the 
appropriate amount o f medium without serum. Lipofectamine was mixed gently 
before use and diluted in the appropriate amount o f medium without serum. Both 
solutions were mixed gently and incubated for 5 minutes at room temperature (RT). 
After 5 minutes, the diluted DNA and Lipofectamine were combined, mixed gently 
and incubated for 20 minutes at RT to allow complex formation to occur. The DNA- 
Lipofectamine complexes were then added to each well/flask containing cells and 
medium without serum and incubated at 37°C for 5h. After 5h, medium was removed 





r-pi (K)Total RNA from each sample was extracted using the TRI Reagent RNA 
Isolation Reagent (Sigma Aldrich) method; briefly, 1ml o f TRI regent was used to lyse 
adherent cells. After addition o f reagent, the pipette tip was used to scrape the base of 
the well, and pipetted up and down a few times to form a homogenous lysate. The 
lysate was then incubated for 10 minutes at RT to permit the complete dissociation of 
nucleoprotein complexes. 0.2mls o f chloroform was added for each 1ml o f TRI 
reagent used for the initial homogenisation. The lysates were left at RT for 10 minutes. 
Samples were then centrifuged at 12,000g for 15 minutes at 4°C. The resultant 
aqueous phase was carefully removed and transferred to a new tube. The RNA was 
then precipitated from the aqueous phase by mixing with 0.5mls of isopropyl alcohol 
(Sigma Aldrich) per 1ml of TRI reagent used in initial homogenisation. Samples were 
mixed and incubated at RT for 10 minutes to allow RNA to precipitate. Samples were 
then centrifuged at 12, OOOg for 10 minutes at 4°C, to pellet the RNA. The supernatant 
was removed and the RNA pellet was washed by adding 1ml of 75% ethanol (Fisher 
Scientific). Samples were vortexed and centrifuged at 7, 500g for 5 minutes at 4°C. 
Supernatant was again removed and samples were washed a second time as before in 
75% ethanol. The RNA pellet was allowed to dry for 10 minutes at RT before 
resuspending in 20|ul o f RNase free-water (Life Technologies).
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2.2.4.2 Examining concentration and purity o f extracted RNA
The RNA concentration and purity (260/280) were determined by measuring the 
absorbance o f the sample using the NanoDrop 2000. To confirm the quality o f RNA, 
0.5mg of each sample was run on a 1% non-denaturing agarose gel in TBE (Tris 
Borate Ethylenediaminetetracetic acid EDTA) containing a lx  solution o f GelRed™ 
Nucleic Acid Gel Stain and bands visualized under UV light. For good quality RNA, 
two bands should be present, representing the ribosomal 18S and 28S RNA. Samples 
with degraded RNA were signified with an unspecific smear on the gel instead o f two 
distinct bands, which were then excluded from subsequent steps.
2.2.4.3 cDNA synthesis
Two micrograms of RNA was then reverse transcribed into cDNA using the 
Enhanced Avian RT First Strand Synthesis Kit (Sigma Aldrich). One microlitre of 
oligo dT (Fisher Scientific) was added to 2pg of RNA to be reverse transcribed. The 
total volume was made up to 1 O j l i I  using nuclease-free water. The mixture was 
incubated at 70°C for 10 minutes before being placed on ice for 5 minutes. Two 
microlitres o f lOx M-MLV Reverse Transcriptase Buffer, lp l o f dNTP (lOmM) 
(Sigma Aldrich), lp l of M-MLV Reverse Transcriptase enzyme and 6pl o f nuclease- 
free water were then added bringing the total volume to 20(il. The samples were 
briefly centrifuged before being incubated at 42°C for lh  and 80°C for 10 minutes to 
denature the M-MLV reverse transcriptase enzyme. The samples were then stored at - 
20°C for future use.
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2.2.4.4 Relative Quantitative Real Time PCR
2.2.4.4.1 Basic principle of SYBR Green I based QPCR
Relative Quantitate Real time PCR was performed using the SYBRK Green 
JumpStart™ Taq ReadyMix™ (Sigma Aldrich). The diagram below represents a 
schematic representation of the steps involved in the real-time SYBR-Green reaction.
slrrirrirnr'm i  i n  s in  mu i n Double stranded DNA
i m w w w w 3'
mm linn iiiia mill mm;














Figure 2-1 Schematic representation of the steps involved in the real-time SYBR- 
Green reaction (Sigma Aldrich)
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Double stranded DNA is denatured by heating to 94°C. During this period, the 
double-stranded DNA helix separates into two single-stranded DNA templates. The 
temperature then falls to 60°C during which the DNA polymerase enzyme anneals to 
the DNA strands and extends the sequence specific primers with the incorporation of 
nucleotides that are complementary to the template yielding a double-stranded DNA 
complex. The SYBR Green I is then able to bind to the newly synthesised double­
stranded DNA complexes and fluoresce. The fluorescence accumulates as the cycling 
o f the PCR continues and is measured at the end o f each cycle. The intensity of 
fluorescence generated by the SYBR Green I above the background level or cycle 
threshold (Ct value) is measured and used to quantify the amount o f newly generated 
double-stranded DNA strands. After repeated cycles of denaturing, annealing and 
extension, approximately 40 times, the Ct is used to measure gene expression (Sigma 
Aldrich).
2.2.4.4.2 SYBR Green I data parameters
To detect gene expression between test samples based on the number o f cycles 
passed before possible detection of fluorescence, the baseline and the threshold must 
first be set. The baseline is the noise level in the early cycles where there is no 
detectable increase in fluorescence due to amplification products. The threshold is an 
adjustable value above the background but significantly below the plateau o f the 
amplification plot. The threshold is usually placed within the linear region o f the 
amplification, and is usually determined by the computer software. The Ct for a given 
amplification curve is defined as the cycle number at which the fluorescence generated 
within a particular reaction surpasses the defined threshold and signifies a point at
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which there is a significant increase in detectable product. The fewer number o f cycles 
required to reach the detectable level o f fluorescence, indicates a greater initial copy 
number o f the target nucleic acid.
2.2.4.4.3 Endogenous control reference gene
This is a gene whose expression level does not differ between samples, such as 
housekeeping genes. The use of a reference gene or endogenous control is important in 
order to standardise the quantity and monitor the quality o f cDNA added to each 
reaction. Initially, three housekeeping genes RPLPO, 18S and GAPDH 
(Glyceraldehyde-3-phosphate dehydrogenase) were tested for this study. Validation 
experiments indicated RPLPO was the best housekeeping gene to determine the 
relative levels of gene expression. Hence, RPLPO was used as an internal reference 
gene for this study.
2.2.4.4.4Calculating relative gene expression
The Ct number for both the gene of interest and the housekeeping gene were 
verified for each sample. This would permit the expression o f the gene o f interest to be 
normalised to the endogenous housekeeping gene. The comparative method, 
sometimes called the 2~AACt method, was used for calculating the relative gene 
expression. This involved comparing the ACt of the samples with a non-treated 
sample. This involved calculating the AACt, by subtracting ACWtreated from the 
ACtsampie- Changes in C, values for the gene of interest were normalised relative to 
RPLPO. In all experiments, gene expression was expressed as fold-change relative to 
no treatment control.
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2.2 A A. 5 Primer design
Primers for genes were designed from sequences in the Genebank database. The 
forward and reverse sequences o f the primers for each gene are shown in section 2.1.4. 
All primers sets were designed such that the PCR product size was a maximum of 250 
base pairs and primers only spanned exon-exon junctions. However, it was later 
discovered that TNFR2 primers might be amplifying residual genomic DNA as they 
were buried in one exon. Therefore, TNFR2 primers were validated for subsequent 
experiments. All primer sets were tested by BLAST searching to ensure primers did 
not bind to other sequences and that primer dimers were not formed. Primer sequences 
were then sent to Sigma Aldrich for production. An attempt was made to design TNFa 
primers, but this proved unsuccessful. Primers were therefore purchased from 
Primerdesign. RPLPO was selected as a housekeeping gene because in preliminary 
experiments, mRNA expression o f RPLPO did not change following treatment.
2.2.4.4.6Primer concentration optimisation for qPCR
Before primers could be used to detect gene expression for qPCR, they first had 
to be optimised to determine the concentration o f forward and reverse primers that 
produced the smallest Ct number with the highest fluorescent signal. For the purpose 
o f these experiments, the real time PCR reactions were initially performed with lp l o f 
cDNA template and different combinations o f forward and reverse primer 




















Table 2-2 Combination o f forward and reverse primer concentrations for 
optimisation experiments for qPCR
Primer optimisation was performed for all primers with experiments indicating 
the optimum combination of primer concentrations for the quantitate amplification of 
RPLPO, SOCS3, TNFR2, TLR4 and TGFP to be lOOOnM forward and lOOOnM 
reverse for each gene.
2.2.4.4.7 Primer validation
For the AACt calculation to be valid, the amplification efficiencies o f the target 
and the endogenous reference genes must be roughly the same. This can be established 
by observing how ACtsampie varies with template dilution. The ACt is plotted against 
the logarithm (log) o f the template amount. If the gradient o f the cDNA dilution versus 
ACt is near to 0 (<0.1) then this indicates the amplification o f the housekeeping and 
the target genes are comparable.
To validate primers, cDNA was diluted 1 in 2 as a serial dilution. Six dilutions 
were performed ranging from lOOng to 3.125ng. The same cDNA was used for all 
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Figure 2-2 Example o f a validation experiment for the SOCS3 primer in relation to the
RPLPO housekeeping gene
Figure 2-2 shows the variation of ACt value for SOCS3 in relation to RPLPO 
housekeeping gene when template input is diluted. The x-axis depicts the logio o f the 
cDNA added, whereas the y-axis depicts the ACt value. For the 2 'AACt method to be 
valid, the amplification efficiencies of SOCS3 and RPLPO must be equal in the range
o f template input used. This is confirmed when the slope value is less than 0.1. The 
slope value for RPLPO was -3.1324 and SOCS3 was -3.158. The ACt values for 
SOCS3 in relation to RPLPO are therefore acceptable when the range o f cDNA is 
between 100 and 3.125ng.
Validation experiments were also performed for TNFR2, TLR4 and TGFp 
primers in relation to RPLPO as the internal reference gene; the ACt values were 
acceptable when the range o f cDNA was between 100 and 3.125ng.
2.2.4.4.8 SYBR Green I cDNA amplification reaction
Relative Quantitate real-time PCR was performed in a 15pl reaction volume in a 
96-well plate in the C l000 Real Time Thermocycler (Bio-Rad). The mixture was 
prepared according to the following recipe:
7.5pl 2x SYBR Green I Mastermix
1.5 |l i1 (10pM) Forward primer Final concentration o f lOOOnM
1.5pl (1 OpM) Reverse primer Final concentration o f 1 OOOnM
1 pi o f cDNA
H2 O (Nuclease free water) to 15pl
The concentrations o f primers were used according to the optimised experiments 
(section 2.2.4.4.6). Cycling conditions were 94°C for 2 minutes, 40 x 94°C for 15 
seconds and 60°C for 1 minute. No Template Control (NTC) were always included in 
each real-time PCR run to ensure amplification was not due to reagent contamination.
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2.2.5 SDS-PAGE and Western blotting
2.2.5.1 Preparation of lysates and electrophoresis
The Abeam method of SDS-PAGE and western blotting was used to determine 
protein expression levels. Following treatment, the 6-well cell culture dish was placed 
on ice and washed once with ice-cold Phosphate Buffered Saline (PBS) (Gibco). It 
was important to remove as much PBS after washing, as this would dilute the lysis 
buffer. Wells were then lysed with 50pl o f ice-cold lysis buffer (50mM Tris-HCL 
pH7.5, 150mM NaCl, 1% Nonidet P40, 10% Glycerol and 5mM EDTA) containing 
phosphatase inhibitor (Sigma Aldrich) and protease inhibitor (Sigma Aldrich). 
Adherent cells were scrapped off the base o f the plate using a pipette; the cell 
suspension was then gently transferred to a pre-cooled tube and centrifuged at 12,000 
RPM for 20 minutes at 4°C. Tubes were removed from centrifuge and placed on ice, 
supernatant was aspirated to a fresh tube and placed on ice, discarding pellet.
2.2.5.2 Determining protein concentration
Before performing immunoblotting, it was necessary to determine the 
concentration o f protein present in the samples to be tested. Bradford reagent (Sigma 
Aldrich) was used to determine protein concentration o f samples; this involved a 
coloumetric assay for measuring total protein concentration. Briefly, 6 protein 
standards o f between lOOpg and 0 were generated in duplicate using BSA in a final 
volume o f lOOpl. Five hundred microlitres o f Bradford reagent was then added to 
standards and samples, and incubated at RT for 5 minutes. After 5 minutes, 
absorbance o f standards and samples were measured at 595nm. A standard curve was
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then generated by plotting the 595 nm values (y-axis) versus their concentration in 
pg/ml (x-axis). The standard curve was then used to determine the unknown sample 
concentration. Protein aliquots o f 25pg were generated and boiled at 95°C for 10 
minutes with 4x Sample buffer (Life Technologies) and 2-Mercaptoethanol (Sigma 
Aldrich).
2.2.5.3 Western blotting technique
Proteins were run alongside the Precision Plus Protein™ All Blue Standard 
(Bio-Rad) to monitor electrophoretic separation and molecular weight sizing o f 
separated proteins on a 10% SDS-PAGE gel at 40mA for lh. Proteins were 
subsequently electro-transferred onto a nitrocellulose membrane (Macherey-Nagel) 
using the semi-dry Trans-Blot® Turbo™ Transfer system (Bio-Rad) using lOx Fast 
Transfer Buffer (Life Technologies) for 30 minutes. The membrane was treated with 
3% bovine serum albumin (BSA) (PAA) in TBST (Tris Buffered Saline-Tween) for lh 
at RT, then incubated with primary antibody (SOCS3, 1:1000, Cell Signalling 
Technology, Rabbit, 26kDa), (P-actin, 1:1000, Cell Signalling Technology, Rabbit, 
45kDa), (NF-*B, 1:1000, Cell Signalling Technology, Rabbit, 65-80kDa), (pSTAT3, 
1:1000, Cell Signalling Technology, Rabbit, 79, 86kDa) or (STAT3, 1:1000, Cell 
Signalling Technology, Mouse, 79, 86kDa) overnight at 4°C. Membrane was then 
washed three times for 10 minutes in TBST and incubated in anti-rabbit IgG-HRP 
(Santa Cruz, 1:5000) or anti-mouse IgG-HRP (Santa Cruz, 1:5000) conjugated 
secondary antibody for lh at RT. The membrane was again washed three times in 
TBST and once in TBS, 10 minutes for each wash. The Pierce® ECL Western Blotting 
Substrate kit (Thermo Scientific) was then used to detect Horseradish peroxidase
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(HRP), this was later detected and quantified using the ChemiDoc XRS imaging 
system (Bio-Rad). Western blots were carried out in a minimum of three independent 
experiments.
To blot for loading control (p-actin) or normalise pSTAT3 expression to total 
STAT3 expression, primary antibody was removed from probed membranes using 
mild stripping buffer (1.5% glycine, 1% SDS and 1% Tween-20) for 10 minutes two 
times at RT, before being washed two times for 10 minutes each in PBS and two times 
for 5 minutes each in TBST. Consequently, membranes were ready to be blocked in 
3% BSA in TBST then probed with the next primary and secondary antibody as 
described above.
Protein expression levels were again quantified through densitometry using the 
ChemiDoc XRS imaging system.
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2.2.6 Proliferation assay
The CyQUANT® Cell proliferation Assay kit (Molecular Probes, Invitrogen) 
which includes the CyQUANT® GR dye and cell lysis buffer were used to determine 
the proliferation capabilities o f cells after treatment with microbial ligands. The 
CyQUANT method works by incorporating the fluorescent dye into total DNA, which 
correlates directly to the number o f cells in culture.
Stock cell densities were determined by visual counting using a haemocytometer 
and Trypan blue (Sigma Aldrich). Cells were then resuspended in medium and plated 
in 24-well culture plates at a concentration o f 25,000 cells per well in 500pl volumes; 
and incubated overnight at 37°C, thus allowing cells to adhere to the well surface. 
Following microbial stimulation, no treatment cultures were also included allowing 
comparison; plates were harvested after 48h by removing growth medium and freezing 
plates at -80°C.
To establish the number o f cells; a standard calibration curve o f known cell 
number was constructed. A cell suspension 2 x 106 cells was centrifuged (Harrier 
18/80) for 5 minutes at 1000 RPM. The suspension was carefully removed and the 
pellet frozen for lh  at -80°C. The dye in cell lysis buffer was made up immediately 
prior to reading plates by diluting the dye stock solution 20-fold in cell lysis buffer; 
followed by diluting this solution 20-fold in distilled water. The pellet was thawed at 
RT and 1.6mls o f the dye/lysis buffer was added to the pellet, and the lysate 
resuspended by brief vortexing, to generate a suspension o f 1.25 x 106 cells/ml. A cell 
dilution series ranging from 500,000 to 10,000 cells was formed in duplicate in a 24- 
well cell culture plate with the dye/lysis buffer cell suspension mixture in final 
volumes o f 400|il per well. A 400pl control well with no cells (dye/lysis buffer only) 
was also prepared and the plate was incubated in darkness for 4 minutes at RT. The
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plate was then read by measuring fluorescence using a plate-reader with
excitation/emission maxima: 480/520nm for dye bound to nucleic acids (WALLAC
2 •VICTOR 1420 Multicaler). A standard calibration curve was generated by plotting
measured fluorescence values versus cell number from the standard curve as described 
previously. Four hundred microlitres o f dye/lysis buffer was added to each well o f the 
sample plate, and incubated in darkness for 4 minutes at RT, absorbance readings for 
sample plate was then obtained (WALLAC VICTOR2 1420 Multicaler).
To evaluate cellular proliferation in response to treatment; values had been 
expressed as percentage change in cell number relative to no treatment controls for 
treatment.
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2.2.7 Wound healing assay
An in vitro wound healing assay was performed using the modified method as 
described by Han and colleagues (2000). Four reference lines were drawn horizontally 
across the outer bottom of a 24-well cell culture plate. Caco-2 cells (2 x 105 cells/well) 
were then seeded at 80-90% confluence and allowed to form monolayers for 7 days at 
37°C. After 7 days, linear wounds were made with a sterile lOpl plastic pipette tip 
perpendicular to lines drawn on the bottom of the plate. To remove floating cells, cells 
were washed three times in PBS. Cells were then treated as required; with no 
treatment controls also included to allow comparison. Medium and treatment within 
wells was replaced with freshly prepared medium and respective treatment after 24, 48 
and 72h with the no treatment wells also replaced with complete medium to remove 
floating cells, replenish nutrients and restore treatment levels.
Figure 2-3 Phase-contrast images of Caco-2 monolayer's with images taken at (a) 0 
Hours (b) 24 Hours (c) 48 Hours after wounding (xlO magnification)
Images of wounds were obtained using the confocal microscope (Leica 
DMIRE2 inverted microscope) at lOx magnification using standard protocols at the 
predetermined location at various times after wounding. To attain an accurate
113
determination o f wound repair in response to ligand treatment, the area o f the acellular 
region was measured using ImageJ and data calculated as % wound healed Vs. Oh.
To investigate the effect o f SOCS3 overexpression on wound repair, IEC were 
transfected with the pBIG2i plasmid either containing the entire coding sequence for 
SOCS3 (S3) or empty vector (EV) control. To establish levels o f SOCS3 after 
monolayers have formed (i.e. 7 days), Caco-2 IEC were seeded in a 24-well culture 
plate at 2 x 105 cells/well in 1ml of medium without antibiotics such that they were 80- 
90% confluent minimising post-transfection proliferation and ready to be transfected 
the next day. Caco-2 IEC were then transfected with 1 pg o f EV or S3 plasmid as 
described in section 2.2.2. After 7 days, total RNA was extracted, cDNA generated 
and SOCS3 mRNA expression levels monitored in triplicate between EV and S3 
cultures as described previously (section 2.2.4)
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2.2.8 ELISA Assay
Supernatant collected from IEC which had previously been treated with TLR 
ligands was used for the quantitative measurement o f hTNFa in a sandwich ELISA 
format using the Human TNFa ELISA Development Kit purchased from PeproTech 
(900-K25).
To prepare plate, capture antibody was diluted with PBS to a concentration of 
lpg/m l, lOOpl o f this solution was used to coat each well o f an ELISA plate, and 
sealed overnight at RT. The following day, liquid was aspirated from wells and 
washed 4 times in wash buffer (0.05% Tween-20 in PBS) with plate inverted and 
blotted on paper to remove residual buffer. The TNFa standard was then prepared 
from 1.5ng/ml to zero in diluent (0.005% Tween-20, 0.1% BSA in PBS). One 
hundred microlitres o f standard or sample was immediately added to each well in 
duplicate and incubated at RT for two hours. After 2h, plate was washed as before 
then incubated with lOOpl o f detection antibody in diluent to a concentration of 
0.5pg/ml for 2h at RT. Wells were again aspirated and washed as previously 
described. Avidin Peroxidase was diluted 1:2000 in diluent, lOOpl was added to each 
well and incubated for 45 minutes at RT. Wells were again washed as before, lOOpl 
o f ABTS liquid substrate solution (Sigma Aldrich) was then added to each well and 
incubated at RT for colour development before reading ELISA plate at 405nm with 
wavelength correction set at 650nm. Experiment was repeated three times with data 
pooled together and a student t test used to determine statistical effect in contrast to no 
treatment with p<0.05.
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2.2.9 Im m unocytochem istry
C overslips were sterilized with ethanol, and carefully placed in each well o f  a 
12-well plate. IEC were then seeded onto coverlsips at 1 x 105 lEC/w ell and allowed 
to adhere. Follow ing TLR treatm ent, medium  was rem oved and IEC w ere w ashed 3 
tim es for 5 m inutes each in 1ml o f  PBS. IEC were then incubated in 1ml o f 
ethanohm ethanol for 10 m inutes at -20°C. IEC were again w ashed as before and 
blocked in 1ml o f  2%  BSA in PBS-Tween-20 for 30 m inutes at RT. IEC w ere w ashed 
in PBS, and incubated with 500pl o f primary antibody ((A nti-H um an sTNF Receptor 
Type II(Peprotech 500 -P 168)) at 0.5pg/m l in blocking solution at 4°C overnight. IEC 
were washed in PBS. then incubated with Alexa Fluor®" 488 Donkey A nti-R abbit IgG 
secondary antibody (Life Technologies, 1:200) for lh  at RT in the dark. Secondary 
antibody solution was then decanted and IEC washed as described previously. To 
counterstain IEC, wells were incubated with 500pl o f  propidium  iodide (Life 
Technologies, P3566, 1:3000 in PBS) for 1 minute, then washed once w ith PBS. 
C overslips were then m ounted onto slides and sealed with nail varnish to prevent 
drying and m ovem ent under m icroscope. Slides were stored in the dark  at 4°C  ready to 
be viewed using the Zeiss LSM 510 M eta Confocal M icroscope.
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To determine the role of SOCS3 in IEC replenishment and repair, we initially 
wanted to generate an in vitro model system. This enabled the investigation o f the role 
o f SOCS3 in mediating cellular responses and epithelial repair following microbial 
induced TLR signalling. We used models of transient and stable IEC transfection.
We were successfully able to overexpress SOCS3 in both SW480 (8.2) and 
Caco-2 (5.9) IEC. Transient transfection has its disadvantages in that cells only
overexpress the inserted gene for a limited period. Cells are therefore required to be
transfected for each experiment which could result in experimental variation in terms 
o f levels o f gene expression.
Stable transfection involves DNA to be integrated into the host genome therefore 
cells continue to express traits caused by the genetic material, even after many 
generations o f cell division. SW480 IEC were successfully transfected, resulting in a 
12-fold increase in mRNA and a 25% increase in SOCS3 protein expression in 
comparison to SOCS3nomi IEC. However we were unable to stably transfect Caco-2 
IECs. To investigate the effect of SOCS3 on TLR-mediated wound repair, IEC were 
transfected and monolayers allowed to form for 7 days. SOCS3 mRNA expression
levels were then tested before wounding. qPCR data showed Caco-2 IEC were
successfully transfected with SOCS3 mRNA expression 5.3 times greater in SOCS3 
transfected cultures than empty vector control cultures.
In the following chapters, both transient and stable IEC (SW480 and Caco-2) 
will be used in conjunction with control (EV or SOCS3norm) IEC to investigate the role 




Studies have begun to investigate the mechanisms that push the development of 
IBD (Breynaert, Vermeire et al. 2008; Saleh and Trinchieri 2010; Li, de Haar et al. 
2011; Li, de Haar et al. 2012). The activation of the immune system in IBD initiates 
the production o f mediators that promote the destruction of the epithelium further 
augmenting inflammation. Studies have uncovered the molecular mechanism of 
intracellular signalling pathways of inflammatory cytokines such as TNFa and IL-6. 
Binding o f these inflammatory cytokines to their corresponding receptors activates 
JAK2; subsequently permitting the phosphorylation of the transcription factor STAT3 
(Mitsuyama, Matsumoto et al. 2006; Croker, Kiu et al. 2008). The pSTAT3 then 
translocates to the nucleus, where it interact with specific DNA sequences and induces 
the transcription o f target genes (Krebs and Hilton 2001; Yoshimura, Naka et al. 2007; 
Li, de Haar et al. 2010).
SOCS3 is a natural endogenous regulator of inflammatory cytokine-mediated 
signalling, and has been shown to block TNFa-induced NF-*B translocation and IL-6 
induced STAT3 phosphorylation (Rigby, Simmons et al. 2007). SOCS3 inhibits 
signalling through the JAK/STAT signalling pathway by inhibiting both JAK kinase 
and STAT phosphorylation (Sasaki, Yasukawa et al. 1999; Li, de Haar et al. 2012).
Suzuki and colleagues (2001) have shown that SOCS3 expression is upregulated 
in both animal and human intestinal inflammation (Suzuki, Hanada et al. 2001). There 
is also compelling evidence to support the role of SOCS3 as a tumour suppressor in 
the intestine, with studies showing targeted removal of SOCS3 encouraging tumour 
incidence and growth in the bowel; and methylation silencing o f SOCS3 shared in 
multiple tumours (Ogata, Chinen et al. 2006; Rigby, Simmons et al. 2007). In human
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lung cancer cells, restoring SOCS3 expression decreased STAT3 activation and 
reduced tumour growth (He, You et al. 2003).
Numerous studies have shown that commensal bacteria are recognised by IEC 
which express TLRs (Abreu, Fukata et al. 2005; Kawai and Akira 2007; Beutler 
2009). Studies have shown that TLR signalling plays a fundamental role in the 
maintenance o f intestinal epithelial homeostasis, with commensal flora and TLR 
signalling protecting from intestinal epithelial injury. Conversely, germ-free mice also 
have a lower incidence of tumour burden within the colon (Rakoff-Nahoum, Paglino 
et al. 2004).
As evidence also supports TLRs as imperative mediators o f mucosal 
homeostasis, repair o f damaged tissue and protection against the development o f colon 
cancer; this project seeks to investigate the dual and perhaps integrated role o f SOCS3 
and TLRs in mediating intestinal epithelial homeostasis and repair following damage.
The aim of the first section was to develop IEC which constitutively overexpress 
SOCS3; enabling me to investigate the role of SOCS3 in mediating cellular responses 
and epithelial repair following microbial induced TLR signalling.
3.3 Aim: To develop SOCS3 overexpressing IECs
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3.4 M ethods
3.4.1 Generating transient SOCS3 overexpressing IEC 
3 A A A  SOCS3 vector containing pBIG2i plasmid
The plasmid (pBIG2i) either containing the entire coding sequence for SOCS3 
(S3) or a control empty vector (EV) was a gift from Dr. Richard Furlenetto. The S3 
plasmid had previously been used to overexpress SOCS3 in IEC lines (Rigby, 





SOCS3 cassette inserted 








Figure 3-1 Diagram displaying the pBIG2i plasmid
The diagram above displays the pBIG2i plasmid, either containing the entire 
coding sequence of hSOCS3 cloned into the EcoRI site (S3) or a control empty vector 
(EV).
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3.4.1.2 Transient transfection using the SOCS3 vector containing pBIG2i 
plasmid
SW480 and Caco-2 IEC were seeded in 24-well culture plates at 2 x 105 
cells/well in 1ml of medium without antibiotics such that they were 80-90% confluent 
minimising post-transfection proliferation and ready to be transfected the following 
day. IECs were then transfected with 1 pg of plasmid (pBIG2i) either containing the 
entire coding sequence for SOCS3 (S3) or a control empty vector (EV) using the 
method described in section 2.2.3. To validate overexpression o f SOCS3, mRNA 
expression was compared between S3 and EV plasmid transfected IEC.
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3.4.2 Generating stable S0CS3-overexpressing IEC
3.4.2.1 GS50726 pIERESneo-Human_SOCS3 plasmid
The GS50726 pIERESneo-Human_SOCS3 plasmid, which contains the SOCS3 
gene, was cloned into the Eco RV digested pIERESneo plasmid. The plasmid was 
purchased from Epoch Life Sciences. The pIERESneo contains the internal ribosome 
entry site (IRES) o f the encephalomyocarditis (ECMV) allowing the translation o f two 
open reading frames from one mRNA. The expression cassette of pIERESneo contains 
the human cytomegalovirus (CMV) major intermediate early promoter followed by a 
multiple cloning site (MCS), a small intron known to enhance the stability o f mRNA, 
the neomycinphosphotransferase (NPT II) gene, and the polyadenylation signal. Upon 
arrival, the plasmid was resuspended in 20jnl of autoclaved dH20 then stored on ice.
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Figure 3-2 GS50726 pIERESneo-Human_SOCS3 plasmid
Base sequence of the GS50726 pIERESneo-Human_SOCS3 plasmid which 
contains 5968 base pairs
G A C G G A T C G G G A G A T C T C C C G A T C C C C T A T G G T C G A C T C T C A G T A C A A T C T G C T C T G A T G C C G C A T A G T
T A A G C C A G T A T C T G C T C C C T G C T T G T G T G T T G G A G G T C G C T G A G T A G T G C G C G A G C A A A A T T T A A G C T A
C A A C A A G G C A A G G C T T G A C C G A C A A T T G C A T G A A G A A T C T G C T T A G G G T T A G G C G T T T T G C G C T G C T T C
G C G A T G T A C G G G C C A G A T A T A C G C G T T G A C A T T G A T T A T T G A C T A G T T A T T A A T A G T A A T C A A T T A C G G
G G T C A T T A G T T C A T A G C C C A T A T A T G G A G T T C C G C G T T A C A T A A C T T A C G G T A A A T G G C C C G C C T G G C T
G A C C G C C C A A C G A C C C C C G C C C A T T G A C G T C A A T A A T G A C G T A T G T T C C C A T A G T A A C G C C A A T A G G G A
C T T T C C A T T G A C G T C A A T G G G T G G A C T A T T T A C G G T A A A C T G C C C A C T T G G C A G T A C A T C A A G T G T A T C
A T A T G C C A A G T A C G C C C C C T A T T G A C G T C A A T G A C G G T A A A T G G C C C G C C T G G C A T T A T G C C C A G T A C A
T G A C C T T A T G G G A C T T T C C T A C T T G G C A G T A C A T C T A C G T A T T A G T C A T C G C T A T T A C C A T G G T G A T G C
G G T T T T G G C A G T A C A T C A A T G G G C G T G G A T A G C G G T T T G A C T C A C G G G G A T T T C C A A G T C T C C A C C C C A
T T G A C G T C A A T G G G A G T T T G T T T T G G C A C C A A A A T C A A C G G G A C T T T C C A A A A T G T C G T A A C A A C T C C G
C C C C A T T G A C G C A A A T G G G C G G T A G G C G T G T A C G G T G G G A G G T C T A T A T A A G C A G A G C T C T C T G G C T A A
C T A G A G A A C C C A C T G C T T A C T G G C T T A T C G A A A T T A A T A C G A C T C A C T A T A G G G A G A C C C A A G C T T G G T
A C C G A G C T C G G A T C G A T A T C G C C A C C A T G G T C A C C C A C A G C A A G T T T C C C G C C G C C G G G A T G A G C C G C C
C C C T G G A C A C C A G C C T G C G C C T C A A G A C C T T C A G C T C C A A G A G C G A G T A C C A G C T G G T G G T G A A C G C A G
124
T G C G C A A G C T G C A G G A G A G C G G C T T C T A C T G G A G C G C A G T G A C C G G C G G C G A G G C G A A C C T G C T G C T C A
G T G C C G A G C C C G C C G G C A C C T T T C T G A T C C G C G A C A G C T C G G A C C A G C G C C A C T T C T T C A C G C T C A G C G
T C A A G A C C C A G T C T G G G A C C A A G A A C C T G C G C A T C C A G T G T G A G G G G G G C A G C T T C T C T C T G C A G A G C G
A T C C C C G G A G C A C G C A G C C C G T G C C C C G C T T C G A C T G C G T G C T C A A G C T G G T G C A C C A C T A C A T G C C G C
C C C C T G G A G C C C C C T C C T T C C C C T C G C C A C C T A C T G A A C C C T C C T C C G A G G T G C C C G A G C A G C C G T C T G
C C C A G C C A C T C C C T G G G A G T C C C C C C A G A A G A G C C T A T T A C A T C T A C T C C G G G G G C G A G A A G A T C C C C C
T G G T G T T G A G C C G G C C C C T C T C C T C C A A C G T G G C C A C T C T T C A G C A T C T C T G T C G G A A G A C C G T C A A C G
G C C A C C T G G A C T C C T A T G A G A A A G T C A C C C A G C T G C C G G G G C C C A T T C G G G A G T T C C T G G A C C A G T A C G
A T G C C C C G C T T G A T T A C A A G G A T G A C G A C G A T A A G T A A G A T A T C T G C G G C C G C G T C G A C G G A A T T C A G T
G G A T C C A C T A G T A A C G G C C G C C A G T G T G C T G G A A T T A A T T C G C T G T C T G C G A G G G C C A G C T G T T G G G G T
G A G T A C T C C C T C T C A A A A G C G G G C A T G A C T T C T G C G C T A A G A T T G T C A G T T T C C A A A A A C G A G G A G G A T
T T G A T A T T C A C C T G G C C C G C G G T G A T G C C T T T G A G G G T G G C C G C G T C C A T C T G G T C A G A A A A G A C A A T C
T T T T T G T T G T C A A G C T T G A G G T G T G G C A G G C T T G A G A T C T G G C C A T A C A C T T G A G T G A C A A T G A C A T C C
A C T T T G C C T T T C T C T C C A C A G G T G T C C A C T C C C A G G T C C A A C T G C A G G T C G A G C A T G C A T C T A G G G C G G
C C A A T T C C G C C C C T C T C C C T C C C C C C C C C C T A A C G T T A C T G G C C G A A G C C G C T T G G A A T A A G G C C G G T G
T G C G T T T G T C T A T A T G T G A T T T T C C A C C A T A T T G C C G T C T T T T G G C A A T G T G A G G G C C C G G A A A C C T G G
C C C T G T C T T C T T G A C G A G C A T T C C T A G G G G T C T T T C C C C T C T C G C C A A A G G A A T G C A A G G T C T G T T G A A
T G T C G T G A A G G A A G C A G T T C C T C T G G A A G C T T C T T G A A G A C A A A C A A C G T C T G T A G C G A C C C T T T G C A G
G C A G C G G A A C C C C C C A C C T G G C G A C A G G T G C C T C T G C G G C C A A A A G C C A C G T G T A T A A G A T A C A C C T G C
A A A G G C G G C A C A A C C C C A G T G C C A C G T T G T G A G T T G G A T A G T T G T G G A A A G A G T C A A A T G G C T C T C C T C
A A G C G T A T T C A A C A A G G G G C T G A A G G A T G C C C A G A A G G T A C C C C A T T G T A T G G G A T C T G A T C T G G G G C C
T C G G T G C A C A T G C T T T A C A T G T G T T T A G T C G A G G T T A A A A A A A C G T C T A G G C C C C C C G A A C C A C G G G G A
C G T G G T T T T C C T T T G A A A A A C A C G A T G A T A A G C T T G C C A C A A C C C G G G A T A A T T C C T G C A G C C A A T A T G
G G A T C G G C C A T T G A A C A A G A T G G A T T G C A C G C A G G T T C T C C G G C C G C T T G G G T G G A G A G G C T A T T C G G C
T A T G A C T G G G C A C A A C A G A C A A T C G G C T G C T C T G A T G C C G C C G T G T T C C G G C T G T C A G C G C A G G G G C G C
C C G G T T C T T T T T G T C A A G A C C G A C C T G T C C G G T G C C C T G A A T G A A C T G C A G G A C G A G G C A G C G C G G C T A
T C G T G G C T G G C C A C G A C G G G C G T T C C T T G C G C A G C T G T G C T C G A C G T T G T C A C T G A A G C G G G A A G G G A C
T G G C T G C T A T T G G G C G A A G T G C C G G G G C A G G A T C T C C T G T C A T C T C A C C T T G C T C C T G C C G A G A A A G T A
T C C A T C A T G G C T G A T G C A A T G C G G C G G C T G C A T C G T A C T C G G A T G G A A G C C G G T C T T G T C G A T C A G G A T
G A T C T G G A C G A A G A G C A T C A G G G G C T C G C G C C A G C C G A A C T G T T C G C C A G G C T C A A G G C G C G C A T G C C C
G A C G G C G A T G A T C T C G T C G T G A C C C A T G G C G A T G C C T G C T T G C C G A A T A T C A T G G T G G A A A A T G G C C G C
T T T T C T G G A T T C A T C G A C T G T G G C C G G C T G G G T G T G G C G G A C C G C T A T C A G G A C A T A G C G T T G G C T A C C
C G T G A T A T T G C T G A A G A G C T T G G C G G C G A A T G G G C T G A C C G C T T C C T C G T G C T T T A C G G T A T C G C C G C T
C C C G A T T C G C A G C G C A T C G C C T T C T A T C G C C T T C T T G A C G A G T T C T T C T G A G G G G A T C A A T T C T C T A G A
G C T C G C T G A T C A G C C T C G A C T G T G C C T T C T A G T T G C C A G C C A T C T G T T G T T T G C C C C T C C C C C G T G C C T
T C C T T G A C C C T G G A A G G T G C C A C T C C C A C T G T C C T T T C C T A A T A A A A T G A G G A A A T T G C A T C G C A T T G T
C T G A G T A G G T G T C A T T C T A T T C T G G G G G G T G G G G T G G G G C A G G A C A G C A A G G G G G A G G A T T G G G A A G A C
A A T A G C A G G C A T G C T G G G G A T G C G G T G G G C T C T A T G G C T T C T G A G G C G G A A A G A A C C A G C T G G G G C T C G
A G T G C A T T C T A G T T G T G G T T T G T C C A A A C T C A T C A A T G T A T C T T A T C A T G T C T G T A T A C C G T C G A C C T C
T A G C T A G A G C T T G G C G T A A T C A T G G T C A T A G C T G T T T C C T G T G T G A A A T T G T T A T C C G C T C A C A A T T C C
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G T G G C G A A A C C C G A C A G G A C T A T A A A G A T A C C A G G C G T T T C C C C C T G G A A G C T C C C T C G T G C G C T C T C C
T G T T C C G A C C C T G C C G C T T A C C G G A T A C C T G T C C G C C T T T C T C C C T T C G G G A A G C G T G G C G C T T T C T C A
A T G C T C A C G C T G T A G G T A T C T C A G T T C G G T G T A G G T C G T T C G C T C C A A G C T G G G C T G T G T G C A C G A A C C
C C C C G T T C A G C C C G A C C G C T G C G C C T T A T C C G G T A A C T A T C G T C T T G A G T C C A A C C C G G T A A G A C A C G A
C T T A T C G C C A C T G G C A G C A G C C A C T G G T A A C A G G A T T A G C A G A G C G A G G T A T G T A G G C G G T G C T A C A G A
G T T C T T G A A G T G G T G G C C T A A C T A C G G C T A C A C T A G A A G G A C A G T A T T T G G T A T C T G C G C T C T G C T G A A
G C C A G T T A C C T T C G G A A A A A G A G T T G G T A G C T C T T G A T C C G G C A A A C A A A C C A C C G C T G G T A G C G G T G G
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G A T C T T C A C C T A G A T C C T T T T A A A T T A A A A A T G A A G T T T T A A A T C A A T C T A A A G T A T A T A T G A G T A A A C
T T G G T C T G A C A G T T A C C A A T G C T T A A T C A G T G A G G C A C C T A T C T C A G C G A T C T G T C T A T T T C G T T C A T C
C A T A G T T G C C T G A C T C C C C G T C G T G T A G A T A A C T A C G A T A C G G G A G G G C T T A C C A T C T G G C C C C A G T G C
T G C A A T G A T A C C G C G A G A C C C A C G C T C A C C G G C T C C A G A T T T A T C A G C A A T A A A C C A G C C A G C C G G A A G
G G C C G A G C G C A G A A G T G G T C C T G C A A C T T T A T C C G C C T C C A T C C A G T C T A T T A A T T G T T G C C G G G A A G C
T A G A G T A A G T A G T T C G C C A G T T A A T A G T T T G C G C A A C G T T G T T G C C A T T G C T A C A G G C A T C G T G G T G T C
A C G C T C G T C G T T T G G T A T G G C T T C A T T C A G C T C C G G T T C C C A A C G A T C A A G G C G A G T T A C A T G A T C C C C
C A T G T T G T G C A A A A A A G C G G T T A G C T C C T T C G G T C C T C C G A T C G T T G T C A G A A G T A A G T T G G C C G C A G T
G T T A T C A C T C A T G G T T A T G G C A G C A C T G C A T A A T T C T C T T A C T G T C A T G C C A T C C G T A A G A T G C T T T T C
T G T G A C T G G T G A G T A C T C A A C C A A G T C A T T C T G A G A A T A G T G T A T G C G G C G A C C G A G T T G C T C T T G C C C
G G C G T C A A T A C G G G A T A A T A C C G C G C C A C A T A G C A G A A C T T T A A A A G T G C T C A T C A T T G G A A A A C G T T C
T T C G G G G C G A A A A C T C T C A A G G A T C T T A C C G C T G T T G A G A T C C A G T T C G A T G T A A C C C A C T C G T G C A C C
C A A C T G A T C T T C A G C A T C T T T T A C T T T C A C C A G C G T T T C T G G G T G A G C A A A A A C A G G A A G G C A A A A T G C
C G C A A A A A A G G G A A T A A G G G C G A C A C G G A A A T G T T G A A T A C T C A T A C T C T T C C T T T T T C A A T A T T A T T G
A A G C A T T T A T C A G G G T T A T T G T C T C A T G A G C G G A T A C A T A T T T G A A T G T A T T T A G A A A A A T A A A C A A A T
A G G G G T T C C G C G C A C A T T T C C C C G A A A A G T G C C A C C T G A C G T C
Figure 3-3 Genetic sequence o f the GS50726 pIERJESneo-Human_SOCS3 plasmid, 
with the S0CS3 coding sequence highlighted.
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3.4.2.2 Generation of stable SOCS3hlIEC
IECs (1 x 106) were seeded in a T25 flask in growth medium (without 
antibiotics). Twenty four hours later cells were transfected with 4pg o f GS50726 
pIERESneo-Human_SOCS3 plasmid (2.2.3). After 5h, medium was replaced with 
serum-containing media and antibiotics to avoid cytotoxicity to cells. After two days, 
IEC were trypsinized, and sub-cultured with selection media containing 0.3, 0.4 or 0.5 
mg/ml o f G418 (Neomycin) antibiotic. A control experiment where non-transfected 
IEC (SOCS3norm) are incubated with selection media containing 0.3, 0.4 or 0.5 mg/ml 
o f G418 antibiotic was also included.
The highest concentration of G418 antibiotic which kills SOCS3norm IEC while 
allowing the SOCS3hl IEC to survive indicates the SOCS3hl IEC have acquired the 
plasmid and are therefore antibiotic resistant to the G418.
3.4.2.3 Confirmation of SOCS3 overexpression
To validate overexpression of SOCS3, protein and mRNA levels were measured 
in SOCS3norm and SOCS3hl IEC using qPCR and Western blot respectively. Once 
overexpression o f SOCS3 was confirmed; IECs were continually incubated with the 
highest concentration of G418 antibiotic at which SOCS3-transfected IEC (SOCS3hi) 
were able to survive while killing the SOCS3norm IEC.
127
3.5 Results
3.5.1 SW480 and Caco-2 IEC were both shown to transiently 
overexpress SOCS3 mRNA
The expression of SOCS3 mRNA was normalised relative to RPLPO 
(housekeeping gene) mRNA, and results displayed as relative increase in SOCS3 
plasmid transfected SW480 IEC vs. EV plasmid transfected SW480 IEC. A student t 














EV pBIG2i plasmid SOCS3 pBIG2i plasmid
Figure 3-4 Relative increase in SOCS3 mRNA in SW480 S0CS3 transfected IEC 
in relation to SW480 IEC which were transfected with the EV plasmid. Results 
indicate an 8.2 relative-increase in SOCS3 mRNA expression in SOCS3 transfected 
IEC (p <0.01) (n=3).
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Data from figure 3-4 suggest that the transfection process was successful as 
SW480 IEC transfected with the SOCS3 plasmid significantly showed an 8.2 (±1.3) 
relative-increase in SOCS3 mRNA expression in comparison to SW480 IEC which 
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Figure 3-5 Relative increase in SOCS3 mRNA in Caco-2 SOCS3 transfected IEC 
in relation to Caco-2 IEC which were transfected with the EV plasmid. Results 
indicate a 5.9 relative-increase in SOCS3 mRNA expression in SOCS3 transfected 
IEC (p <0.01) (n=3).
Data from figure 3-5 suggests that the transfection process was successful as 
Caco-2 IEC transfected with the SOCS3 plasmid showed a 5.9 (±1.2) relative-increase 
in SOCS3 mRNA expression in comparison to Caco-2 IEC which were transfected 
with the EV plasmid (p <0.01).
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3.5.2 SW480 IEC were shown to stably overexpress SOCS3 at both 
mRNA and protein levels
Selection media containing 0.4mg/ml was found to be the highest concentration 
o f G418 antibiotic at which SOCS3-transfected SW480 (SOCS3hl) were able to 
survive while killing the SW480 SOCS3norm IEC. Selection media containing 
0.5mg/ml was found to be the highest concentration of G418 antibiotic at which 
SOCS3-transfected Caco-2 (SOCS3hl) were able to survive while killing the 
SOCS3norm IEC. To validate overexpression of SOCS3, mRNA and protein levels 
were measured in both SW480/Caco-2 SOCS3nomi and SOCS3h' IEC. The expression 
o f SOCS3 mRNA was normalised relative to RPLPO mRNA, and results displayed as 
relative expression vs. SOCS3norm IEC. SDS-PAGE and western blotting was also 
used to measure SOCS3 protein expression with expression normalised to p-actin. A 
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Figure 3-6 qPCR and western blots illustrating SOCS3 expression in SW480 
SOCS3norm and SOCS3hi IEC, with {3-actin used as a loading control for 
immunoblotting. SOCS3 is shown to be overexpressed at both mRNA and protein 
levels in SOCS3hi SW480 IEC (p <0.01) (n=3)
SW480 SOCS3hl IEC depicted a 12 (±2) fold increase in SOCS3 mRNA in 
comparison to SOCS3nom1 IEC. Immunoblotting also showed a 25% (±9%) increase in 
SOCS3 protein expression when compared to SOCS3norm SW480 IEC (Figure 3-6). 
Once overexpression of SOCS3 was confirmed; SW480 SOCS3hl IEC were 
maintained with 0.4mg/ml of G418 antibiotic.
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S0CS3 expression was also measured in SOCS3nonT1 and SOCS3hl Caco-2 IEC. 
RT-PCR data showed a decrease in mRNA expression (0.53±0.19) however; 
immunoblotting data showed a negligible increase in SOCS3 protein expression 
(2±15%) in comparison to SOCS3norm IEC indicating transfection was not successful 
(data not shown).
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3.5.3 Caco-2 IEC were shown to overexpress SOCS3 mRNA after 
forming monolayers
Caco-2 IEC were transfected and allowed to form monolayers for seven days. 
SOCS3 mRNA expression levels were then monitored before wounding to ensure 
Caco-2 IEC were still overexpressing SOCS3 (section 4.5.7). The expression of 
SOCS3 mRNA was normalised relative to RPLPO (housekeeping gene) mRNA, and 
results displayed as relative increase in SOCS3 plasmid transfected Caco-2 IEC vs. 
EV plasmid transfected Caco-2 IEC. A student t test was then used to determine if 
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Figure 3-7 Relative increase in SOCS3 mRNA in Caco-2 SOCS3 transfected IEC 
in relation to Caco-2 IEC which were transfected with the EV plasmid then allowed to 
form monolayers for 7 days. Results indicate a 5.2 relative-increase in SOCS3 mRNA 
expression in SOCS3 transfected IEC (p <0.01) (n=3).
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3.6 Discussion
SOCS3 is a natural endogenous regulator of inflammatory cytokine mediated 
signalling within IEC and SOCS3 elicits its effects by inhibiting signalling through the 
JAK-STAT3 pathway (Suzuki, Hanada et al. 2001; Rigby, Simmons et al. 2007). 
There is overwhelming evidence to support the role o f SOCS3 as a tumour suppressor 
within IECs, as targeted deletion of SOCS3 promotes tumour incidence and growth 
within the colon (Ogata, Chinen et al. 2006; Rigby, Simmons et al. 2007).
To examine the upregulation of SOCS3; actively dividing SW480 and Caco-2 
IECs were transiently transfected with either SOCS3 pBIG2i plasmid (S3) or a control 
empty vector (EV) pBIG2i plasmid to ensure plasmid uptake. Relative SOCS3 
mRNA levels were then compared to IECs which were transfected with EV plasmids. 
SW480 IECs were successfully transfected as SW480 S3 transfected IEC showed an 
8.2 fold increase in relative expression of SOCS3 mRNA in comparison to SW480 EV 
transfected IEC cultures. Caco-2 IECs were also successfully transfected with the 
SOCS3 pBIG2i plasmid with Caco-2 S3 transfected IEC showing a 5.9 fold increase 
in relative expression of SOCS3 mRNA in comparison to Caco-2 IECs which were 
transfected with the EV pBIG2i plasmid. These results confirm that both SW480 and 
Caco-2 IECs can successfully be transfected with the SOCS3 pBIG2i plasmid yielding 
an increase in SOCS3 mRNA expression in comparison to the EV control. Other 
groups have also used the SOCS3 containing pBIG2i plasmid to transiently transfect 
Caco-2 and IEC6 IEC and constitutively overexpress SOCS3. (Rigby, Simmons et al. 
2007).
During transient transfection, foreign DNA is delivered into the nucleus but is 
not integrated into the host genome, thus the new gene will not be replicated following
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cell division. The downside to transient transfection is that cells will only express the 
transiently transfected gene for a finite period, after which the foreign gene is lost 
through cell division. Being able to transiently upregulate SOCS3 will be good for 
short term experiments e.g. proliferation and signalling. However, it is not good for 
long term experiments e.g. wound healing (Wurm 2004; Recillas-Targa 2006; Kim 
and Eberwine 2010). Therefore, cells would have to be repeatedly transfected which 
could result in experimental variation in terms of levels of gene expression. Stable 
transfection is another technique whereby foreign DNA is delivered to the nucleus by 
passage through the nucleus and nuclear membranes. The foreign DNA is then 
integrated into the host genome with cells continuing to express traits caused by the 
genetic material, even after many generations of cell division (Recillas-Targa 2006; 
Kim and Eberwine 2010). To overcome variation between transient experiments, 
efforts were made to generate IECs which were stably overexpressing SOCS3.
Actively dividing SW480 and Caco-2 IECs were stably transfected with 
GS50726 pIERESneo-Human_SOCS3 plasmids (SOCS3hi). To validate 
overexpression, relative SOCS3 mRNA and protein expression levels were compared 
to IECs which had not been transfected with the SOCS3 overexpressing plasmid 
(SOCS3norm). Results indicated SW480 IECs were successfully transfected as SW480hl 
IECs significantly expressed a 12 fold-increase in relative expression o f SOCS3 
mRNA in comparison to SW480norm IECs cultures. Protein expression o f SOCS3 was 
also verified, and SW480hl IEC expressed a 25% fold-increase in SOCS3 protein 
expression in comparison to SW480nornl IEC cultures. Efforts were also made to stably 
transfect Caco-2 IECs. However, this proved unsuccessful as SOCS3hl IECs did not 
show a significant overexpression of SOCS3 in comparison to SOCS3norm IECs. Caco-
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2 S0C S3hl IEC showed a 0.53 fold-decrease in SOCS3 mRNA and a 2% increase in 
SOCS3 protein expression in comparison to SOCS3norm IECs.
To evaluate SOCS3s role in TLR-induced wound repair, Caco-2 IEC would 
have to be transiently transfected, monolayers allowed to form then SOCS3 levels 
monitored to ensure IEC were still overexpressing SOCS3 before wounding. Results 
indicated that Caco-2 IEC transfected with the SOCS3 pBIG2i plasmid were still 
overexpressing SOCS3 (5.2) in comparison to Caco-2 IEC which were transfected 
with the EV pBIG2i plasmid.
Results indicate IEC can be transfected to upregulate the expression of SOCS3. 
In the following chapters, both transient and stable IECs (SW480 and Caco-2) which 
overexpress SOCS3 will be used to investigate the role of SOCS3 in mediating 
cellular responses following microbial-induced TLR signalling.
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TLR signalling is imperative for repair of damaged tissue with microbial 
signalling inducing cell migration, wound repair and proliferation o f IEC. SOCS3, a 
mediator o f cytokine signalling is upregulated in both animal and human models of 
inflammation. Conversely, lack of epithelial SOCS3 promotes proliferation and 
tumourgenesis in the colon.
In these studies we have used model human SW480 and Caco-2 cell lines over­
expressing SOCS3 (described in Chapter 3) to develop an in vitro model and assess 
SOCS3 and TLR ligands on epithelial wound repair. Additionally, the role o f SOCS3 
on TLR-induced IEC proliferation was also assessed.
Proliferation data indicates that SOCS3 limits LPS and T. muris 
excretory/secretory protein (ES) induced proliferation. Wound healing data implies ES 
promotes both proliferative and restitutive wound repair, whereas LPS and flagellin 
only promote restitutive wound repair in our model. This could be due to ES ligating 
with multiple TLR (TLR2, TLR4 and TLR6) whereas LPS (TLR4) and flagellin 
(TLR5) binding exclusively to a single receptor. It was also established wound repair 
was due to direct TLR ligation not secondary effects of induced cytokines. Data from 
this study also indicated SOCS3 was shown to limit T. muris induced wound repair.
In conclusion our results support previous data implicating the role o f TLR 
ligands being imperative for the repair of damaged epithelial surfaces, and highlights a 
pivotal role o f SOCS3 in mediating TLR-induced epithelial repair.
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4.2 Introduction
The integrity o f the intestinal epithelium is pivotal as this establishes a barrier 
that separates the luminal contents with its immunogenic, noxious compounds and 
commensal flora from the underlying immune system (Sturm and Dignass 2002). 
Injury or impairment o f the intestinal surface barrier is perceived in the course o f a 
number o f diseases, which may consequently result in an elevated penetration of 
luminal contents, leading to inflammation and disequilibrium o f the homeostasis o f the 
host. Therefore, rapid repair of the epithelium following injury or damage is 
imperative to conserve normal homeostasis (Rakoff-Nahoum, Paglino et al. 2004; 
Ben-Neriah and Schmidt-Supprian 2007). Chronic relapse and remittance of 
inflammation causes damage to the intestinal epithelium, a hallmark o f IBD (Hanauer 
2006).
The continuity of the surface epithelium following injury is re-established by 
three distinctive phases (Wilson and Gibson 1997; Dignass 2001). Firstly, restitution 
where IEC migrate into the damaged area, this can arise within minutes to hours after 
injury. Restitution is followed by proliferation where IEC divide to replenish reduced 
cell numbers. Thirdly, differentiation where IEC mature and differentiation to 
maintain the functional activity of the epithelium (Dignass 2001; Dignass, Baumgart et 
al. 2004).
IECs are able to communicate with microbes in the colon via a cohort o f pattern 
recognition receptors termed Toll-like receptors (TLR). TLRs are involved in several 
features o f mammalian homeostasis such as recognition o f cellular tissue injury, 
proliferation, tissue repair and regeneration, all fundamental for healing (Schottelius 
and Dinter 2006; Zhang and Schluesener 2006; Rakoff-Nahoum and Medzhitov 2008).
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TLR signalling has also been shown to be imperative for repair o f damaged tissue 
following chemical, radiation and colonic injury (Fukata, Michelsen et al. 2005; 
Rakoff-Nahoum and Medzhitov 2008).
Wound healing models have shown that the absence o f TLR4 had notable 
consequences on both the inflammatory and repair phases of lesions (Mollen, Anand 
et al. 2006). This can be supported by other researchers which have demonstrated that 
mice deficient in TLR4 expression are at an increased risk o f injury following DSS 
induced mucosal injury (Rakoff-Nahoum, Paglino et al. 2004; Abreu, Fukata et al.
2005). Microbial signalling via TLR5 within human epithelial cells induce a series of 
non-immune epithelial responses including cell migration, wound repair and 
proliferation (Shaykhiev, Behr et al. 2008). Numerous studies have also demonstrated 
that exposure to helminths prevents TNBS-type colitis (Elliott, Summers et al. 2007; 
Ruyssers, De Winter et al. 2008; Motomura, Wang et al. 2009); suggesting helminth 
products promote mucosal healing in animal models of colitis. These studies indicate 
microbes play a pivitol role in miantaining mucosal homeosis and restoration of 
epithelial integrity following damage.
Following tissue injury, TLRs are also able to activate numerous intracellular 
signalling molecules with one of these being NF-*B (Barnes and Karin 1997). N F-aB  is 
important because several inflammatory cytokine genes implicated in the pathogenesis 
o f IBD including TNF-a, 1L-6 and IL-12 are all known to contain an NF-*B binding 
site and have been shown to be transcriptionally regulated by NF-*B (Barnes and 
Karin 1997; Schottelius and Dinter 2006). The bacterial components LPS, an outer cell 
membrane constituent o f Gram-negative bacteria, derived from E. coli and flagellin a 
major constituent o f the flagellum of the Gram-negative bacterium S. typhimurium 
were both chosen as both exist as part of the normal flora within the human colon.
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Helminth products from T. muris were also chosen as exposure to helminth products 
are shown to prevent TNBS-type colitis (Khan, Blennerhasset et al. 2002; Elliott, Li et 
al. 2003).
SOCS3 a natural endogenous regulator of inflammatory cytokine-mediated 
signalling is upregulated in both animal and human intestinal inflammation (Suzuki, 
Hanada et al. 2001). Additionally, elevated levels o f SOCS3 mRNA expression have 
been detected in inflamed biopsies of patients with UC compared to non-inflamed 
biopsies (Miyanaka, Ueno et al. 2007). Lack of epithelial SOCS3 promotes 
proliferation and tumourgenesis in the colon (Rigby, Simmons et al. 2007) and 
conversely, SOCS3 overexpression can hamper skin epithelial wound healing, 
enhancing inflammation (Ivory, Wallace et al. 2008; Linke, Goren et al. 2009). In 
vivo studies have shown SOCS3 overexpression limits proliferation o f IEC and colon 
cancer cell lines (Rigby, Simmons et al. 2007).
Conclusively, these studies suggest that although SOCS3 may have a significant 
anti-tumourgenic role, inhibiting inflammation-associated CRC (Rigby, Simmons et 
al. 2007) SOCS3 may also inhibit repair and restitution o f the epithelial barrier 
associated with UC. This section aims to develop an in vitro model to investigate the 
function o f SOCS3 overexpression on TLR-mediated epithelial wound healing.




4.4.1 Assessment of SOCS3 on TLR-induced IEC proliferation
SW480 IEC were seeded overnight then transfected. Cells were then treated with 
1 pg/ml LPS, 1 pg/ml flagellin or 1Opg/ml T. muris excretory/secretary products (ES) 
(gift from Kathryn Else, University of Manchester) for 48h.Concentrations were 
selected because these concentrations were identified as having optimal effects on 
wound healing. Cell number was determined using method described in section 2.2.6. 
To evaluate cellular proliferation in response to treatment; values had been expressed 
as percentage change in cell number relative to no treatment controls for treatment.
4.4.2 Assessment of TLR ligands and SOCS3 on epithelial wound repair
Caco-2 IEC were seeded at 80% confluence to minimise post-transfection 
proliferation and minimise loss of SOCS3 overexpression. IEC were transfected, and 
monolayers allowed to form for 7 days. Monolayers were scored then treated with 
lOpg/ml LPS, lpg/m l flagellin or either 10 or 5pg/ml o f ES. Confocal imaging was 
carried out at 0, 6, 24, 48 and 72h (x 10 magnifications) post wounding. Ligand 
containing media was replaced prior to measurements taken at 24h, 48h and 72h to 
remove floating cells, replenish nutrients and restore treatment concentrations. The 
area o f the acellular region was measured using ImageJ and data calculated as % 
wound healed Vs. Oh.
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4.4.3 Assessing wound repair as a consequence of direct TLR ligation or 
secondary effects of induced cytokines
Caco-2 cells were treated with LPS (lOpg/ml) or flagellin (lpg/m l). After 24, 48 
and 72h, supernatant was collected and centrifuged to remove floating cells. 
Monolayers were scored, washed and treated with either freshly prepared medium 
containing TLR ligands or supernatants collected from cells treated with ligands for 
24h. Photomicrographs of wounds were taken at 0, 6, 24, 48 and 72h (at xlO 
magnification) post wounding. Media, ligands and supernatant were replaced prior to 
measurements taken at 24, 48 and 72h to remove floating cells, replenish nutrients and 
restore treatment concentrations. The area of the acellular region was measured using 
ImageJ and data calculated as % wound healed Vs. Oh.
4.4.4 Assessment of restitutional vs. proliferative wound repair
Immediately following wounding, Caco-2 monolayers were treated with varying 
concentrations o f hydroxyurea (10, 5 and 2pM) to limit restitution or mitomycin C 
(10, 5 and 2pg/ml) to limit proliferative wound repair. Photomicrographs o f wounds 
were taken at 0, 6, 24, 48 and 72h (at xlO magnification) post wounding. Inhibitor- 
containing media was replaced prior to measurements taken at 24, 48 and 72h to 
remove floating cells, replenish nutrients and restore inhibitor concentrations. The area 
o f the acellular region was measured using ImageJ and data calculated as % wound 
healed vs. Oh.
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4.4.5 Assessing proliferative inhibitor on TLR-mediated epithelial repair
Immediately following wounding, Caco-2 monolayers were treated with LPS 
(1 Ojng/ml) or flagellin (lpg/m l). A second set of wells were also treated in a similar 
manner but with the addition of mitomycin C (10pg/ml). Photomicrographs o f wounds 
were taken at 0, 6, 24, 48 and 72h (at xlO magnification) post wounding. TLR 
ligand/inhibitor-containing media was replaced prior to measurements taken at 24, 48 
and 72h to remove floating cells, replenish nutrients and restore TLR ligand/inhibitor 
concentrations. The area of the acellular region was measured using ImageJ and data 
calculated as % wound healed vs. Oh.
Experiment was repeated again, but photomicrographs o f wounds were taken at 
0, 4, 8, 12, 16, 20 and 24h (at xlO magnification) post wounding. The area o f the 




4.5.1 SOCS3 overexpression limits LPS and ES induced IEC 
proliferation
To evaluate cellular proliferation in response to ligand treatment; values have 
been expressed as percentage change in cell number relative to no treatment controls 
for treatment. The bar graph shows the percentage change in cell proliferation when 
human SW480 IECs were transfected with EV or SOCS3 over-expressing plasmids 
then incubated with ES (lOpg/ml), LPS (lpg/m l) or flagellin (lpg/m l) for 48h. An 
unpaired student t test was used to determine if there was significant effect in contrast 
to no treatment controls with p <0.05.
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Figure 4-1 Effect of ES, LPS and flagellin on proliferation of SW480 IECs 
transfected with plasmid either containing the entire coding sequence for SOCS3 (S3) 
or a control empty vector (EV) after 48h. * = indicates a significant change Vs. No 
Tx (p <0.05) (n=4)
From the bar chart we can conclude that both ES (8%) and LPS (21%) were 
shown to significantly promote IEC proliferation in comparison to no treatment, 
however this was no longer observed after treatment in SOCS3 overexpressing IEC as 
p >0.05. Flagellin was shown to have no significant effect on cell proliferation, even in 
SOCS3 overexpressing IEC.
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4.5.2 LPS and Flagellin promote initial (restitutive) wound healing 
whereas T. muris promotes both restitutive and proliferative wound 
healing.
To attain an accurate determination of wound repair in response to ligand 
treatment, the area of the acellular region was measured using ImageJ and data 
calculated as % wound healed vs. Oh, a student t test was then used to determine if 
there was a significant effect in contrast to no treatment controls.
* p < 0.05 Vs. No Tx
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Figure 4-2 Effect of LPS, flagellin and ES treatment on wound healing of Caco-2 
monolayers. * = indicates a significant change Vs. No Tx (p <0.05) (n = l6)
Figure 4-2 depicts treatment with LPS (lOpg/ml) had a 2% significant increase 
in wound repair after 6h as p <0.05. A significant increase in wound repair was also 
observed when Caco-2 monolayers were scarred then treated with flagellin (lpg/m l)
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after 6 and 72h, with repair 4 and 3% greater respectively than no treatment cultures. 
A 2 and 9% significant increase in wound repair was also observed after treatment 
with ES (10pg/ml) after 6 and 72h as p < 0.05. Treatment with ES (5pg/ml) was 
shown to promote wound repair by 6, 15, 17 and 27% respectively for all time points 
as p <0.05.
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4.5.3 Increased wound repair is due to direct TLR ligation, not secondary 
effects o f induced cytokines.
In figure 4-2 data indicated that TLR ligation promotes epithelial wound repair. 
To confirm wound repair is due to direct TLR signalling and not a secondary effect of 
TLR ligation, scored monolayers were treated with either freshly prepared medium 
containing TLR ligands or supernatants collected from cells treated with ligands. 
Again, the acellular region was measured using ImageJ and data calculated as % 
wound healed Vs. Oh, a student t test was then used to determine if there was a 
significant effect in contrast to direct treatment.
* p  < 0.05 Vs.Direct Tx 
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Figure 4-3 Effect of LPS and flagellin indirect and direct treatment on wound 
healing o f Caco-2 monolayers * = indicates a significant change Vs. Direct Tx (p 
<0.05) (n=4)
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The bar graph in figure 4-3 indicates that supernatant collected from IEC which 
had previously been treated with LPS (lOpg/ml) as having an 18% significant 
decrease in wound repair at 48h in comparison to IEC which were directly treated with 
medium containing LPS. A 3 and 17% significant decrease in wound repair was also 
observed 6 and 72h after treatment with supernatant which had previously been treated 
with flagellin (lpg/m l) in comparison to direct flagellin stimulation.
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4.5.4 Mitomycin C (10pg/ml) is shown to inhibit proliferative wound 
repair
Data from figure 4-2 indicates TLR signalling helps mediate wound healing. To 
determine whether TLR signalling encourages restitutive or proliferative wound repair 
Caco-2 monolayers were wounded then treated with varying concentrations of 
hydroxyurea (10, 5, and 2pM) to inhibit restitution or mitomycin C (10, 5 and 2pg/ml) 
to limit proliferative wound repair. Hydroxyurea works by inactivating ribonucleotide 
reductase, blocking the synthesis of deoxynucleotides, inhibiting DNA synthesis and 
inducing cell death in S-phase. Mitomycin C is an inter-strand cross-linking, 
alkylating agent that targets guanine nucleoside in the 5'CpG-3 sequence. To attain an 
accurate determination of wound repair in response to inhibitor treatment, the area of 
the acellular region was measured using ImageJ and data calculated as % wound 
healed Vs. Oh, a student t test was then used to determine if there was a significant 
effect in contrast to no treatment controls.
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Figure 4-4 Effect of hydroxyurea (10, 5 and 2pM) and mitomycin C (10, 5 and 
2|ag/ml) treatment on wound healing of Caco-2 monolayers. * = indicates a 
significant change Vs. No Tx (p <0.05) (n=4)
To identify the inhibitor which had the greatest inhibitory effect and its optimum 
effective inhibitory concentration on IEC wound repair, values have been expressed as 
% wound healed Vs. Oh. The experiment was repeated 4 times (n=4) with all results 
pooled together. The bar graph in figure 4-4 indicates mitomycin C at 10pg/ml had the 
greatest inhibitory effect on proliferative wound repair at 24, 48 and 72h post 
wounding with repair 2, 31 and 67% respectively significantly less than wounds which 
had not been treated with mitomycin C.
152
4.5.5 Flagellin may promote restitutive wound repair
Data from figure 4-4 indicated that treatment with mitomycin C at 10|ig/ml had 
the greatest inhibitory effect on epithelial wound healing. To investigate the effect of 
mitomycin C on TLR-mediated wound repair, monolayers were scored then treated 
with LPS (lOpg/ml) or flagellin (lpg/ml), a second set of cultures were treated in a 
similar manner but with the addition of mitomycin C. The acellular region was 
measured as before and data calculated as % wound healing Vs. Oh, a student t test 
was then used to determine if there was a significant effect in contrast to cultures 


















* p <  0.05 Vs.Direct Tx t  Mitomycin C (lOpg'ml) 
c a  6 Hours e- 3 48 Hours 








Flagellin (lpg,'ml) + 
Mitomycin C 
(lOfjgml)
Figure 4-5 Effect of mitomycin C, LPS and flagellin treatment on wound healing 
o f Caco-2 monolayers. * = indicates a significant change Vs. No Tx + mitomycin C 
Tx (p <0.05) (n=3)
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To evaluate TLR-mediated wound healing in response to mitomycin C 
(10|ag/ml) treatment, values were expressed as % wound healed Vs. Oh. The 
experiment was repeated 3 times (n=3) with all results pooled together. From figure 4- 
5 we can conclude that treatment with mitomycin C (lOpg/ml) and TLR ligands (LPS 
and flagellin) had no significant effect in wound repair in comparison to cultures 
which were only treated with mitomycin C. However, data hints treatment with 
flagellin (lpg/m l) may promote restitutive wound repair at 24h (p= 0.06) as repair was 
8% greater in flagellin-treated cultures than cultures which had only been treated with 
mitomycin C.
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4.5.6 Flagellin is shown to promote proliferative wound repair
Data from figure 4-5 indicated treatment with mitomycin C (lOpg/ml) 
significantly inhibited flagellin (lpg/ml) induced wound repair at 6h with repair 6% 
significantly lower in mitomycin C (lOjig/ml) treated cultures. To further investigate 
the effect o f mitomycin C (lOpg/ml) on TLR-mediated proliferative repair (0-24 h) the 
acellular region was measured every four hours and data calculated as % wound 
healed Vs. Oh, a student t test was then used to determine if there was a significant 
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Figure 4-6 Effect o f mitomycin C, LPS and flagellin treatment on wound healing 
o f Caco-2 monolayers. * = indicates a significant change Vs. No Tx + mitomycin C 
Tx (p <0.05) (n=3)
From figure 4-6 we can conclude that treatment with flagellin (lpg/m l) and 
mitomycin C (lOpg/ml) was shown to significantly promote wound repair by 5, 4, 4 
and 7% at 12, 16, 20 and 24h respectively post wounding in comparison to cultures
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which had only been treated with mitomycin C (lOpg/ml) as p<0.05. Treatment with 
LPS (l|ig /m l) and mitomycin C (lOpg/ml) had no significant effect on wound repair 
in comparison to cultures which had only been treated with mitomycin C (lOpg/ml).
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4.5.7 SOCS3 limits T. mwra-induced wound repair.
To evaluate SOCS3s role in TLR-induced wound repair, Caco-2 IEC were 
transfected with SOCS3 over-expressing plasmids or empty vector (EV) controls. 
Again, the acellular region was measured using ImageJ and data calculated as % 
wound healed Vs. Oh, a student t test was then used to determine if there was a 
significant effect in contrast to EV plasmid transfected lECs.
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Figure 4-7 Effect of LPS, flagellin and ES treatment on wound healing o f Caco-2 
monolayers after transfecting Caco-2 IEC with empty (EV) or SOCS3 vector (S3) 
plasmids. * = indicates a significant change vs. Empty vector (P <0.05) (n=9)
Overexpression of SOCS3 had no significant effect on flagellin-induced wound 
repair at all times (p>0.05). Likewise, over-expression of SOCS3 had no significant 
effect on LPS-induced wound repair. However, SOCS3 limited ES- induced wound 
repair at 6 and 72h by 8% and 16% respectively, as p <0.05.
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4.6 Discussion
Previous studies have demonstrated germ free mice are more susceptible to 
DSS-induced intestinal injury inferring intestinal microbiota stimulate cytoprotective 
pathways to promote epithelial repair (Rakoff-Nahoum, Paglino et al. 2004; Kluwe, 
Mencin et al. 2009). Conversely, germ-free mice also have a lower incidence of 
tumour burden within the colon (Rakoff-Nahoum, Paglino et al. 2004). Mounting 
evidence suggests that TLR signalling is involved in maintaining intestinal 
homeostasis (Rakoff-Nahoum et al., 2008, Zhang et al., 2006, Fukata et al., 2005). T. 
muris excretory/secretory protiens (ES) form a heterogeneous solution o f worm 
proteins containing substances that are able to ligate with multiple TLR (TLR2, TLR4 
and TLR6) (deSchoolmeester, Martinez-Pomares et al. 2009) whereas LPS (TLR4) 
and flagellin (TLR5) bind exclusively to a single receptor. TLR2 has been shown to 
heterodimerize with TLR1 and TLR6 (Ozinsky, Underhill et al. 2000; Takeuchi, 
Kawai et al. 2001; Morr, Takeuchi et al. 2002) to expand the ligand spectrum and 
permit the immune system to identify numerous structures of bactererial lipopeptides 
in various pathogens (Farhat, Riekenberg et al. 2008). Here, we demonstrate TLR 
ligation promotes both proliferative and restitutive wound repair. LPS and flagellin are 
shown to promote restitutive healing whereas ES is shown to promote both restitutive 
and proliferative types of wound healing. This could be due to ES ligating with 
multiple TLR whereas LPS and flagellin binding exclusively to a single receptor.
According to the hygiene hypothesis, lack of exposure to intestinal parasites such 
as helminths, negatively effects immune development, which may predispose 
individuals to immunological diseases later in life. This is a proposed rationale for the 
high incidence o f IBD in industrialized countries compared with developing countries
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(Talley et al., 2011). Several studies exploring the therapeutic potential o f helminth 
infection on IBD have been conducted; with positive findings indicating the potential 
use o f helminths as a therapeutic tool (Ruyssers et al., 2008, Weinstock et al., 2005, 
Weinstock et al., 2009). Treatment with living helminths, however, may have its 
disadvantages such as continual infection or invasion of parasite to other host tissues, 
where they may cause pathology. Therefore, treatment with immunologically active 
helminth proteins might overcome complications of therapies associated with living 
parasites. Both in vivo infection to helminths and in vitro exposure to ES stimulate 
colonic epithelial cells to produce IFN-y, TNFa and CCL2 mRNA and protein 
(deSchoolmeester et al., 2006; Artis et al., 2008; Cruickshank et al., 2009).
These cytokines and chemokines then have the potential to recruit and activate 
immune cells including dendritic cells (DC) from the colonic lamina propria to the 
epithelial layer directing the appropriate immune response. Mice resistant to T.muris 
infection have significantly increased levels of epithelial-derived chemokines 
compared with susceptible mice (Cruickshank et al., 2012), allowing for a more rapid 
recruitment and localisation of colonic DC to the epithelium following infection in 
comparison with susceptible mice. These results provide further evidence that IEC are 
the initial responders and are critical in determining the ensuing immune response, as 
well as maintaining barrier function. Our studies show the direct effect o f TLR ligation 
on IEC; indicating increased wound repair is due to direct TLR ligation, and not 
secondary effects of TLR-induced cytokines, supporting previous studies that IEC 
directly respond to ES. However, we cannot guarantee that there will not be any TLR 
ligands in the supernatant collected from IEC which were previously treated with TLR 
ligands, but TLR-induced cytokines should be present.
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In vitro studies have shown that SOCS3 is a potent supressor o f proliferation in 
both transformed and non-transformed IEC lines (Rigby et a l ,  2007). Furthermore, 
other studies have shown that SOCS3 overexpression can hamper skin epithelial 
wound repair (Ivory et al., 2008, Linke et al., 2010, Linke et a l, 2010B). Our results 
expand upon previous studies where SOCS3 limited spontaneous proliferation o f IEC 
(Rigby, 2007) by demonstrating SOCS3 can also limit microbial-induced proliferation 
and wound repair and support previous studies showing SOCS3 limits cytokine- 
induced and spontaneous IEC proliferation (Rigby, 2007).
Normal gut homeostasis is likely to be due to maintenance o f TLR signalling 
and regulation of these signalling pathways may be dependent on oscillatory 
behaviour o f regulatory molecules such as SOCS3 (Yoshiura et a l, 2007) as without 
this regulatory behaviour, TLR signals are likely to induce pathological states. The 
regulation o f SOCS3 levels may subsequently influence IEC turnover or repair o f 
epithelium following injury. For example, targeted deletion o f SOCS3 in IEC 
promotes tumour incidence and growth in the colon (Rigby, 2007); with methylation- 
silencing o f SOCS3 shared in multiple tumour types (Ogata et al., 2006). 
Unconditional cell proliferation could be due to SOCS3 no longer providing a negative 
feedback mechanism in response to perpetual TLR ligation within the intestine. 
SOCS3 levels are comparatively low in the colon of germ-free mice (Rigby, 
unpublished data), presumably as TLR signalling which would normally initiate the 
expression of SOCS3, no longer present. On the other hand; the overexpression of 
SOCS3 observed in IBD (Suzuki et al, 2001) is likely to be limiting microbial-induced 
wound repair. This is supported by the fact that germ-free mice show severe mortality 
and morbidity when given DSS because of defective epithelial repair responses,
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indicating controlled microbial stimulation is essential for intestinal homeostasis 
(RakoffNahoum et al 2004).
In conclusion, our results support previous data implicating the role o f TLR 
ligands being imperative for the repair of damaged epithelial surfaces, and highlight a 
pivotal role o f SOCS3 in mediating TLR-induced wound repair.
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5. SUPPRESSOR OF 
CYTOKINE 
SIGNALLING 3 (SOCS3) 
ENHANCES TOLL-LIKE 







The homeostatic influence of microflora on IEC turnover occurs in a highly 
regulated environment whereby signals from the microflora are regulated and 
processed by IEC. Breakdown in this regulated network o f interactions is implicated in 
the onset of intestinal diseases such as IBD and CRC.
Ligation of TLR causes the activation of NF-*B, consequently influencing the 
expression o f a number of inflammatory cytokine such as TNFa, IL-6 and IL-8. 
SOCS3, an endogenous modulator of epithelial turnover acts as a regulator o f 
inflammatory cytokine-mediated signalling by restricting TNFa-induced NF-*B 
translocation and IL-6 induced STAT3 phosphorylation. TNFa signals through its 
transmembrane receptor TNFR2, with TNFR2 expression upregulated in IBD and 
AOM/DSS models of colitis associated cancer.
These studies aimed to assess the effects of IEC-derived SOCS3 upon cytokine 
responses following TLR stimulation Our results indicate activation o f TLR5 
signalling pathways significantly increased the expression of TNFa and not TGFp 
mRNA in IEC compared with TLR3 and TLR4, in a dose dependent manner; and that 
SOCS3 further enhances the production of TLR5-induced TNFa mRNA. Increases in 
TNFa protein in the supernatant were not detectable possibly due to secreted TNFa 
either binding to its receptor, or protein destruction through SOCS3 driven 
proteasomal degradation. Our results also show TLR5 ligation significantly promotes 
TNFR2 mRNA expression within IEC but SOCS3 limits TLR5-induced TNFR2 
mRNA expression. These results may indicate increased expression o f SOCS3 in IBD 
may perpetuate ‘inflammation’ by promoting the production o f TNFa in response to 
bacteria through down-regulating expression of TNFR2 on IEC.
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5.2 Introduction
Intestinal epithelial cells (IEC) lining the human colon are in perpetual 
communication with commensal microflora. This host-commensal relationship is 
known to contribute to preserving the steady-state equilibrium necessary for gut 
physiology and fortification against damage and invasion (Barbosa et a l, 2010, 
Shaykhiev et al., 2008). The homeostatic influence of microbiota with IEC occurs in 
an actively regulated environment, dictated both by signals from the microbiota, and 
by the fine-tuned regulatory activity of IEC and IEC-conditioned components o f the 
immune system. Failure of this regulated network of interactions is implicated in the 
onset o f IBD (Barbosa et al., 2010). Damage to the intestinal barrier is a hallmark of 
IBD, a cohort o f diseases in which there is chronic relapse and remittance of 
inflammation within the bowel, characteristic of both UC and CD (Hanauer, 2006).
IEC are able to converse with microbes in the colon via a cohort o f pattern 
recognition receptors termed Toll-like receptors (TLR). The detection o f microbial 
ligands such as Poly I: C, LPS and flagellin are recognised by TLR3, TLR4 and TLR5 
respectively (Abreu et al., 2005). The core mechanism through which TLR5 signals is 
similar to that of other TLR. Ligation of TLR5 by flagellin leads to the activation of 
MAP kinase and NF-*B, influencing the expression of a number o f pro-inflammatory 
cytokines such as TNFa, IL-6 and IL-8 (Vijay-Kumar et al., 2008). As well as 
maintaining mammalian host defence from hostile microbes, TLR are also responsible 
for several aspects of mammalian homeostasis for example development, recognition 
o f tissue injury, tissue repair and renewal (Rakoff-Nahoum et a l, 2008, Zhang et a l,
2006). Studies have demonstrated the importance of TLR5 signalling to be imperative 
in conserving intact epithelial barrier function, with TLR5 knock-out mice exhibiting
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deficient repair following injury and development o f spontaneous colitis (Li et al., 
2010, Vijay-Kumar et al., 2007). Colitis is supressed by inhibiting inflammatory 
cytokines (TNFa and IL-12) or stimulating the production o f immunoregulatory 
cytokines (TGF0 and IL-10) (Elliott, Summers et al. 2007; Ruyssers, De Winter et al. 
2008).
Germ-free mice and mice deficient in MyD88, an adaptor molecule crucial for 
TLR signalling given DSS to induce intestinal injury display increased colonic 
bleeding and epithelial injury compared to control animals (Rakoff-Nahoum et al., 
2004). TLR2 and TLR4 knockout mice also have a reduced capacity to repair colonic 
mucosa, compared with wild-type controls upon DSS administration, though not to the 
same extent as MyD88_/' mice (Rakoff-Nahoum et al., 2004). MyD88'A mice 
administered with AOM a model used to simulate intestinal colonic tumourgenesis are 
shown to have a lower incidence of tumour formation in comparison to wild-type 
control mice. Signifying MyD88-dependent signalling pathways are necessary in 
contributing to carcinogen-induced colonic tumourgenesis (Rakoff-Nahoum et al.,
2007).
Suppressor of cytokine signalling-3 (SOCS3), an endogenous modulator of 
epithelial turnover is enhanced in IBD (Suzuki, 2001; Karin et al., 2005, Rakoff- 
Nahoum et a l, 2006). SOCS3 acts as a regulator of inflammatory cytokine-mediated 
signalling by restricting TNFa-induced NF-*B translocation and IL-6-induced STAT3 
phosphorylation (Rigby et al., 2007). There is much evidence to support the role of 
SOCS3 as a tumour suppressor in the intestine, for example targeted deletion of 
SOCS3 in IEC promotes tumour incidence and growth in the colon; with methylated 
silencing o f SOCS3 shared in multiple tumour types (Rigby et a l, 2007, Ogata et a l,
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2006). In vitro studies have depicted SOCS3 as a potent suppressor o f proliferation in 
both transformed and non-transformed IEC lines (Rigby et a l, 2007).























Inflammation, Immune regulation. Survival, Proliferation
Figure 5-1 TLR5 and TNFR2 receptor signalling pathways, causing the expression 
o f SOCS3 and its negative feedback mechanism on both signalling pathways (Luo, 
Maeda et al. 2004; Croker, Kiu et al. 2008; Onizawa, Nagaishi et al. 2009).
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It has been well documented that levels of TNFa are elevated in serum and 
intestinal mucosa of patients with IBD, with neutralisation o f TNFa associated with 
improved health, particularly in patients with CD (Stillie and Stadnyk 2009, Van 
Dullemen et a l, 1995, Sandbom et a l, 2004). This supports the role o f anti-TNFa 
therapies in their effectiveness in treating patients with IBD.
TNFa is a key regulator of inflammation, signalling through two transmembrane 
receptors TNFR1 and TNFR2. Ligation of TNFR2 permits binding o f TRAF2 to the 
receptor, subsequently TRAF3, cIAPl and cIAP2 all form a signalling complex. This 
complex induces the activation of the transcription factors AP-1 and NF-*B through 
MAPK and IKK respectively. TNFR2 trimerization and activation also leads to NF-*B 
activation through NIK (Hauer, et a l, 2005; Cabal-Hierro and Lazo, 2012). TNFR1 
(p55) is expressed on almost all cell types, with activation leading to the induction of 
both proliferative and apoptotic processes (Chan et a l, 2000; Grell et a l, 2012). 
Alternatively, TNFR2 (p75) activation leads to transcriptional activation o f genes 
linked to cell proliferation and survival (Wallach et a l, 2005; Cabal-Hierro and Lazo, 
2012). TNFR2 can be proteolytically cleaved, making it a soluble antagonist of TNFa 
(Stillie and Stadnyk 2009). Studies have also shown that TNFR2 is upregulated in IBD 
and AOM/DSS models of inflammation-associated cancer (Hernandez et a l, 2000; 
Mizoguchi et a l, 2002; Onizawa et a l, 2009). TNFa and IL-6 act together, but neither 
alone to induce TNFR2 expression on colon cancer cells (Mizoguchi et a l, 2002).
TGFJ3 produced by most immune cells is a potent regulator o f proliferation and 
differentiation o f most immune cells (Chen 2006). Studies have proposed TGFJ3 
functions as a negative regulator of TLR4-induced macrophage activation; with mice 
lacking TGF0 associated with LPS hyperresponsiveness, subsequently leading to 
overexpression of pro-inflammatory cytokines (Comalada, Cardo et al. 2003;
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McCartney-Francis, Jin et al. 2004). Activation o f TLR4 signalling and its 
downstream components without negative regulation of TGF(3 may therefore promote 
abnormal immune responses and contribute to unregulated inflammation.
5.3 Aim: To investigate whether SOCS3 influences IEC cytokine 
production in response to microbial challenge
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5.4 Methods
5.4.1 Assessment of TLR ligands and SOCS3 on cytokine and receptor 
expression
SW480 SOC3norm and SOCS3hl IEC were seeded in a 24-well plate at 2 x 105 
cells/well. IEC were allowed to proliferate for 48h before serum-starving overnight. 
IEC were then treated with varying concentrations o f LPS (0.1, 1 and lOpg/ml), 
flagellin (1, 0.1 and 0.01pg/ml) and poly I:C (O.lpg/ml), for 2h. TNFa, TGF0 and 
TNFR2 mRNA expression levels were then measured using QPCR.
Following treatment, supernatant was collected and TNFa levels measured using 
an ELISA assay.
5.4.2 Assessment o f TLR ligands and SOCS3 on transcription factor 
expression
SW480 SOCS3norm and SOCS3hi IEC were seeded in a 12-well plate at 4 x 105 
cells/well. IEC were allowed to proliferate for 48h before serum-starving overnight. 
IEC were then treated with varying concentrations o f LPS (10, 1 and O.lpg/ml) and 
flagellin (1, 0.1 and O.Olpg/ml) for 2h. STAT3 phosphorylation and NF-*B expression 
were then measured using SDS-PAGE and western blotting. Values will be expressed 
as fold-change in transcription factor protein expression vs. no treatment ± standard 
error o f the mean (SEM).
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5.4.3 Assessment o f TNFR2 protein expression.
SW480 IEC were seeded in a 12-well plate at 1 x 105 cells/well and allowed to 
adhere overnight to coverslips. IEC were then treated with flagellin (O.lpg/ml) for 1, 
2, 4, 6, and 12h with no treatment controls also included to allow comparison. 
Immunocytochemistry was then used to observe distribution o f TNFR2, with IEC 
TNFR2 expression visualised using the Zeiss LSM 510 Meta Confocal Microscope.
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5.5 Results
5.5.1 TLR5 ligation is shown to promote TN Fa mRNA expression
Inflammatory TNFa and regulatory TGFp cytokine mRNA expression were 
assessed in response to TLR ligand treatment. Expression was normalised to RPLPO 
mRNA, and results displayed as fold-change in cytokine relative to no treatment. A 
student t test was used to determine statistical difference in contrast to no treatment 
with p <0.05.
1 6 1 *p<0.05 
I I TNFa 
I ITGFfi
OJu
Flagellin 0.1 jug/nilPoly (I:C) O.lpg/ml
Figure 5-2 Fold-change in cytokine mRNA expression after TLR ligation (* = p  
<0.05 vs. No Tx) (n=3)
Data from Figure 5-2 indicate treatment with flagellin, but not poly I:C or LPS 
caused a significant increase in TNFa mRNA expression (6.4). No significant 
increases in TGFp mRNA expression were observed after ligation o f TLR3, TLR4 or 
TLR5.
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5.5.2 TLR5 ligation had no effect on TGFp mRNA expression
TGFp mRNA expression was observed when IEC were treated with varying 
concentrations o f flagellin (0.01|ig/ml O.lpg/ml and lpg/m l) for 2h. Figure 5-3 shows 
fold-change in TGFp mRNA expression relative to no treatment. An unpaired student t 
test was used to determine if there was significant effect in contrast to no treatment 
controls with p <0.05.
* p <  0.051.15 n
|  0 0 .95 -
0 .85 -
FLA 0.01ug/m l FLA 0 .lug/m l FLA lug/m l 
Figure 5-3 Fold-change in TGFp mRNA expression after TLR5 ligation. (*  = p 
<0.05 vs. No Tx) (n=3)
From figure 5-3 we can conclude that all concentrations o f flagellin (0.01, 0.1 
and 1 pg/ml) had no effect on TGFp mRNA expression as p >0.05.
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5.5.3 TLR5 induces TN Fa mRNA expression in a dose dependent
manner
TNFa mRNA expression was observed when IEC were treated with varying 
concentrations o f flagellin (O.Olpg/ml O.lpg/ml and lpg/m l) for 2h. Figure 5-4 shows 
fold-change in TNFa mRNA expression relative to no treatment. An unpaired student t 
test was used to determine if there was significant effect in contrast to no treatment 
controls with p <0.05.
1 2  —i
*p<0.05
FLA 0.01 (ig/ml FLA 0.1 pg/ml FLA 1 fig/ml 
Figure 5-4 Fold-change in TNFa mRNA expression after TLR5 ligation. (* =  p 
<0.05 vs. No Tx) (n=3)
From figure 5-4 we can conclude that O.lpg/ml o f flagellin significantly 
promotes TNFa mRNA expression in IEC (6.4 ± 1.6, p <0.03) when compared to no
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treatment control. Additionally, treatment with lpg/m l o f flagellin was also shown to 
significantly promote TNFa mRNA expression in IEC (8.7 ± 1.8, p <0.01) when 
compared to no treatment control. Treatment with the lowest concentration o f flagellin 
(0.01 (ng/ml) hinted o f an increase in TNFa mRNA expression in IEC (4.0 ± 1.1, p = 
0.06).
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5.5.4 SOCS3 enhances TLR5 induced TN Fa mRNA expression
To establish how SOCS3 affects 1EC TLR signalling, TNFa mRNA expression 
was measured after SOCS3norm and SOCS3hl IEC were treated with varying 
concentrations flagellin for 2h. Figure 5-5 shows fold-change in TNFa mRNA 
expression relative to no treatment. An unpaired student t test was used to determine 
statistical effect in contrast to SOCS3norm IEC with p <0.05.
5 0 - i
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FLA 0.1 Mg/ml FLA 1 pg/ml
Figure 5-5 Effect o f varying concentrations o f flagellin treatment (0.01, 0.1 and 
lpg/m l) on the expression o f TNFa mRNA in SOCS3norm and SOCS3hl IEC (* =  p 
<0.05 vs. SOCS3nomi IEC (n=5).
From figure 5-5 we can conclude that SOCS3 overexpression enhanced the 
mRNA expression o f TNFa in a dose dependent manner after TLR5 ligation. 
Treatment with the lowest concentration o f flagellin (O.Olpg/ml) showed a 3.8 fold-
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increase in TN Fa mRNA expression in SOCS3hl IEC in comparison to SOCS3norm 
IEC. Fold-increases o f 3.2 and 3.7 were also observed in SOCS3hl IEC in comparison 
to SOCS3norm IEC after treatment with 0.1 and lpg/m l o f flagellin respectively.
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5.5.5 SOCS3 driven increases in mRNA do not appear to translate to 
increase in secreted TNFa
Data from figure 5-5 indicates SOCS3 overexpression enhances flagellin- 
induced mRNA expression. To determine if increases in TN Fa mRNA translated into 
secreted protein, soluble TNFa was detected in the supernatant. Figure 5-6 shows 
TNFa secretion after SOCS3norm and SOCS3hl IEC were treated with varying 
concentrations o f flagellin. An unpaired student t test was used to determine statistical 
effect in contrast to SOCS3norm IEC with p <0.05.
* p <  0.05
c- 0.7-







Figure 5-6 Effect o f flagellin treatment on TNFa secretion from SOCS3r 
SOCS3hl IEC ( * =  p <0.05 vs. SOCS3norm IEC) (n=6).
and
Modest increases in sTNFa were detected by ELISA, but increases in secreted 
protein were nowhere near as marked as increases in mRNA, leading us to speculate 
that increases in TNFa mRNA were not reflected in the secreted form maybe due to
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either rapid binding to membrane receptor or post-translational regulation, possibly 
regulated by SOCS3.
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5.5.6 SOCS3 overexpression had no significant effect on LPS or FLA 
induced-pSTAT3 expression
To observe the effect o f TLR ligation and SOCS3 status on the phosphorylation 
o f STAT3, SOCS3norm and SOCS3hl IEC were treated with varying concentrations of 
LPS and flagellin for 2h. Figure 5-7 shows fold-change in TLR-induced pSTAT3 
expression in SOCS3norm and SOCS3hl IEC in comparison to no treatment. An 
unpaired student t test was used to determine statistical effect in contrast to SOCS3norm 
IEC with p <0.05.
*  p < 0 .0 5  
tH ] SO C S3nom i 
WM SO CS3hi
L P S O .lp g /m l LPS lp g /n il LPS lOpg ml FLA O.Olpg ml FLA O .lpg ml F L A lp g .m l
Figure 5-7 Effect o f LPS and flagellin. treatment on STAT3 phosphorylation in 
SOCS3norm and SOCS3hl IEC ( * =  p <0.05 vs. SOCS3norm No Tx) (n=3).
From figure 5-7 we can conclude that SOCS3 overexpression had no significant 
effect on LPS or flagellin induced pSTAT3 expression as p >0.05.
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5.5.7 Flagellin does not induce NF-*B p65 expression
To observe the effect o f TLR ligation and SOCS3 status on NF-JB p65 
expression, SOCS3norm and SOCS3hl IEC were treated with varying concentrations of 
LPS and flagellin for 2h. Figure 5-8 shows fold-change in TLR-induced NF-^B p65 
expression in SOCS3norm and SOCS3hl IEC in comparison to SOCS3norm no treatment. 
An unpaired student t test was used to determine statistical effect in contrast to 
SOCS3norm no treatment IEC with p <0.05.
* p <  0.05 
I I SOCS3norm 
■ 1  SOCS3hi
LPS LPS LPS FLA FLA FLA
0. lug/ml lug/ml lOug/ml O.Olug/ml 0. lug/ml lug/ml
Figure 5-8 Effect o f LPS and flagellin, treatment on NF-*B p65 in SOCS3nomi and 
SOCS3hi IEC. ( * =  p <0.05 vs. SOCS3norm No Tx) (n=3).
Figure 5-8 shows that LPS (10|ig/ml) caused an increased in NF-*B p65 
expression (1.6 ± 0.2,/? <0.04) in SOCS3norm IEC; with SOCS3-overexpression again 
causing an increase in NF-*B p65 expression (1.34 ± 0.14, p  <0.05) after LPS 
stimulation (O.lpg/ml). All concentrations o f flagellin (0.01, 0.1 and lfig/ml) were 
shown to have no significant effect on NF-*B p65 expression.
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5.5.8 SOCS3 blocked TLR3, and TLR5-induced TNFR2
SOCS3 overexpression was shown to enhance TLR5-induced TNFa mRNA 
expression in IEC; however this was not translated to secreted protein possibly due to 
TNFa binding to its receptor TNFR2. To establish how SOCS3 affects TNFR2 
transcription in response to varying concentrations o f flagellin, Poly I: C and LPS, 
SOCS3norm and SOCS3hl IEC were treated for 2h. An unpaired student t test was used 
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Figure 5-9 Effect o f flagellin, Poly I:C and LPS treatment on the expression o f 
TNFR2 mRNA in SOCS3norm and SOCS3h' IEC (*  = p <0.05 vs. SOCS3norm No Tx) 
(n-6).
Results from figure 5-9 indicate that in SOCS3norm IEC treatment with most 
concentrations o f flagellin (0.1 and lpg/m l) and Poly I:C (O.lpg/ml) were shown to 
significantly enhance TNFR2 mRNA expression by 3.0, 2.9 and 2.9 respectively, as p
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<0.05. However, overexpression in TNFR2 mRNA expression in response to TLR3 
and TLR5 ligation were no longer observed in SOCS3hl IEC.
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5.5.9 Flagellin was shown to down- then up-regulate TNFR2 protein 
expression
Data from figure 5-9 indicated TLR5 ligation increased TNFR2 mRNA 
expression. To determine whether TLR5 ligation also induced the expression o f 
TNFR2; immunocytochemistry was used to observe TNFR2 expression in SOCS3norm 








Figure 5-10 D istribution o f  TNFR2 in SOCS3norm IEC after exposure to flagellin 
(O .lpg/m l) for 1, 2, 4, 6, and 12h using imm unocytochemistry. Green represents 
TNFR2, Red represents propidium  iodide (n=3).
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From figure 5-10 we can conclude that baseline levels o f TNFR2 show 
distribution o f receptor at both cytoplasmic and membrane locations. Treatment o f 
IEC with flagellin (O.lpg/ml) depicted a down-regulation in TNFR2 distribution at 
both cytoplasmic and membrane locations after 1 and 2hrs. Cytoplasmic and 
membrane TNFR2 protein expression steadily began to increase again back to no 
treatment levels after stimulating with flagellin for 4, 6 and 12h; with greatest levels o f 
TNFR2 at both cytoplasmic and membrane locations observed 12h post-stimulation.
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5.6 Discussion
TLR signalling pathways have been shown to be important activators o f NF-*B, 
influencing the expression o f a number o f ‘pro-inflammatory’ genes such as TNFa, 
IL-6 and IL-8 (Vijay-Kumar et a l, 2008) essential for immunity and tissue repair. 
However, if persistently activated, excessive levels o f these cytokines can lead to 
certain pathologies. TGFp is an immunoregulatory cytokine regulating proliferation, 
differentiation and function o f both immune and non-immune cells (Hartsough and 
M ulder 1997; Letterio and Roberts 1998; Yue, Sun et al. 2004). Studies have shown 
TGFp is a potent inhibitor o f DC activation. TGFp-conditioned myeloid DCs appear 
to be tolorogenic as they do not respond to microbial stimuli and protect mice against 
lethal LPS-induced inflammation (Neurath, Fuss et al. 1996). Our studies indicate 
TLR4 or TLR5 ligation has not effect on TGFp mRNA expression. Here, we also 
demonstrate that TLR ligation with flagellin and not Poly I:C or LPS causes an 
increase in TN Fa mRNA expression. Moreover, SOCS3 enhances TLR5 induced 
TNFa in a dose dependent manner.
Increases in TNFa mRNA upon flagellin stimulation did not appear to translate 
to increases in secreted TNFa. This led us to hypothesise that this was perhaps due to 
TNFa binding to its receptor. Numerous studies have shown that TNFa signals 
through two transmembrane receptors TNFR1 and TNFR2. In vitro studies using 
colonic IEC have demonstrated that stimulation with TNFa causes an upregulation o f 
both TNFR2 mRNA and sTNFR2 protein (Hamilton, Simmons et al. 2011). Other 
studies demonstrate TNFR2 can be proteollytically cleaved making it a soluble 
antagonist o f TNFa (Stillie and Stadnyk 2009). This suggests a possible rationale that 
although sTNFa maybe secreted upon flagellin stimulation; TNFa may not be
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detectable by the ELISA assay as sTNFR2 could act as a decoy receptor. Alternatively 
it could also be due to a post-translational regulatory mechanism.
SOCS3, an endogenous negative feedback inhibitor o f inflammatory cytokine- 
mediated signalling is shown to limits transcription factor activation/translocation in 
response to inflammatory stimuli within IEC. Examples o f inhibitory effects include 
TNFa-induced NF-*B translocation and IL-6 induced STAT3 phosphorylation (Rigby, 
Simmons et al. 2007; Li, de Haar et al. 2010). There is overwhelming evidence to 
support the role o f SOCS3 as a regulator o f intestinal epithelial homeostasis, including 
IEC overexpression in IBD (Suzuki, Hanada et al. 2001), targeted deletion o f IEC 
SOCS3 promoting tumour incidence and growth (Rigby, Simmons et al. 2007); and 
epigenetic silencing o f SOCS3 observed in intestinal tumours (Li, de Haar et al. 2012; 
Li, Deuring et al. 2012).
Toll-like receptors have been shown to influence IEC turnover through 
promoting phosphorylation o f STAT3 and activating NF-*B regulating the 
transcription o f several hundred genes with kB binding sites (Suzuki, Hanada et al. 
2001; Ghosh and Karin 2002; Abreu, Thomas et al. 2003). Our results indicate 
SOCS3 overexpression had no effect on TLR4 or TLR5 induced-STAT3 
phosphorylation and that TLR4, but not TLR5 signalling promoted NF-*B activation, 
although SOCS3 had little effect on TLR4 induced NF-*B in our system.
TNFR2 activation leads to transcriptional factors triggering genes linked to cell 
proliferation and survival (Rodriguez-Vita and Lawrence 2010; Hamilton, Simmons et 
al. 2011). Studies have shown that TNFR2 is upregulated in IBD and AOM/DSS 
models o f inflammation associated cancer (Crespo, Cayon et al. 2001; Mizoguchi, 
Mizoguchi et al. 2002; Onizawa, Nagaishi et al. 2009). Hamilton and colleagues 
(2011) have shown that overexpression o f SOCS3 decreases cytokine induced TNFR2
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expression, limits proliferation o f colon cancer cells and decreases anchorage- 
independent growth o f colon cancer cells, even cells overexpressing TNFR2 
(Hamilton, Simmons et al. 2011). Our results indicate that both TLR3 and TLR5 
ligation show increases in TNFR2 mRNA expression, with SOCS3 limiting this 
upregulation. The limiting effect o f SOCS3 on TNFR2 expression could account for 
the increase in TNFa, or equally the increase in TNFa could account for limitation of 
TNFR2 upregulation. IHC data indicates TLR5-induced TNFa causes a rapid 
downregulation o f TNFR2, and expression is restored to habitual levels by 6h post 










Figure 5-1 1 Possible mode of SOCS3 action in TLR5-induced TNFR2 signalling
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The dual roles o f SOCS3 in cancer and inflammatory diseases have been 
recognised. Our findings indicate SOCS3 may perpetuate microbial-induced TNFa 
which may drive mucosal inflammation, thus promoting pathological symptoms o f 
UC. Furthermore, as silencing o f SOCS3 promotes cancer, SOCS3 limitation o f 
microbial-induced TNFR2 may be one mechanism by which SOCS3 limits tumour 
formation, but promotes pro-mitotic inflammation.
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Innate immune interactions o f IEC with microbial constituents drive the 
expression o f pro-inflammatory genes, and secretion o f cytokines which subsequently 
activate the adaptive immune response. The intestinal epithelium regulated 
inflammatory signalling relative to immune cells generates ‘tolerance’ to commensal 
flora. Breakdown o f tolerance to commensal flora is associated with the pathogenesis 
o f IBD and NEC.
These studies aimed to assess whether SOCS3 mediates IEC tolerance to TLR 
ligation and assess in what way differentiation status o f IEC affects cytokine, and 
SOCS3 expression. Our results indicate pre-treatment with LPS is shown to attenuate 
LPS-induced SOCS3 and TLR4 expression, suggesting IEC become tolerant or 
hyporesponsive to successive stimulations o f LPS. An in vitro model was developed to 
assess TLR4-induced SOCS3 and cytokine expression in conventional (differentiated) 
and damaged (proliferating) IEC monolayers. Our results show damaged monolayers 
express greater levels o f LPS-induced SOCS3 and TNFa than conventional 
monolayers, parallel to observations in IBD. However; TGFp is shown to be 
upregulated in both damaged and conventional monolayers following TLR ligation, 
supporting its role as an TLR-induced immunoregulatory cytokine. These results 
suggest IEC become tolerant to commensal flora, protecting against incessant immune 
activation by commensals. Furthermore, expression o f microbial-induced 




The intestinal epithelium serves as a physical barrier that separates luminal 
microflora and food antigens from the internal milieu. As well as constituting a barrier 
to luminal contents, IEC are active contributors to the intestinal innate immune 
response, responding to signals from both the luminal (apical) and lamina propria 
(basolateral) environments (Madara 1997; Hecht 1999). Interaction o f  IEC with 
pathogenic bacteria provoke the expression o f pro-inflammatory genes, and secretion 
o f cytokines and chemokines, recruitment o f inflammatory cells, and subsequent 
activation o f the adaptive immune system (Jung, Eckmann et al. 1995; M adara 1997; 
Kim, Eckmann et al. 1998; Elewaut, DiDonato et al. 1999). The innate immune 
responses o f IEC have evolved restricting infection by luminal pathogens. IEC are 
able to detect molecules associated with pathogens via a cohort o f pattern recognition 
receptors termed Toll-like receptors (TLR). The detection o f microbial ligands such as 
lipopolysaccharide (LPS) is recognised by TLR4 (Abreu, Fukata et al. 2005; Kawai 
and Akira 2007; Beutler 2009). Stimulation o f TLR influences the expression o f a 
number o f pro-inflammatory cytokine such as TNFa, IL-6 and IL-8 (Kawai and Akira 
2007; Beutler 2009).
Although none o f the TLR microbial ligands are unique to pathogens, with many 
also common to non-pathogenic organisms, this proves an enigma to the intestinal 
epithelium which is constitutively exposed to vast numbers o f microbes and their 
products (Rakoff-Nahoum, Paglino et al. 2004). Despite this, under physiological 
conditions, the intestinal epithelium does not appear to activate the pro-inflammatory- 
signalling cascade in response to commensal flora. Therefore, mechanisms must exist 
to regulate the intestinal immune system between mucosal defence from adverse
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microbes and ‘tolerance’ to commensal flora. Idiopathic IBD is described as chronic 
intestinal inflammation in the absence o f identified bacterial pathogens.
Studies have shown that several microbial components trigger innate immune 
responses and can incite endotoxin shock-like symptoms in experimental animals. 
However, these microbial components also generate tolerance following successive 
stimulation, conceivably safeguarding the host from dysregulated immune responses 
(Biberstine, Darr et al. 1996; Zeisberger and Roth 1998).
The transition from a sterile inter-uterine environment to a world that is rich in 
microbial antigens elevates the risk o f microbial infection due to the immaturity o f the 
immune system in newborns. The newborn faces a multifaceted array o f 
immunological demands, including fortification against infection and avoidance o f 
harmful inflammatory immune responses. One o f the tolerance mechanisms proposed 
is that shortly after birth, TLR4 is down regulated in the neonate intestine, presumably 
resulting in the “hyporesponsive” nature o f IEC (Levy 2007). Cario and colleagues 
(2000) had previously demonstrated that TLR4 is sparsely expressed on human IEC. 
However, TLR4 expression is up-regulated in both CD and UC. TLR5 remains 
unaffected, indicating IBD is associated with dysregulated TLR4 expression (Cario 
and Podolsky 2000). Other researchers have shown that TLR4 is primarily expressed 
on the surface o f IEC, but can become internalised making it less responsiveness to 
LPS (Abreu, Vora et al. 2001; Abreu, Fukata et al. 2005).
Necrotising enterocolitis (NEC) is one o f the most common and distressing 
gastrointestinal emergencies in neonates. The exact pathogenesis o f NEC is still 
unconfirmed, however one hypothesis suggests that NEC occurrence may be due to 
inappropriate initial microbial colonisation or the naivety o f the under-developed
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immune system o f the gastrointestinal tract in newborns, as NEC arises 8-10 days after 
birth (Claud and Walker 2001). Intestinal samples o f NEC neonates are shown to have 
increased pro-inflammatory cytokines, suggesting these mediators play a part in NEC 
development. Another study has depicted rat models o f NEC overexpressing TLR2, as 
well as NF-*B in IEC correlating with severity o f mucosal damage (Martin and Walker 
2006; Schultz, Bonnard et al. 2007). Additionally, IEC expression o f TLR and 
cytokines precedes histological injury in experimental NEC (Liu, Zhu et al. 2009). 
NEC is also associated with increased expression o f TLR4 in the intestinal mucosa 
(Leaphart, Cavallo et al. 2007). These findings demonstrate the critical role o f TLR 
expression in the development o f NEC.
Endotoxin shock is often a fatal consequence o f bacterial infection, that may 
occur when LPS enters the blood stream (bacteremia), causing systemic inflammatory 
reaction. Although, some studies have indicated modest concentrations o f LPS do not 
induce TLR4-mediated responses in several cell lines, suggesting IEC are more 
tolerant to LPS than other cell lines.
Transforming growth factor-p (TGFP), is produced by most immune cells, and is 
a potent regulator o f proliferation and differentiation o f immune cells (Chen 2006). 
TGFp is shown to negatively regulate TLR4-induced macrophage activation. 
Furthermore, mice lacking TGFp display elevated levels o f TLR4 mRNA expression 
and are LPS hyperresponsive, subsequently expressing increased levels o f pro- 
inflammatory cytokines (Comalada, Cardo et al. 2003; McCartney-Francis, Jin et al. 
2004).
Hamilton and colleagues (2009) had shown that the helminth Fasciola hepatica 
(F. hepatica), the causative agent o f fasciolosis is evolving as a significant disease in
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humans (Mas-Coma, Bargues et al. 1999). The F. hepatica tegumental antigen 
(FhTeg) renders dendritic cells hyporesponsive to TLR activation. Furthermore, 
FhTeg is also shown to suppress LPS induced NF-*B activation in dendritic cells 
(Hamilton, Dowling et al. 2009). Other studies have gone on to demonstrate that 
FhTeg’s inhibitory effects on TLR4 signalling are not only limited to the suppression 
o f NF-*B activation, but also MAPK, an important intermediate in TLR4 signalling 
(Vukman, Adams et al. 2013). FhTeg is also shown to induce the expression o f 
SOCS3 in mast cells, impairing ability to drive Thl immune responses, a characteristic 
feature o f Fasciola infection (Vukman, Adams et al. 2013). The upregulation o f 
SOCS3 following pre-treatment with FhTeg could provide a rationale for the 
hyperresponsiveness o f LPS-induced cytokine secretion.
Conclusively, these studies suggest that neonatal IEC become hyporesponsive to 
microbial-induced TLR signalling following birth. Since aberrations o f TLR and 
inflammatory cytokine expression are associated with NEC development; this chapter 
aims to investigate the potential role o f SOCS3 as a mediator o f hyporesponsiveness to 
TLR ligation. Furthermore, SOCS3 and cytokine expression levels will also be 
assessed in a model o f conventional and disrupted IEC monolayers.




6.4.1 Assessment of TLR ligand pre-treatment on SOCS3 and TLR 
receptor expression
These experiments utilised the Caco-2 IEC which were seeded in 12-well plates 
at 2 x 105 cells/well and allowed to adhere overnight. IEC were either pre-treated with 
LPS lOpg/ml for 6h, or left in complete medium, then subjected to a subsequent 
lOpg/ml LPS treatment for varying time points (1, 2, 3, 4, and 6h), or not. SOCS3 and 
TLR4 mRNA levels were then measured using qPCR. Experiment was repeated 3 
times (n=3) with all results pooled together.
6.4.2 Assessment o f IEC differentiation status on SOCS3, TGFp and 
TNFa expression
Proliferating Caco-2 cells which had been seeded overnight, and Caco-2 cells 
which had been allowed to differentiate for 7 days were treated with 1 pg/ml LPS for 
2h. SOCS3, TGFp and TNFa mRNA levels were then measured using qPCR. 
Experiment was repeated 3 times (n=3) with all results pooled together.
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6.5 Results
6.5.1 SOCS3 expression upregulated following treatment with LPS
To evaluate the effect o f treatment with LPS on the expression o f SOCS3 in 
proliferating IEC, SOCS3 mRNA was assessed. A unpaired student t test was used to 
determine if there was significant effect in contrast to No Tx with p <0.05.
63 421
Incubation (II)
Figure 6-1 Effect o f LPS treatment (1, 2, 3, 4 and 6h) on SOCS3 mRNA 
expression vs. No Treatment. A unpaired student t test was used to determine 
significant effect in contrast to no treatment cultures. * = indicates a significant 
change Vs. No Tx IEC cultures (p <0.05) (n=3)
In figure 6-1 we can conclude that SOCS3 mRNA expression showed fold- 
increases o f 4.2, 5.1, 4.0 and 2.8 following stimulation with LPS for 1, 2, 3, 4 and 6h 
respectively, in comparison to no treatment cultures.
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6.5.2 LPS pre-treatment attenuated IEC SOCS3 expression following 
LPS stimulation.
To evaluate the effect o f pre-treatment with LPS on the expression o f SOCS3 in 
proliferating IEC, SOCS3 mRNA was assessed. A student t test was used to determine 
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Figure 6-2 Effect o f LPS pre-treatment (6h) and subsequent LPS treatment (1, 2, 
3, 4 and 6h) on SOCS3 mRNA expression vs. No Treatment. A student t test was used 
to determine significant effect in contrast to pre-treated cultures with p <0.05. * =
indicates a significant change Vs. pre-treated cultures (p <0.05) (n=3)
Figure 6-2 shows that pre-treatment with LPS for 6h was shown to attenuate 
SOCS3 mRNA transcription by 48, 68 and 62% at 2, 3 and 4h respectively, in 
comparison to naive cells.
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6.5.3 TLR4 IEC expression attenuated response following pre- treatment 
with LPS
To evaluate the expression o f TLR on proliferating Caco-2 IEC which had either 
been pre-treated with 10(ig/ml LPS or not, then treated again with LPS for varying 
periods, values have been expressed as relative increase in TLR4 mRNA vs. No 
Treatment. A student t test was used to determine if there was significant effect in 
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Figure 6-3 Effect o f LPS pre-treatment (6h) and subsequent LPS stimulation (1, 2, 
3, 4 and 6h) on TLR4 mRNA expression. * = indicates a significant change Vs. pre­
treated cultures (p <0.05) (n=3)
From figure 6-3 we can conclude that pre-treatment with LPS for 6h was shown 
to inhibit TLR4 mRNA expression by 50 and 58% at 1 and 2h respectively, in 
comparison to naive cultures which were also treated with LPS for 1 or 2h with p 
<0.05.
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6.5.4 Proliferating IEC express greater levels o f SOCS3 than
differentiated IEC following TLR4 ligation
To evaluate SOCS3 expression in differentiated and proliferating Caco-2 cells in 
response to lpg/m l LPS treatment, values have been expressed as relative increases in 
SOCS3 mRNA vs. proliferating No Treatment IEC. A student t test was used to 
determine if there was significant effect in contrast to No Tx with p <0.05.
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Figure 6-4 Effect o f Caco-2 IEC differentiation status and LPS treatment (2h) on 
SOCS3 mRNA expression. * = indicates a significant change Vs. No Tx IEC (p 
<0.05) (n=3)
From figure 6-4 we can conclude that treatment with LPS for 2h depicted a 4.6 
fold-increase in SOCS3 mRNA expression in proliferating IEC in comparison to no 
treatment IEC cultures. Treatment with LPS for 2h was shown to have no significant 
effect on SOCS3mRNA expression in differentiated IEC.
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6.5.5 Proliferating IEC express greater levels o f  TN Fa than differentiated
IEC following TLR4 ligation
To evaluate TNFa expression in differentiated and proliferating Caco-2 cells in 
response to lpg/m l LPS treatment, values have been expressed as relative increases in 
TNFa mRNA vs. proliferating No Treatment IEC. A student t test was used to 
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Figure 6-5 Effect o f Caco-2 IEC differentiation status and LPS treatment (2h) on 
TNFa mRNA expression. * = indicates a significant change Vs. No Tx (p <0.05) 
(n=3)
From figure 6-5 we can conclude that proliferating IEC showed a 7.4 fold- 
increase in TNFa mRNA expression in comparison to no treatment IEC cultures. 
Treatment with LPS for 2h was shown to have no significant effect o f TNFa mRNA 
expression in differentiated IEC.
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6.5.6 TGFp is upregulated in both proliferating and differentiated IEC 
following TLR4 ligation
To evaluate TGFp expression in differentiated and proliferating Caco-2 cells in 
response to lpg/m l LPS treatment, values have been expressed as relative increases in 
TGFp mRNA vs. differentiated No Treatment IEC. A student t test was used to 
determine if there was significant effect in contrast to No Tx with p < 0.05.
Figure 6-6 Effect o f Caco-2 IEC differentiation status and LPS treatment (2h) on 
TGFp mRNA expression. * = indicates a significant change Vs. No Tx (p <0.05) 
(n=3)
From figure 6-6 we can conclude that treatment with LPS for 2h depicted a 4.5 
fold-increase in TGFp mRNA expression in proliferating IEC in comparison to no 
treatment IEC cultures. Treatment with LPS for 2h was also shown to depict a 2.7
* p<0.05
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Previous studies have demonstrated that the gut can be colonized by as much as
8 1 0 *10 to 10 microflora per gram of faeces within the first few days o f birth (Bettelheim, 
Breadon et al. 1974; Bezirtzoglou 1997; Fanaro, Chierici et al. 2003). Recognition o f 
these microbial components such as LPS by TLR4 results in the expression o f a 
number o f pro-inflammatory genes such as TNFa, IL-6 and IL-8 (Vijay-Kumar, 
Aitken et al. 2008). However, if persistently activated, excessive levels o f these 
cytokines may initiate certain pathologies such as IBD and NEC. Failure o f pre-term 
neonates to correctly down-regulate responses to LPS appears to significantly 
contribute to neonates susceptibility to NEC (Jilling, Simon et al. 2006; Lin and Stoll
2006). Nevertheless, in most cases microflora do not typically elicit an inflammatory 
response from IEC.
The mechanisms by which IEC are protected against incessant immune 
activation by commensals and LPS is o f great importance. Studies by Levy (2007) 
have shown that following birth, neonates down-regulate the expression o f IEC TLR4, 
resulting in the “hyporesponsiveness” nature o f IEC (Levy 2007). Our results also 
indirectly support these findings by indicating that IEC down-regulate the expression 
o f TLR4 mRNA following successive treatments o f LPS, with IEC developing LPS 
tolerance.
SOCS3, inhibits TNFa-induced NF-*B translocation and IL-6 induced STAT 
phosphorylation (Rigby, Simmons et al. 2007; Li, de Haar et al. 2010). There is much 
evidence to support the role o f SOCS3 as a governor o f IEC homeostasis. SOCS3 is 
upregulated in IBD (Suzuki, Hanada et al. 2001) and targeted removal o f SOCS3 is 
shown to encourage intestinal tumour incidence and development (Rigby, Simmons et
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al. 2007). Baetz and colleagues (2004) have shown that LPS induces the expression o f 
SOCS3 in macrophages (Baetz, Frey et al. 2004). Our results mirror these findings by 
demonstrating stimulation with LPS promotes the expression o f SOCS3 mRNA in 
IEC. Furthermore, our results also indicate pre-treatment with LPS attenuates LPS- 
induced SOCS3 mRNA expression. SOCS3 mRNA expression following LPS 
stimulation suggests it is oscillatory in behaviour. Other studies have also depicted 
similar findings with SOCS3 mRNA expression oscillating with peaks at 50 and 70 
minutes after serum stimulation. Moreover, western blot analysis also showed SOCS3 
protein expression displaying oscillations with peaks at 2 and 4h after serum 
stimulation, indicating a delay o f about lh  between mRNA and protein synthesis 
(Yoshiura, Ohtsuka et al. 2007). It is worth noting that the reduction o f SOCS3 mRNA 
expression following pre-treatment could entirely be due to down-regulation o f 
signalling only at the receptor level and not down-regulation o f both TLR4 and 
SOCS3.
Epithelial homeostasis, that which is the physiological equilibrium o f IEC 
proliferation, differentiation and apoptosis, is fundamental for the growth and 
maintenance o f complex tissues. However, there are a number o f instances when this 
delicate equilibrium is pathologically disrupted, leading to distorted epithelial 
architecture, a loss o f epithelial barrier function, and in severe cases- tumourgenesis 
(Rakoff-Nahoum, Paglino et al. 2004; Artis 2008; Maloy and Powrie 2011; Koch and 
Nusrat 2012). A distinguishing feature o f IBD is that the rate o f IEC proliferation and 
apoptosis is enhanced, correlating with disease severity (Serafini, Kirk et al. 1981; 
Sipos, Bela Molnar et al. 2005). Pathologically heightened IEC apoptosis in IBD is 
thought to potentiate the epithelial barrier defect, permitting the translocation o f 
luminal antigens exuberating the inflammatory immune response (Koch and Nusrat
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2012). Differentiation o f IEC is also affected during chronic colitis to such a degree, 
that mucin depletion has been proposed as a possible diagnostic marker for UC 
(McCormick, Horton et al. 1990). The JAK-STAT3 signalling pathway is regulated by 
SOCS3 and has been identified as a key regulator o f inflammatory cytokines (Rigby, 
Simmons et al. 2007; Li, de Haar et al. 2010). To analyse LPS-induced SOCS3 and 
inflammatory cytokine expression in conventional and damaged monolayers, an in 
vitro model was developed where IEC were either allowed to differentiate and form 
monolayers for 7 days (conventional) or seeded the day before where IEC were 
proliferating, signifying loss o f barrier integrity (damaged) as observed in IBD.
Our results (Fig 6.4) indicate that LPS stimulation promotes a 4.6 fold-increase 
in expression o f SOCS3 in proliferating IEC, indicating proliferating IEC are 
responsive to LPS. LPS did not induce SOCS3 expression in differentiated cells, 
possibly due to polarisation o f Caco-2 cells in monolayers, and limited apical exposure 
to LPS. Further evidence to suggest that differentiated Caco-2 IEC are less responsive 
to TLR stimulation can be seen in Figures 6.5 and 6.6.
TNFa, is upregulated in inflammatory disorders, and has developed as a key 
therapeutic target for IBD (Ghosh 2005; Sfikakis 2010). Numerous studies within 
macrophages have shown TNFa signalling transpires through NF-*B and MAPK. 
Studies have also shown TNFa increases IEC apoptosis and antigen sampling. 
Conversely, it also limits IEC proliferation and barrier function (Soderholm, Streutker 
et al. 2004; Wang, Graham et al. 2005; Kolinska, Lisa et al. 2008; Nava, Koch et al.
2010). Our results (Fig 6.5) indicate TLR ligation promotes a 7.4 fold-increase in 
TN Fa expression in proliferating IEC; however TLR4 ligation had no impact on TNFa 
in differentiated IEC. This emulates observations in IBD where loss o f barrier integrity 
causes an upregulation o f TNFa.
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TGFp, an immunoregulatory cytokine has beneficial effects on epithelial 
homeostasis by rescuing epithelial barrier function in the presence o f IFN-y (Planchon, 
Martins et al. 1994). Other studies have suggested rather than moderating the junctions 
o f epithelial cells directly, TGFp protects the epithelium by preventing the expression 
o f inflammatory cytokines following microbial challenge (Jarry, Bossard et al. 2008). 
Our results (Fig 6.6) indicate TLR4 ligation promotes a 4.5 fold-increase in TGFp in 
proliferating IEC; with a fold-increase o f 2.7 in TGFp also observed in differentiated 
IEC following TLR4 ligation. Data supports the role o f TGFp as an immunoregulatory 
cytokine limiting expression o f other inflammatory cytokines following microbial 
challenge. Furthermore, a greater increase in TGFp expression is detected in 
proliferating IEC than differentiated IEC possibly due to polarisation o f Caco-2 cells 
in monolayers, limiting apical exposure to LPS
Conclusively, our results indicate IEC become hyporesponsive following 
successive stimulations with LPS, making IEC tolerant to LPS and protected against 
incessant immune activation by commensals and LPS. Furthermore, cytokines and 
their endogenous feedback inhibitor, SOCS3 vary in expression levels conditional to 






IEC are able to communicate with microflora in the colon via a cohort o f pattern 
recognition receptors, termed TLR. Numerous studies have demonstrated that TLR 
through interaction with commensals and their products play a pivotal role in inducing 
tissue regeneration following injury (Rakoff-Nahoum, Paglino et al. 2004; Rakoff- 
Nahoum and Medzhitov 2007). Conversely, TLR knockdown or germ-free mice 
display overwhelmingly reduced dysplasia, number and size o f tumours (Fukata, Chen 
et al. 2007). Taken together, these studies indicate controlled microbial stimulation via 
TLR are essential for intestinal homeostasis. SOCS3 is also key in regulating intestinal 
homeostasis indicated by its irregular expression in mouse models o f inflammation 
(Suzuki, Hanada et al. 2001; Li, de Haar et al. 2011). Furthermore, studies have also 
depicted SOCS3 as a tumour suppressor, including in the colon (Rigby, Simmons et al.
2007).
Several studies have investigated the effect o f TLR ligation and SOCS3 
expression o f immune cells such as dendritic cells and macrophages (Krutzik, Tan et 
al. 2005; Liu, Zhang et al. 2008; Posselt, Schwarz et al. 2011; Shibata, Motoi et al.
2011). TLR ligation is shown to promote both cytokine and chemokine production in 
dendritic cells, with SOCS3 influencing cytokine production (Alexander and Hilton 
2004; Strengell, Lehtonen et al. 2006; Barr, Brown et al. 2007; Yoshimura, Naka et al. 
2007; Liu, Zhang et al. 2008), but our study is novel in that no other study to date has 
assessed the innate immune roles of TLR and SOCS3 in IEC. IEC form the first point 
o f contact between commensal microflora and the underlying immune system, thus 
our study focussed on microbial-induced TLR signalling in IEC as this is likely to 
present a pivotal interaction with regard to the ensuing immune response.
As numerous studies substantiate TLR signalling as imperative mediators o f 
mucosal homeostasis, repair o f damaged tissue and fortification against the occurrence
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o f bowel cancer; this project aimed to investigate the duel and perhaps integrated roles 
o f SOCS3 and TLR in mediating epithelial repair following damage. In chapter 3, IEC 
models which constitutively overexpressed SOCS3 were developed enabling the role 
o f SOCS3 in mediating cellular responses and epithelial repair following microbial 
induced TLR signalling to be explored.
To address these issues, stable SOCS3 transfections which involved DNA 
integrating into the host genome by recombination were developed, making IEC 
continually overexpress SOCS3. Both transient and stably transfected IEC (SW480 
and Caco-2) were then used to investigate the role o f SOCS3 in mediating cellular 
responses following microbial-induced TLR signalling.
In vitro wound healing models show that following injury, IEC migrate into the 
damaged area (restitution), this is then followed by proliferation and differentiation to 
preserve the functional activity o f the epithelium (Dignass 2001; Dignass, Baumgart et 
al. 2004). TLR signalling is essential for maintaining tissue integrity and repair o f 
damaged tissue in models o f colonic injury (Fukata, Michelsen et al. 2005; Rakoff- 
Nahoum and Medzhitov 2008). Furthermore, TLR knockdown and germ-free animals 
depict deficient repair o f damaged tissue (Rakoff-Nahoum, Paglino et al. 2004; Abreu, 
Fukata et al. 2005; Kluwe, Mencin et al. 2009). Chapter 4 involved developing an in 
vitro model o f wound repair, permitting investigations on the role o f SOCS3 on TLR- 
mediated wound healing. Our data supports other studies indicating microbial-induced 
TLR signalling is fundamental for epithelial repair following injury. Furthermore, 
novel findings in this study provide a direct link between TLR and inadequate repair 
mechanisms by indicating SOCS3 plays a pivotal role in inhibiting microbial-induced 
proliferation and epithelial repair. These findings provide a rationale for the
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pathogenesis o f IBD, indicating aberrations in SOCS3 expression limit microbial- 
induced wound repair.
Helminth products were shown to promote both proliferative and restitutive 
repair, whereas LPS and flagellin only enhanced restitutive repair. A plausible 
explanation for this observation could be helminth-derived ES proteins contain 
substances that are able to ligate with multiple TLR (TLR2, TLR4 and TLR6) 
(DeSchoolmeester, Martinez-Pomares et al. 2009). Further studies would use anti- 
TLR2, TLR4 and TLR6 antibodies to block distinct TLR signalling pathways 
permitting further investigation o f SOCS3 on ES-induced epithelial repair. Immune- 
mediated diseases such as IBD are increasingly prevalent as populations adopt highly 
clean lifestyles (Elliott, Summers et al. 2007). Helminths interact with both host innate 
and adaptive immune responses activating immune-regulatory pathways dampening 
later pathways that drive aberrant inflammation (Weinstock and Elliott 2009). 
Helminth exposure can avert TNBS-induced colitis by suppressing inflammatory 
cytokines (TNFa, IL-12) or promoting the production o f immune-regulatory cytokines 
(TGFp, IL10) (Khan, Blennerhasset et al. 2002; Hunter, Wang et al. 2005). Our 
studies indirectly support other studies, suggesting exposure to helminths or their 
products can prevent or reverse colitis in animal models o f IBD. Clinical trials are 
already underway exploiting helminths as therapeutic agents to treat immune-mediated 
diseases. Principle characteristics for an ideal therapeutic helminth include, not 
multiplying within the host, have no pathogenic potential, self-limiting colonisation in 
humans and does not alter behaviour in patients with depressed immunity. T. suis is 
shown to be a safe and effective therapy in early studies o f IBD (Summers, Elliott et 
al. 2005; Reddy and Fried 2009).
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The use o f probiotics in improving health in patients with UC have also been 
demonstrated (Venturi, Gionchetti et al. 1999; Guslandi, Mezzi et al. 2000; Kruis, Fric 
et al. 2004; Tursi, Brandimarte et al. 2004; Furrie, Macfarlane et al. 2005; Karimi, 
Pena et al. 2005). One study depicting probiotics having anti-inflammatory properties 
such as, improving appearances o f chronic inflammation, decreasing TNFa and 
improving histology in TNBS models o f rat colitis (Sheil, McCarthy et al. 2004; 
Furrie, Macfarlane et al. 2005; Peran, Sierra et al. 2007). Our findings support these 
studies demonstrating microbial-induced TLR signalling is beneficial for epithelial 
wound repair. Further studies should be carried out in SOCS3 knockdown IEC, to 
ascertain whether reciprocal findings are attained, i.e. SOCS3 knockdown promoting 
TLR-induced epithelial repair.
The influence o f commensal microflora on IEC occurs in an environment that is 
highly regulated. Cessation in this controlled network o f interactions is associated with 
the onset o f IBD and cancer. Levels o f TNFa are elevated in serum and intestinal 
mucosa o f patients with IBD, with neutralization o f TNFa associated with improved 
health, particularly in patients with CD (Stillie and Stadnyk 2009, Van Dullemen et 
al., 1995, Sandborn et al., 2004). The fifth chapter o f this study involved assessing the 
effects o f IEC-derived SOCS3 upon cytokine responses following TLR stimulation. 
SOCS3 was shown to enhance microbial-induced TNFa mRNA expression. However, 
only mild increases in secreted TNFa protein were observed. Studies have suggested 
SOCS3 acts as an adaptor that facilitates ubiquitination and subsequent degredation o f 
the associated signalling molecule (Krebs and Hilton 2001; Babon, Sabo et al. 2008; 
Linossi and Nicholson 2012). Therefore, although the TNFa is transcribed (mRNA) 
and translated (protein) SOCS3 may degrade TNFa before it is secreted in the 
supernatant. Another plausible explanation could be that TNFa binds to its receptor,
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and is therefore no longer detectable in the supernatant. Western blotting has already 
been used to show SOCS3 blocks insulin signalling by ubiquitin mediated degradation 
o f insulin receptor substrates 1 (IRS 1) and IRS2 (Rui, Yuan et al. 2002). Further 
studies would also use this technique to investigate ubiquitination o f TN Fa following 
TLR ligation.
Our studies provide further evidence that SOCS3 plays a pivotal role in normal 
homeostasis and epithelial repair by demonstrating an impact on microbial induced 
intestinal epithelial responses. Moreover, the findings also support the role o f anti- 
TN Fa therapies such as infliximab, adalimumab and certolizumab being beneficial for 
mucosal healing and treating patients with IBD (Rutgeerts, Van Assche et al. 2004; 
Ghosh 2005; Assche, Vermeire et al. 2010). These findings also suggest a role o f 
modulating mucosal SOCS3 levels as a therapy, reducing secondary TNFa levels. 
Further studies should investigate the effect o f TLR ligation on TN Fa expression in 
SOCS3 knockdown IEC to determine whether observations are reciprocal to findings 
in SOCS3 overexpressing IEC.
The mechanism by which IEC are sheltered from incessant immune activation 
by commensal flora is o f great importance. Failure o f neonates to correctly 
downregulate responses to LPS appear to radically contribute to the development o f 
NEC (Jilling, Simon et al. 2006; Lin and Stoll 2006). Other studies have shown that 
following birth, neonates downregulate the expression o f IEC TLR4 becoming 
“hyporesponsive” to LPS (Levy 2007). Our findings also support other studies by 
indicating IEC become hyporesponsive to microbes by downregulating TLR4 
expression to LPS. Further studies should investigate the hyporesponsive nature o f 
other TLR, such as TLR2, TLR3 and TL5 following ligation with their respective 
ligands.
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LPS induces expression o f SOCS3 in macrophages (Baetz, Frey et al. 2004), 
data within this study also showed similar findings but in an IEC model. Furthermore, 
results also indicated pre-treatment with LPS attenuated LPS-induced SOCS 
expression making IEC hyporesponsive to LPS. An interesting observation in this 
experiment was the time-course expression profile o f SOCS3 following LPS 
stimulation, with results depicting an oscillatory pattern upon TLR4 ligation. Other 
researchers have also suggested SOCS3 behaves in a wavelike motion following 
TLR4 ligation (Yoshiura, Ohtsuka et al. 2007). Future studies would investigate the 
oscillatory behaviour o f SOCS3 further by observing SOCS3 protein expression 
following LPS stimulation. Furthermore, it would also be interesting to determine 
whether activation o f other TLR signalling pathways exhibit this SOCS3 oscillatory 
behaviour.
Regulation o f cytokine expression is important as they effect mucosal 
homeostasis, with dysregulated expression o f cytokines implicated in the onset o f 
intestinal diseases (Planchon, Martins et al. 1994; Ghosh 2005). Differentiated IEC 
which had formed monolayers were used as a model o f normal homeostasis, whereas 
proliferating IEC were used as a model to signify loss o f barrier integrity, 
characteristic o f IBD. TLR4 stimulation was shown to upregulate SOCS3 and TNFa in 
proliferating IEC; emulating observations in IBD. This indicates improper barrier 
integrity, absent in IBD elevates expression of SOCS3 and TNFa following microbial 
stimulation.TLR4 ligation was shown to promote TGFp expression in both normal and 
damaged models, supporting its role as an immuno-regulatory cytokine limiting 
expression o f other cytokines following microbial challenge. Further studies would 
assess the effect o f other TLR on SOCS3 and cytokine expression in our model o f 
normal and damaged epithelium.
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In conclusion, the work presented within this thesis suggests that SOCS3 does 
impact on TLR-induced intestinal epithelial responses associated with normal 
homeostasis and epithelial repair. Furthermore, our data supports other data indicating 
SOCS3 oscillates in expression, with overexpression impeding TLR-induced epithelial 
wound repair. The oscillatory expression o f SOCS3 must be tightly regulated allowing 
microbial-induced epithelial repair. Aberrations in the oscillatory expression o f 
SOCS3 are associated with pathological states, such as continual overexpression in 
IBD or silencing in cancer. SOCS3 overexpression is also shown to enhance the 
expression o f TNFa, a pro-inflammatory cytokine further enhancing inflammation. 
Future studies should be carried out generating SOCS3 knockdown IEC allowing 
investigation o f SOCS3 on TLR-induced IEC proliferation and epithelial wound 
repair. Additionally, primary or non-cancerous cell lines such as HIEC would also be 
used to generate SOCS3 overexpressing and knockdown IEC. The findings presented 
within this study provide a good foundation for future in vivo translational studies on 
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